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ABSTRACT
Aspects of the toxicology of bracken (Pteridium aguilinum) were studied 
in sub-acute and chronic studies using male Wistar-albino rats.
In a chronic study, bracken induced i l e a l  adenomas in an 8.5 month 
period but after 24 months, no tumours were seen in both the quercetin- and 
shikimate-fed rats.
Tissue ornithine decarboxylase (ODC) levels were enhanced over a 90-day 
test period when shikimate was fed alone or in conjunction with BBN and MNNG 
as in it ia to rs  and with cyclophosphamide, saccharin and lithochola te  as 
promoters, suggesting that shikimate might be a tumour promoter.
Quercetin, was able to enhance ODC le v e ls  in conjunction with 
cyclophosphamide, BBN and MNNG as in it ia to rs  and with cyclophosphamide, 
saccharin and lithocholate as promoters. However, i t  did not enhance tissue 
ODC levels when administered alone.
Bracken, shikimate and quercetin induced a macrocytic, normochromic, 
non-regenerative anaemia with thrombocytopenia and granulocytopenia at the 
termination of the 90-day study.
♦
The bracken-induced ataxia of monogastrics was attributed additionally 
to n it r i t e  and cyanide, due to the very high le ve ls  found in the urine and 
serum respectively of bracken-fed rats over a 28-day test period.
The high urinary n it r i t e  le ve ls  o f the bracken-fed rats prompted an 
in v e s t ig a t io n  in to  the ro le  o f  N -n itro sa tio n  in bracken-induced 
carcinogenesis. To this end, the Nitrosation Assay Period (NAP) revealed the 
presence of nitrosatable entities in the gut of the bracken-, quercetin- and 
shikimate-fed rats and in the urine of the bracken- and quercetin-fed rats. 
This suggests that nitrosation, probably via the formation of nitrosamides, 
might be an important mechanism for the mediation o f bracken-induced 
carcinogenesis.
The p la u s ib ility  o f explaining various aspects o f the sub-acute and 
chronic tox icity o f bracken in monogastrics and ruminants on the basis of a 
"nitrosamide hypothesis" is discussed.
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C H A P T E R  O N E
INTRODUCTION
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1.1 G e n e r a l
The plant, bracken fern (Pteridium aquilinum (L) Kuhn) is generally 
regarded as a single species with two subspecies - aquilinum, found in the 
Northern Hemisphere and Africa and caudatum (L) Bonap, found in the Southern 
Hemisphere. These two subspecies overlap in the West Indies and Malaysia 
(Tryon, 1941).
Others however believe that the genus actually consists of five  or six 
distinct species (Pichi-Sermolli et al., 1965; Copeland, 1947). I t  is thus 
clear that the issue at stake in the taxonomy of bracken is whether each of 
the va r ie tie s  should be treated as such or raised to a higher rank. That 
Pteridium is  a sp ec ific  genus is  however not in doubt and i t  has been 
classified  as follows:-
Division Pterophyte
Class Fern
Order F ilicales
Family Dennstaedt iaceae
Subfamily Pteridorideae
Genus Pteridium
Species Aquilinum
It  is an ubiquitous plant ranging from the Arctic c irc le  in Norway to 
the mid tropics. I t  has a preference for light acid soils, but may be found 
in woodlands, thickets, grassy places, open h illsides, peaty soils, burned 
over areas, is especially adept at taking over "abandoned ground" (Atkinson, 
1923; Tryon, 1941) and has been known to grow at areas ranging from sea 
le v e l to  700 metres in the B ritish  Is le s  and to 3,000 metres on the 
Continent.
I t  is  a perennial, ranging in height from 1 to 13 fe e t , has an 
extensive root stock system (rhizome) which enables i t  to colonise a wide 
variety of habitats speedily and ensures that i t  survives adverse weather 
conditions like drought and severe environmental influences like f ir e  (Vogl, 
1964). I t  has a stout, erect stem, it s  leaves (fronds) are broadly 
triangular with pinnules oblong in the apices o f the pinnae.
PLATE I - Bracken (Pteridium aguilinum)
PLATE I I  - Bracken (Pteridium aguilinum) 
showing how i t  colonises the undergrowth
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Apart from the creeping rhizome system which enables i t  to take up 
water and nutrients readily and in greater quantities thus depriving other 
competing plants of a means of survival, other factors responsible for its  
su rv iva l include the vast array o f chemical constituents assembled in 
bracken which ensure that i t  is protected from potential predators (Farrow, 
1917; Long and Fenton, 1938). I t  was shown that rabbits for example tended 
to consume other plants, thus ensuring the survival of bracken (Watt, 1955). 
Of a l l  the factors that ensure its  survival however the most important would 
appear to be its  ab ility  to release toxic compounds into the environment to 
re ta rd  or "smother" i t s  com petito rs . This concept recogn ised  as 
"a lle lopathy" (R ice, 1974) has being the main factor in making bracken an 
agricultural problem as well as a veterinary and public health problem.
1.2 Bracken as an Agricultural problem
. Although bracken has long been recognised as part of the native flora 
in the British Is les, i t  has become more widespread as the effects of man's 
a c t iv it ie s  have become more intensive. As the fo res t canopy has been 
removed due to increased demand for wood and space, bracken has been able to 
th rive  better since i t  has a greater spore output in open areas than in 
shaded areas (Page, 1982).
Its  ab ility  grow well in a l l  types of habitats means that there is less 
available land for agricultural purposes. In Scotland, for example, i t  is 
estimated that about 187,500 hectares o f land is bracken-infested and about 
half o f this is well drained prime agricultural land (MacLeod, 1982).
In addition, bracken-intoxicated cattle yield less milk and the milk so 
produced may be tainted and is thus rejected as unfit for human consumption 
with loss of income for the farmer (Cooper and Johnson, 1984).
1.3 Bracken as a Veterinary Problem
The drought which affected the British Isles in the spring and summer 
o f 1893 made grazing pastures fo r livestock  sparse and led to the f i r s t  
reported outbreaks o f bracken to x ic ity  in livestock  (Storrar, 1893; 
Penberthy, 1893).
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The acute c lin ico -pa th o log ic  signs in ca tt le  were described as 
hyperpyrexia (106°F-108°F), anorexia, depression, cachexia, blood stained 
faeces, bloody discharges from eyes, n os tr ils  and vulvae, la ryn g itis , 
palpitations and increased pulse and respiratory rates, slight jaundice and 
ulcerations of mucosae and udder.
Although therapy was in stitu ted  i t  was o f l i t t l e  a va il and i t  was 
believed that recovery where i t  occurred was more fortuitous rather than due 
to the effects of any medicinal treatment. In most cases death supervened.
At necropsy, the lungs were congested as were the rumen, omasum and 
abomasum, small and large intestines, with "zebra marking" of the rectum. 
There were sub-endocardial and sub-pericardial blood staining, cirrhosis of 
the liv e r , distension of the ga ll bladder, hyperaemia o f the urinary bladder 
and congestion o f the kidneys. The spleen was normal in s ize  and 
consistency as well as colour.
Attempts to isolate an infectious agent fa iled  and the only significant 
guide for the fie ld  veterinary o fficers  was the observation that the tips of 
the young bracken fronds had been bitten o ff. This led to the speculation 
that bracken might be responsible fo r th is  syndrome and opened an era o f 
intensive in ves tiga tive  a c t iv ity  to  delineate the problem o f bracken 
tox icity.
1.3.1 Bovine Studies
The reports o f Penberthy (1893) and Storrar (1893) were confirmed by 
experiments which showed that cows fed bracken developed a haemorrhagic 
syndrome (Almond, 1894).
The i n i t i a l  s tu d ies  o f  Stockman (1909; 1910) were considered 
unsuccessful because he used small quantities of bracken for rather short 
periods, but his la te r  studies reproduced the c lin ico -pa th o log ic  signs 
reported by earlier workers (Stockman, 1917; 1922). He also inferred that 
the bracken toxin was present in small amounts, required a latent period 
before i t  could exert its  effects and because of its  haemorrhagic effects, 
he also inferred that i t  was similar to abrin or ricin. He also suggested 
that it-was heat-resistan t because the e ffe c ts  o f the toxin  persisted in
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sp ite  o f the pyrexia in a ffec ted  ca ttle . A further contribution o f 
Stockman's investigations was to establish that the haemorrhagic syndrome in 
bracken-intoxicated cattle was not due to avitaminosis C.
The investigations of Shearer (1945) confirmed the c lin ico -pa th o log ic  
signs o f bracken to x ic ity  in c a tt le  and also suggested that the tannin 
content o f bracken which was found to be a catechol tannin might be 
responsible for the toxic e ffects of bracken.
Apart from experimental studies, there were observations made by 
agriculturists and other scientists which aided the understanding o f bracken 
tox icity in cattle. I t  was shown that the rhizome could be toxic (Gleeson, 
1944; Langley, 1944). Furthermore, two forms of acute bracken tox icity in 
c a t t le  were described - the en teric  form in which there is  depression, 
pyrexia, a weak pulse, e n te r it is , blood c lo ts  in the faeces and p a llid  
conjunctivae, and the la ryn g itic  form characterised by sw elling o f the 
throat region, roaring, dyspnoea, increased respiratory rates and pyrexia 
(Fletcher, 1944).
An important epidemiological observation was made by Boddie (1947) who 
noted that most of the deaths in Scottish cattle occurred amongst the cattle 
on the bracken-infested highland regions which were re lative ly  bracken-free. 
He attributed this to the H ill Cattle Subsidy Scheme of 1946 which required 
that cattle had to remain on the highlands for 16 weeks continuously for the 
owners to qualify for subsidy, prior to the scheme, many owners had brought 
th e ir c a t t le  to  the lowlands for three-weekly in terva ls  and noted that 
losses had been minimal or non-existent.
Aside from the c lin ico -pa th o log ic  aspects o f the disease in cows, 
biochemical studies revealed that bracken-intoxicated cows had lowered 
thiamine levels in their sera, an observation which was prompted by similar 
observations in rats (Evans and Evans, 1949).
Attention was also paid to the haemorrhagic syndrome in bracken 
toxicity. Naftalin and Cushnie (1951) reported that thrombocytopenia and 
leucopenia were the haematological lesions in bracken-intoxicated cows. 
However, they found that the packed c e ll volume and the haemoglobin levels 
were not affected (Naftalin and cushnie, 1956), but there was regenerative 
bone marrow damage as shown by the appearance of primitive ce lls  late in the
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course o f the disease. The persistence of the haematological syndrome in 
spite o f thiamine therapy and supplementation of the diet , with vitamin C- 
containing swedes and hay convinced them that a chemical toxin rather than a 
nutritional factor was responsible for the toxic signs observed.
.Further haematological work by Heath and Wood (1958) showed that the 
on ly s ig n i f ic a n t  fa c to r  respon sib le  fo r  the haemorrhages was 
thrombocytopenia. They found that thrombin and fibrinogen were abnormally 
high in bracken-intoxicated cows. These workers also in ferred  that the 
leucopenia might be ' responsible for the profuse bleeding seen in bracken- 
intoxicated calves. This process might work through the proteolytic action 
of plasminogen activators produced by amongst other tissues and c e ll types, 
leucocytes.-These would s p lit  peptide linkages in fibrinogen and fib r in , 
thus promoting the lys is o f clots. This process is however not necessarily 
dependent on the number o f leucocytes as on the type and nature o f the 
leucocytes, in th is  regard they likened bracken to x ic ity  to radiation 
sickness. In so doing they were to  open’ an en tire  new area o f the 
toxicology of bracken - the possible carcinogenicity of bracken.
1.3.2 Equine studies
The to x ic ity  o f bracken to horses was reported by Muller (1897), 
Chesnut and Wilcox (1901) and Pott (1907) but the experimental work o f 
Hawden and Bruce (1917) was the f i r s t  demonstrated proof that the disease 
called "Equine staggers" was due to the ingestion of bracken. The clin ico- 
pathologic signs of acute bracken tox icity in the horses were progressive 
incoordination, hard breathing, papillary dilation, loose faeces and rapid 
pulse. At necropsy the brain was apparently congested as were the kidney 
cortices, but there were no other significant gross pathological lesions.
Further studies reproduced the clinico-pathologic signs and in addition 
blood thiamine was observed to drop s tead ily , pyruvate to  rise  s tead ily , 
leucocytosis to occur early  in the course o f the disease but to return to 
normal la te r , eosinopenia occurred during the staggering episodes and 
thrombocytopenia occurred but were reversed by thiamine therapy (Evans et 
a l., 1951).
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At necropsy, th ere  were tym p an itis , congestion  o f the l i v e r ,  
petechiations of the spleen, excessive pericardial effusions, petechiations 
of the myocardium, a flabby right ventricle, congested kidneys, and bruising 
and oedema of the sciatic nerve.
Histopathology revealed degeneration o f the Purkinje fib res  and 
disappearance o f their nuclei.
The key symptom o f bracken to x ic ity  in the horse is  neurological and 
the equine staggers can be corrected by thiamine therapy giving rise to the 
hypothesis that bracken contains a thiaminase or "antithiamine factor".
1.3.3 Ovine Studies
The report o f a suspected case o f bracken to x ic ity  in sheep in New 
Zealand (Hickman, 1910) was regarded with scepticism. Other reports however 
fo llow ed, indicating that though sheep were susceptible to bracken, they 
were more resistant than cattle {Sampson and Malmstcn, 1935; Perkins, 1950; 
Foggie, 1951).
I t  was however, the experimental studies o f Moon and Raafat (1951a) 
which showed conclusively that sheep developed signs upon ingesting bracken 
similar to those of cattle  intoxicated by bracken. Sheep developed pyrexia 
(104°C), fo e t id ,  b lood -s ta in ed  faeces  and at necropsy there were 
petechiations o f the gut, kidneys, spleen and heart. The lungs had a 
purple mottled appearance.
In the bracken-infested North York moors, sheep involved in an outbreak 
had leucopenia and thrombocytopenia, blood-stained faeces, hyperpyrexia 
(102.4°F - 106°F) and at autopsy there were haemorrhages in the stomach, 
small and large intestines, on the myocardium, spleen, kidneys, subcutis and 
serosa (Parker and McCrea, 1965).
Another sign seen in bracken-intoxicated sheep was progressive 
retinopathy or "bright blindness" (Watson et al., 1965). This sign has also 
been confirmed by a subsequent report, which also indicated that the lactate 
dehydrogenase levels in the retinae of bracken-intoxicated sheep were lower 
than in unaffected sheep (Watson et al., 1972).
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When the bracken rhizome which is more toxic than the fronds was fed to 
sheep they developed ataxia in addition to leucopenia, thrombocytopenia and 
lowered blood pyruvate. When treated with thiamine, they responded 
dram atically but i f  l e f t  untreated, they developed cereb ro-cortica l 
necrosis. I t  was concluded that the antithiamine factor which was found in 
greater quantities in the rhizome than the fronds was responsible for this 
lesion  (Evans et a l., 1975).
The c l in ic a l pathologic p icture o f bracken to x ic ity  in sheep would 
therefore include progressive retinopathy, bone marrow aplasia resulting in 
a haematological syndrome, and cerebro-cortica l necrosis probably due to 
avitaminosis B^ .
I t  would however appear that sheep are less susceptible to bracken 
toxicity than cattle. The reason for this is uncertain, but i t  may be due to 
a more discerning eating habit in sheep than c a tt le  which enables them to 
avoid bracken more easily.
1.3.4 Porcine Studies
Although Forsyth (1954) reported that bracken tox icity in pigs was due 
to eating fronds and not the rhizomes, that report has never been 
corroborated. Attempts to  induce bracken to x ic ity  in pigs with bracken 
fronds have been in e ffe c t iv e  while pigs fed the rhizome developed 
avitaminosis B ,^ elevated blood pyruvate, anorexia and listlessness but not 
leucopenia nor thrombocytopenia. There was however a drop in reticulocytes 
which was corrected by the in s titu tion  o f thiamine therapy, and i t  was 
inferred that thiamine played a central role in red blood c e ll formation in 
monogastrics. I t  is  noteworthy that though the thiamine le v e ls  dropped, 
there was no ataxia or nervous degeneration. At necropsy the heart was 
mottled and dilated, the lungs oedematous, the trachea frothy and the ga ll 
bladder enlarged (Evans et al., 1963; Evans et al., 1972; Harding, 1972).
I t  would thus appear that though pigs are highly susceptible to the 
antithiamine factor in bracken they do not develop haematological changes. 
This ra ises the p o s s ib il ity  o f two d is tin c t poisons in bracken - the 
antithiamine factor which in monogastrics would induce ataxia and the bone
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marrow toxin which in ruminants and monogastrics would induce bone marrow 
depression. Further studies were required to c la rify  these issues and these 
were to be done in laboratory animals. •
1.4 Laboratory Animal Studies
The advantages o f using laboratory animals for toxicological studies 
l ie  in the cost, reproducibility and speed with which studies can often be 
carried out.
The clinico-pathologic signs of feeding bracken to rats were anorexia, 
ataxia and bone marrow damage resu lting in a haemorrhagic syndrome. 
Biochemical analyses revealed low tissue thiamine le v e ls , high blood 
pyruvate and a dysfunction o f thiamine pyrophosphate dependent enzymes. 
There were thrombocytopenia and leucopenia when black rats were used and at 
necropsy, there was atrophy of the hair fo llic le s , • epidermis and sebaceous 
glands. These signs could not be reproduced when autoclaved bracken was 
used suggesting that the bracken toxin was susceptible to heat (Weswig et 
a l., 1946; Evans and Evans, 1949; Nafta lin  and Cushnie, 1951; Cordy, 1952). 
I t  was shown by Evans and Evans (1949) that 0.1 mg thiamine administered 
subcutaneously a lle v ia ted  the c l in ic a l and pathologica l signs o f bracken 
tox ic ity  in the rat.
1.5 The Treatment of Bracken Toxicity
From the earliest reported cases o f bracken tox icity, i t  was imperative 
that a means of c lin ica l management had to be devised in order to minimise 
losses in livestock. However, the lack of certainty as to the nature of the 
poison proved an obstacle and made attempts at therapy largely unsuccessful 
(Storrar, 1893; Fletcher, 1944). The view was taken by Stockman (1917) that 
preventative rather than therapeutic measures would be a better way o f 
controlling bracken toxicity.
• Thiamine therapy was however useful especially with regard to cases in 
horses, rats, pigs and i f  administered early, to sheep (Evans et al., 1951; 
Ueda et a l., 1950; Carpenter e t a l,, 1950; Evans and Evans, 1949; Cordy, 
1952; Evans, 1976; Harding, 1972). However, once "bright blindness" had
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developed in sheep along with cerebro-cortical necrosis, thiamine therapy 
was useless. Combined ‘an tib io t ic  - DL batyl alcohol therapy was also 
attempted with some success (Evans et al., 1958).
When i t  was observed that bracken to x ic ity  led to the release of 
histamines and other amines and factors indicative of a strong immunological 
involvement, corticosteroid therapy was attempted with some success (Evans, 
1968)'.
However, the best approach to the bracken problem is preventative and 
eradication of bracken would be a useful adjunct to this as well as denying 
livestock access to bracken infested areas.
In attempting to achieve eradication of bracken, the herbicide, asulam 
(methyl 4-aminobenzene-sulphonyl carbamate) has been the most effective. 
Ploughing is usually d i f f ic u lt  because o f the terra in  and the extensive 
rhizome is further certain to frustrate efforts in this direction. Burning 
is equally ineffective due in part to spore-formation (Holroyd, 1971), and 
the extensive underground rhizome.
1.6 The Carcinogenicity of Bracken
The acute tox icity of bracken is characterised by bone marrow aplasia 
resulting in leucopenia and thrombocytopenia. In addition, primary damage 
occurs in the in tes tin a l mucosa (Evans et a l., 1951, 1954? Nafta lin  and 
Cushnie, 1951, 1954).
These observations led workers to suggest that the bracken toxin was an 
antimitotic agent acting at the sites of the most rapid c e ll division - the 
gut and bone marrow. I t  is possible to envisage a mechanism of action for 
the toxin which simultaneously affects the bone marrow and the intestinal 
tract which is then manifested as a haemorrhagic syndrome. The depression 
o f the bone marrow would lead to a reduction in the vascular system of the 
formed elements o f blood while the destruction o f the gut mucosa which 
contains large amounts o f serotonin would lead to lack o f ca p illa ry  
stab ility  with resulting extravasation of blood.
This mode o f action is  id en tica l to category 3 o f the radiation 
syndrome (Table 1.1) (Evans et a l., 1958; Heath and Wood, 1958; Schultze et 
a l., 1959; Brown et a l., 1961; Brown, 1962; Evans, 1968).
I t  would be expected that i f  bracken to x ic ity  was lik e  the radiation 
syndrome, appropriate doses o f the bracken toxin administered over an 
appropriate period would eventually result in category 4 of the radiation 
syndrome - that is eventually result in cancer (Table 1.1).
That the bracken toxin was carcinogenic was confirmed by a report which 
showed that a fte r  feeding f iv e  cows on green as w ell as dry bracken, four 
developed haematuria and "changes o f a polypous-tumorous nature" in th e ir 
urinary bladders (Rosenberger and Heeschen, 1960).
This report led various workers to begin in vestiga tive  work on the 
possible carcinogenicity o f bracken.
1.6.1 Bovine Studies
The finding of haematuria and bladder tumours in cows from the bracken- 
infested Bolu D istrict o f Turkey was thought but not conclusively proved to 
be due to bracken (Pamukcu, 1963). This condition, called enzootic bovine 
haematuria (EBH) was thought to be due to a variety o f aetiological agents 
of which bracken was to prove to be the most likely.
Other studies soon reproduced the symptoms o f EBH, haemangiomas, 
papillomas and haematuria in the bladders of cows fed bracken (Sofrenovic et 
a l., 1965; Rosenberger, 1965; Pamukcu et a l., 1967; Price and Pamukcu, 
1968).
These observations would suggest that bracken is carcinogenic, with the 
bladder and the small intestine being the target organs.
They also suggest a role for bracken in EBH but as w ill  be seen, i t  was 
probably not the only causative factor of EBH.
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Enzootic bovine haematuria (EBH) is  a chronic, non-infectious disease 
of cattle, characterised by the development o f haemangiomatous lesions of 
the wall o f the urinary bladder and c lin ica lly  by haematuria resulting in 
anaemia and death (Blood et al., 1979). I t  is ubiquitous in occurrence but 
in each case, i t  is  res tr ic ted  to sp ec ific  areas and is enzootic in nature 
(Figure 1.1).
The aetio logy  o f EBH has been the subject o f much investigation  but 
even now remains undecided. The in it ia l aetiological factor was thought to 
be nutritional but this .was not supported by experimental evidence unlike 
the other aetiological factors such as non-specific irritations (mechanical, 
mycotic or to x ic ), tox ic  plants (oak, ash, p r ive t, hornbean, hazel, dog- 
berry, pine and fern ), trauma due to f i la r ia ,  distoma or pentastomes, 
coccidia and bacteria.
The possib le bacter ia l aetio logy  was examined but the fa ilu re  to 
isolate any bacteria from the urine and internal organs of the early cases, 
and the failure to reproduce the disease by injecting the urine and blood of 
a ffec ted  cases into experimental cases eventually led to the b acter ia l 
aetiology being considered implausible (Hawden, 1917).
The finding of adult Schistosoma japonicum in the bladder of two cases 
in Formosa suggested that Schistosoma spp. may have a role in the causation 
of EBH but fiv e  other cases had no Schistosoma in their bladders (Ichikawa, 
1922).
Oxalic acid has been suggested as a cause o f EBH. I t  was reproduced 
both by ora l drenching and by in jection  o f oxa lic  acid into the urinary 
bladder, the oxa lic  acid being in the form o f calcium oxalate (Hawden, 
1917). This work is supported by the knowledge that the c lin ica l signs of 
oxalate poisoning in cattle include haematuria and bloody nasal discharges 
(Blood et a l., 1979).
The feeding o f the oxalate-containing plants psicaulon absim ile to 
rabbits fa iled  to reproduce the disease (Rimington and Steyn, 1933) as did 
not the feeding o f Oxalis cernua to sheep (Bull, 1929) nor the feeding o f 
Rumex acetosa to cattle (Craig and Kehoe, 1921).
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The oxa la te  theory  o f  Hawden (1917) was not corrobora ted  by 
experimental evidence. I t  has been suggested that in the area o f Canada 
where Hawden's observations were made, there are not many oxalate containing 
plants. I t  may be that he was able to produce signs iden tica l to  EBH 
because o f very high doses o f oxa lic  acid which he used, which would not 
occur in a natural situation. The oxalate theory of EBH causation is also 
implausible.
Observations from Austra lia  that phosphorus and manganese deficiency 
occurred in areas o f high EBH incidence tended to support a chemical 
defic iency theory o f the causation o f EBH (Bull et a l., 1932). E arlier 
however, blood analysis fa iled to show any chemical or dietary deficiencies 
(F lem ing e_t a l . ,  1930). I t  is  p la u s ib le  to  suggest that d ie ta ry  
deficiencies resulting in certain chemical deficiencies would aid the course 
o f any disease but i t  is  unlikely that EBH is  caused by manganese and 
phosphorus deficiency acting on their own.
A protozoan parasite belonging to the genus Entamoeba isolated from the 
urine o f EBH cases was suggested as the cause of the disease (Datta, 1934). 
In later reports however i t  was reclassified as Aspergillus and was thought 
to exist in a symbiotic relationship with lichens and bracken (Datta, 1952; 
1953). Thus i t  appears that the organism is merely an incidental finding 
and that bracken is the real cause of EBH.
The observation in Turkey that haematuria occurred mainly in the 
bracken-infested d istricts would suggest that i t  was the main cause o f EBH 
(Pamukcu, 1955). Further reports seemed to confirm bracken as the main and 
most consistent factor in a l l  cases o f EBH either observed in f ie ld  
conditions and ju s t if ie d  ep idem iologica lly  or reproduced experimentally 
(Rosenberger and Heeschen, 1960; Pamukcu, 1963; Sofrenovic et al., 1965).
The p o s s ib ility  that other factors may co-operate with bracken to 
produce the disease has not been ruled out espec ia lly  in the ligh t o f the
report of Jarrett et al. (1978) which suggests that a papilloma virus might
 ^ t< | also be implicated. This virus had e^lier been considered a passenger virus
not centra l to  the causation o f the disease (Olsen e t  a l., 1965) but
recently a bovine papilloma virus, BPV-2, has been iso la ted  from urinary
bladder neoplasms associated with EBH (Lancaster and Olsen, 1982; Jarrett,
W.F.H., c ited  by Hopkins, 1986). Although BPV-2 is associated with benign
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lesions, i t  is  thought that the fibropapillom a so caused may progress to 
malignancy to  form carcinomas due to  the e ffe c ts  o f  a va r ie ty  o f 
environmental and genetic stim uli o f which bracken may be one (smith and 
Campo, 1985).
Thus the main a e t io lo g ic a l agent of EBH is  bracken but other factors 
might contribute to the course and prognosis o f the disease, that is, there 
is a multifactorial causation of EBH.
1.6.2 Ovine Studies
Although bracken had been linked to sheep tumours (Dodd, 1960? McDonald 
and Leaver, 1965? McCrea and Head, 1978) i t  was the experimental work of 
McCrea and Head (1981) that demonstrated th is conclusively; In the f ie ld  
cases which they reported (McCrea and Head, 1978) they found fibrosarcomas, 
fibropapillomas* a squamous c e l l  papilloma, squamous c e l l  carcinomas, 
adenocarcinomas, primary carcinomas, a lymphosarcoma and a thymoma, compared 
to  th e ir  experim en ta l cases where t r a n s it io n a l c e l l  carcinom as, 
fibrosarcomas and one rumen papilloma were found. Furthermore the f ie ld  
cases did not show any bladder involvement while the'experimental cases did 
and they concluded that other factors such as the l iv e r  fluke might have 
added to the wide va rie ty  o f tumour types seen in the' f ie ld  cases. The 
a b il i t y  o f the l iv e r  fluke, Fasciola to act as a tumour promoter has been 
demonstrated by Flavell and Lucas (1982, 1983K The louping-ill virus, and 
the papilloma virus were also considered to be contributory factors to the 
wider va rie ty  o f tumours seen in f ie ld  cases compared to those in the 
controlled experimental situation.
1.7 Laboratory Animal Studies
The reports o f carcinogenicity due to bracken in livestock could only 
be confirmed by using.large numbers o f animals. Laboratory animals were 
ideal for this purpose.
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1.7.1 Studies in Rats
The carcinogenicity of bracken has been demonstrated in rats by various 
studies which showed that i l e a l  adenocarcinomas, adenomas and sarcomas, 
bladder papillomas, sess ile  or pap illa ry  carcinomas, tran s ition a l c e l l  
carcinomas, adenocarcinomas, fibromas, leimyosarcomas and haemangiomas, 
mammary adenosarcomas and fibroadenomas as well as hyperplastic live r foci 
could be induced in rats by feeding bracken-containing diets (Mason, 1965? 
Evans and Mason, 1965? Price and Pamukcu, 1968? Pamukcu and Price, 1969? 
Schacham et a l., 1970; Pamukcu et a l . , 1970, 1971, 1976; Hirono et a l . , 
1970, 1972, 1973, 1983, 1984a? Yunoki et. a l . , 1973? Kawai et a l., 1981? 
Yoshikawa et a l., 1981? Erturk et a l., 1983).
The ileum was the most common s ite  of bracken induced tumours in rats 
followed by the urinary bladder. The involvement of the mammary glands and 
liver have been shown in isolated reports.
1.7.2 Studies in Mice
The bracken-induced tumours o f mice include pulmonary adenomas and 
adenocarcinomas, urinary bladder carcinomas, intestinal carcinomas, gastric 
carcinomas, hepatomas and leukaemias (Evans and Widdop, 1966; Evans, 1968? 
Evans et a l., 1968, 1969; Pamukcu et a l., 1972, 1977? Jones, 1.974; Miyakawa 
and Yoshida, 1975? Hirono et a l . , 1975).
1.7.3 Studies in the Quail (Coturnix coturnix japonica)
Adenocarcinomas o f the caecae, colon and ileum were observed in 
Japanese quail fed an active  bracken extract (Evans et a l., 1967? Evans, 
1968).
1.7.4 Studies in the Hamster
Caecal and i le a l  adenocarcinomas were found in four o f twenty-four 
Syrian Golden Hamsters fed a 30% by weight bracken diet (Evans, 1968? Kawai 
et a l., 1979).
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1.7.5 Studies in the Guinea-Pig
Bracken-intoxicated guinea-pigs developed haematuria, accompanied by 
carcinomas and in filtra tin g  adenocarcinomas of the urinary bladder. In some 
cases intestinal adenocarcinomas developed (Evans et al., 1967; Evans, 1968) 
(Appendix I; Appendix I I ) .
I t  is pertinent at this stage to summarise the species differences with 
regard to the to x ic ity  o f bracken. The simple-stomached animals lik e  the 
horse, pig and rat develop a neurological ataxia after 28 days on a bracken 
d ie t. This ataxia syndrome has been attributed to  the destruction o f 
thiamine in the monogastrics by the enzyme thiaminase found in bracken.
In the ruminants, however, an exogenous source o f thiamine is  not 
essen tia l as they are able to  synthesise thiamine from the ir rumen 
■microflora. Although they have succumbed to an avitaminosis syndrome due 
to feeding o f bracken rhizomes, the symptoms were not those o f a 
neurological ataxia but cerebrocortical necrosis.
• Both the neurological ataxia o f monogastrics and the cerebrocortical 
necrosis of ruminants respond to thiamine therapy.
Furthermore, there is a haematological syndrome which manifests as part 
of the acute tox icity of bracken in the ruminants (though less severely in 
sheep). The monogastrics are however less susceptible to the bone-marrow 
toxin which affects the ruminants more readily. I t  is thought that the bone 
marrow toxin is different from thiaminase.
The chronic toxicity of bracken in both monogastrics and ruminants is 
the production o f a va rie ty  of tumours, so far, however, no tumours have 
been reported in pigs and horses.
I t  is  also not certain  i f  i t  is  the same toxin that produces the bone 
marrow damage and the tumours.
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1.8 Factors influencing t h e  Carci n o g e n i c i t y  o f  Bracken
1.8.1 Phytomerical and Ecological Factors
Comparative studies showed that the curled tops of young bracken had 
more potent carcinogenic activ ity  than the stalks, and the carcinogenicity 
of the rhizomes was greater than that of the fronds. In addition, the young 
frond was more carcinogenic than the mature plant. The rats on a d ie t o f 
mature bracken had a longer latent period before induction o f cancer than 
those on a d ie t o f young bracken. Furthermore, the young fronds tended to 
induce adenocarcinomas while the mature fronds tended to induce adenomas in 
the ileum, but rats fed the mature bracken tended to have more urinary 
bladder tumours than those fed the young frond (Hirono et al., 1973; Pamukcu 
et a l., 1977).
The geograph ica l lo c a t io n  o f the bracken a lso  in flu en ces  i t s  
carcinogenicity (Hirono et al., 1972).
1.8.2 The Effects of Animal Models on Carcinogenicity
The age, species and strain  o f laboratory animals used for bracken 
carcinogenicity tests have an effect on the nature o f the tumours produced.
Young animals appear to be more susceptible than older animals (Evans, 
1968), F344 rats had a higher tendency to produce bladder tumours (96%) when 
fed bracken than did Sprague Dawley rats (46%) (Erturk et a l . , 1983), 
C57B1/6 mice tended to develop jejunal tumours when fed bracken but Swiss 
mice tended to develop pulmonary adenomas and it  would appear that mice are 
more susceptible to the haematological disorders induced by bracken than are 
rats. Whereas leukaemias have been found in mice they have not been 
reported in rats (Pamukcu et al., 1972).
Neither the sex o f the animal nor presence, absence or nature o f the 
gut f lo r a  are thought to  be o f  s ig n if ic a n c e  in bracken-induced 
carcinogen icity (Sumi et a l., 1981). This is  in contrast to the bracken 
constituents, quercetin and shikimate whose metabolism is strongly dependent 
on the presence or absence and nature o f the gut f lo ra  (Nakagawa et a l., 
1965; Brewster et a l., 1978).
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1.8.3 C h e m i c a l s  a n d  D r u g s  aff e c t i n g  Bra c k e n  C a r c i n o genicity
When bracken-fed rats were given thiamine at 2 mg per rat per week, the 
incidence of urinary bladder tumours was higher than for rats fed bracken 
only (Pamukcu et a l., 1970b). The explanation put forward by the authors 
that thiamine a ltered  the absorption, d istribu tion  and metabolism o f the 
bracken carcinogen may be plausible i f  the role of thiamine with respect to 
the metabolism of some bladder carcinogens and bladder tumour promoters is 
considered. Some tryptophan metabolites lik e  xanthurenic acid and 
kynurenine produce bladder carcinoma in mice (A llen  et a l., 1957). These 
m etabolites are part o f the kynurenine pathway o f tryptophan metabolism. 
The f ir s t  step in this reaction in which tryptophan is converted to N-formyl 
kynurenine requires thiamine as a co-factor fo r the enzyme tryptophan 
pyrrolase (Dalgleish, 1955). In the absence of thiamine these metabolites 
are not produced (Dalgleish, 1955). Thiamine supplementation may therefore 
promote the production of these bladder carcinogens.
Phenothiazine reduces the incidence o f both urinary bladder and 
in tes tin a l tumours in bracken-fed rats (Pamukcu et a l., 1971). They 
suggested that th is  action might be due to the induction o f the mixed 
function oxidase system by phenothiazine resulting in the detoxification of 
the bracken carcinogen. They also suggested a d irect inh ib itory e f fe c t  of 
phenothiazine on the carcinogen. Another explanation could be the cathartic 
action o f phenothiazine which reduces the residence time o f the bracken 
carcinogen in the gut. This explanation is supported by the work of Hirono 
et al. (1977b) which showed that bracken-induced tumours tended to appear in 
the parts of the gut most prone to intestinal stasis.
The antioxidants, d isu lfiram  and butylated hydroxyanisole have been 
shown to in h ib it bracken-induced carcinogenic activ ity  in the intestinal 
tract probably via  a mechanism that prevents au tox id a tion , w h ile  
polyvinylpyrrolidone and calcium chloride were shown to reduce the incidence 
of bracken-induced bladder cancer possibly by forming insoluble complexes 
with the tannins and flavonoids in bracken (Pamukcu et al., 1977).
N itrite  and nitrate supplementation increased the incidence of urinary
bladder tumours in bracken-fed rats (Erturk et a l., 1974). I t  may be that
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this was mediated via the formation o f N-nitroso compounds.
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F in a lly , i f  bracken is  boiled  with wood ash, sodium bicarbonate and 
sodium chloride, its  carcinogenic potency is reduced (Hirono et al., 1972).
The increased' a lk a lin ity  o f the in te s tin a l tract due to the feeding o f
bicarbonate was suggested as the factor responsible fo r the reduced 
intestinal tumours. However, the incidence of bladder tumours in bicarbonate 
fed rats increased (Erturk et al., 1974? Pamucku et al., 1977).
These studies on the effects of various chemicals on the incidence of
tumours in bracken intoxicated animals lead to some conclusions about the 
nature and mechanism o f action o f the bracken carcinogen. The e f fe c t  o f 
phenothiazine would be to  suggest that the bracken carcinogen may be 
metabolised via a pathway dependent on cytochrome p450 but in the same vein, 
the possib ility of a purely physical e ffect in which contact time between 
carcinogen and organ is reduced has to be considered. A possib ility which is 
reinforced by the e ffect o f calcium chloride and PVP.
‘ The effects o f the antioxidants BHA and disulfiram are suggestive of a 
ro le  fo r the process o f autoxidation as one o f the possib le mediating 
mechanisms for bracken carcinogenesis, raising the p o s s ib ility  o f the 
involvement of free radicals. This possib ility is reinforced by the work of 
Evans (1968) which reveals the presence of immunologically active ce lls  in 
the tissues including those with phagocytic activ ity  believed to involve the 
release of free radicals. Antioxidants such as BHA act to interrupt the free 
rad ical chain o f oxidative reactions by contributing hydrogen from the 
phenolic hydroxyl groups, and in the process forming stable free radicals 
which do not in itia te  nor propagate further oxidation of lipids.
The ro le  o f n it r i t e  and n itra te  and the suggested im plication  o f N- 
n itrosation  as another possib le mechanism for the mediation o f bracken 
carcinogenicity is an important point in bracken carcinogenesis.
By far the most important point illu s tra ted  by these apparently 
d isp ara te  p o s s ib i l i t i e s  is  the complex nature o f  bracken-induced 
carcinogenesis and the possib ility that there is a multifactorial causation 
of disease in bracken-induced toxicity. The various aetiological factors or 
mechanisms may. en ta il a ro le  for free  radicals and autoxidation-, fo r N- 
nitrosation and N-nitroso compounds, and a role for the anti-thiamine factor 
and an alteration of the metabolism o f tryptophan.
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I t  also illustrates the d ifficu lty  entailed in making firm comments on 
the mechanism of bracken carcinogenesis without knowing the identity of the 
bracken carcinogen.
1.9 The Teratogenicity o f Bracken
When pregnant ICR-JCL mice were fed a 33% bracken d ie t, there was 
weight loss, intra-uterine growth suppression and retarded ossification of 
the sternebrae (Yasuda et a l., 1974). In C57BL/6 mice there was an 
increased frequency of abortions (Fushimi et al., 1973).
1.10 Bracken as a Public Health Problem
In some parts of Europe, the bracken rhizome was ground and baked into 
bread for human consumption (Medsger, 1939), while in North America, the 
Indians o f the p a c ific  coast used i t  fo r food a fte r  bo ilin g  in water. In 
New Zealand, the Maoris used i t  for food a fte r  treating i t  s im ila r ly . In 
Japan, where the stalks and fronds are processed for human consumption by 
immersion in boiling water containing wood ash or sodium bicarbonate or by 
p ick ling in sa lt and immersion in b o ilin g  water (Anon., 1943; Fernald and 
Kinsey, 1943; Anon., 1967; Shawcross, 1967; Evans, 1976; Hirono et a l., 
1972; Sugimura, 1976; Pamukcu et a l . , 1977), i t  was one o f the factors 
identified as responsible for increasing the re la t iv e  risk to oesophageal 
cancer (Hirayama, 1979). In Norway and Siberia, the stalks and fronds were 
fermented into beer (Harrington, 1967).
The other source of public health hazard is the consumption of milk and 
milk products from cows grazing in bracken-infested f ie ld s . The milk of 
bracken-fed cows was mutagenic to Salmonella typhimurium TA100, and also 
induced intestinal, renal and urinary bladder carcinomas in rats (Pamukcu et 
a l., 1978).
The p o s s ib l i t y  o f ra in  leach ing bracken carcinogens in to  the 
underground water supply from the bracken-infested areas has also been 
suggested (Boyland, 1967; Evans et al., 1971).
22
Another p o s s ib ility  recently raised is  the carcinogen icity o f the 
bracken spores, which upon inhalation may pass through the alveoli into the 
stomach and possibly cause stomach cancer (Evans, I.A. in press).
The geographical corre la tion  between human oesophageal and gastr ic  
cancers, EBH and acute bracken poisoning is illustrated in Figure 1.1.
1.11 The chemical Composition of Bracken
Interest in the chemical composition of bracken arose from its  observed 
tox icity to livestock and the potential public health hazard which i t  may 
pose.
Some of the chemical constituents of bracken have no known direct toxic 
e f fe c t  on livestock  but may aid the plant to  survive in a wide va rie ty  o f 
environments.
The constituents o f the plant known to be o f some b io lo g ic a l 
significance include an antheridogen (Pringle et al., 1960) and the insect 
hormones ecdysone and 20-hydroxyecdysone (Kaplanis et a l., 1967). The 
presence of a thiaminase has also been reported. This enzyme, the f ir s t  of 
its  kind to be reported in the plant kingdom, is concentrated in the rhizome 
although the fronds contain some also. I t  is considered responsible for the 
neurological signs seen in bracken-fed monogastrics and the cerebro-cortical 
necrosis o f sheep (Evans and Evans, 1949; Weswig et a l., 1946; Hawden and 
Bruce, 1933; Evans et a l . , 1950, 1952; Evans et. a l., 1951; Evans et a l., 
1972, 1975; Watkin et a l., 1953; Thomas et a l . , 1957; Harding, 1972; 
Kelleway and Geovjian, 1978; Ueda et al., 1950).
Although the cyanogenic glycoside, prunasin is a constituent o f bracken 
(Kofod and Eyjolfsson, 1966; Cooper-Driver and Swain, 1976) i t  has not been 
ascribed any toxic effects in livestock (Moon and Raafat, 1951b). However, 
i t  has been suggested that i t  plays a role in predator prevention (Cooper- 
Driver and Swain, 1976).
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1.12 The Carcinogenic Constituent(s) of Bracken
Greater attention has been paid to the nature and id en tity  o f the 
bracken carcinogen. To th is end various groups o f compounds have been 
extracted from bracken and tested for carcinogenic activ ity  in a variety of 
animal models and c e ll systems. Bracken isolates that have been considered 
for their carcinogenic potential include flavonoids, terpenoids, tannins and. 
phenolic acids (Appendix I I I ) .
1.12.1 The F lavo n o id  C o n stitu en ts  o f Bracken
Flavonoids are secondary plant constituents, very widely distributed in 
ferns. The flavonol glycosides, kaempferol-3-glycoside (a s tra ga lin ), 
quercetin-3-rhamnoglucoside (rutin), quercetin-3-glucoside (isoquercitrin), 
kaempferol-3-p-coumaryl glucoside ( t i l i r o s id e ) , 3,3',4',5,7-pentahydroxy- 
flavone (quercetin) and its  glycosidic derivative, quercitrin, have a ll  been 
iso la ted  from bracken (Nakabayashi, 1955; Wang et a l., 1973; Pamukcu and 
Bryan, 1979? Pamukcu et al., 1980b).
T iliroside was tested for carcinogenic activ ity  in Swiss albino mice by 
intravesical instilla tion  but the results were negative (Wang et al., 1976) 
as were mutagenicity tests  with Salmonella typhimurium TA 98 and TA 100, 
with or without the s-9 activa tin g system. However, a fte r  pre-incubation 
with hesperidinase, the released aglycone, was mutagenic to both S. 
typhimurium TA 98 and TA 100 in the presence o f the s-9 mix (Nagao et a l., 
1981).
Rutin was not mutagenic in the Ames' test using s. typhimurium TA 98, 
TA 100, TA 1535, TA 1537 and TA 1538 (Brown and D ietrich , 1979). , Upon 
hydrolysis by glycosidase however, i t  is activated to a mutagenic compound, 
quercetin (MacDonald et a l . , 1983; Nagao et a l., 1981). I t  was negative in 
the micronucleus test using male Swiss mice (Sahu et al., 1981) and was not 
•carcinogenic when tested as a 10% diet in male and female non-inbred golden 
hamsters (Morino et al., 1982).
Isoquerc itrin  was non-mutagenic to  S. typhimurium TA 98 and TA 100 
except when pre-incubated with hesperidinase (Nagao et al., 1981).
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Astragalin  was also non-mutagenic to S. typhimurium TA 98 and TA 100 
both with and without the S-9 mix, but on incubation with hesperidinase i t  
was mutagenic to typhimurium TA 98 and TA 100 with s-9 activation.
Although kaempferol was mutagenic to S. typhimurium TA 98 and TA 100 
with S-9 activation  (Sugimura et al.,1977; Hardigree and Epler, 1978; 
MacGregor and Jurd, 1978; Nagao et a l., 1981) to typhimurium TA 1537 
(Brown and D ietrich , 1979), to V79 Chinese hamster c e lls  (Maruta et a l.,
1979) and was positively clastogenic in the micronucleus test (Sahu et al., 
1981) i t  was not carcinogenic when fed as a 0.04% diet to Fischer 344 (F344) 
rats for 540 days (Takanashi et a l . , 1983).
Quercetin is mutagenic to Salmonella typhimurium TA 98 (Hardigree and 
Epler, 1978; Seino et a l., 1978) to TA 98 and TA 100 (Bjeldanes and Chang, 
1977? Sugimura et a l . , 1977; MacGregor and Jurd, 1978? Nagao et a l., 1981) 
to TA 98, TA 100, TA 1537 and TA 1538 (Brown and D ietrich , 1979) without 
activa tion  with the S-9. I t  was clastogenic to male mice (Sahu et a l.,
1981), weakly mutagenic to  Escherichia c o l i , Saccharomyces cerev is iae  
(Hardigree and Epler, 1978) and Drosophila melanogaster (Watson, 1982), but 
non-mutagenic to Bacillus subtilis (MacGregor and Sacks, 1979). I t  was also 
mutagenic to V79 Chinese hamster ce lls  (Maruta et al., 1979) and genotoxic 
to Chinese hamster ovary (CHO) ce lls  (MacGregor et al., 1980? Carver et al., 
1983). I t  induced single-strand breaks in the DNA of mouse lymphoma L5178Y 
c e l ls  (Meltz and MacGregor, 1981) as w ell as a dose-dependent increase in 
sister chromatid exchanges (SCE) in cultured human lymphoblastoid NL3 ce lls  
(Sugimura, 1979), HE 2144 human fibroblasts, Don-6 and B-131 Chinese hamster 
fibroblasts and human lymphocytes (Yoshida et al., 1980).
I t  is  non-teratogenic (W illh ite , 1982) but it s  carcinogen icity is  a 
more equivocal issue. Although some authors claim that i t  is  a urinary 
bladder, intestinal and liver carcinogen (Pamukcu et al., 1980b? Erturk et 
a l . , 1983), others report no such a c t iv ity  (Ambrose et a l . , 1952? Morino et 
a l . , 1982? Takanashi et a l . , 1983). The varying resu lts from d iffe ren t 
workers led others to suggest that i t  might act as an in itia tor or promoter 
of carcinogenesis (Kato et al., 1983? Fukushima et al., 1983; Hirose et al., 
1983).
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Quercetin has a widespread occurrence in the plant kingdom some o f 
which are used for human consumption. I t  is used as an antioxidant in the 
food industry and fo r the improvement o f butter qu ality  (Ambrose et a l., 
1952; Harborne, 1977; Seino et a l., 1978; Stitch et a l., 1981; Siess and 
Vernevaut, 1982; Sahu et a l., 1981).
1.12.2 The Terpenoid Constitutents of Bracken
Sesquiterpenes having the 1-indanone nucleus and called pterosins and 
their O-glucosides (pterosides) have been isolated from bracken (Hikino et 
a l., 1970; 1971; 1972; Fukuoka et a l . , 1972; Yoshihira et a l . , 1972; 
Kuroyanagi et a l., 1974).
They are cytotoxic to HeLa ce lls  but not carcinogenic to rats (Saito et 
a l., 1975).
A lactam isolated by Takatori et aL_ (1972) called pterolactam was non- 
carcinogenic (Hirono et al., 1975).
Recently a compound designated aquilide A was isolated from bracken. I t  
is mutagenic in the Ames Salmonedla Assay and genotoxic to mammalian cells  
in v i t r o . I t  is  unstable being converted in to pterosin d under acid 
conditions and under alkaline conditions into a compound as yet unidentified 
but c lo se ly  resembling the pterosins (van der Hoeven et a l . , 1983). 
Aquilide is the same as a compound isolated from a carcinogenic fraction of 
bracken and designated ptaquiloside (Hirono et al., 1984c).
Ptaquiloside was carcinogenic in Sprague-Dawley rats, inducing mammary 
and intestinal tumours as well as acute bracken poisoning in a ca lf (Hirono 
et a l., 1984b).
The results from ptaquiloside are interesting and suggest that i t  might 
be the bracken carcinogen, and that the bone marrow toxin and the carcinogen 
are the . same compound. Certain features of the chemistry and toxicology of 
ptaquiloside would appear however to render i t  improbable as the bracken 
carcinogen. I t  is  unstable under both acid ic  and basic conditions, being 
rapid ly converted in to pterosin B. This is  in contrast to the chemical 
activ ity  of carcinogenic fractions of bracken (Pamucku et al., 1970a; Evans,
27
1979) (1.13). Furthermore, although very high doses o f ptaquiloside were 
used only mild leucopenia was observed in the experimental c a lf  and even 
this remained within normal lim its. The erythrocytes were unaffected, the 
thrombocytes f e l l  only s l ig h t ly  and haemorrhages were not observed. The 
sternal marrow remained almost normal and i t  can be inferred that they did 
not reproduce the acute disease in the calf.
These do not in va lidate the p o s s ib ility  that ptaquiloside may have a 
role in bracken-induced carcinogenesis, probably an in itia ting role in view 
o f it s  mutagenicity in the Ames assay and it s  genotox ic ity to mammalian 
ce lls .
1.12.3 The Tannin Content o f Bracken
The in it ia l allusions to the involvement of tannins in bracken tox icity 
were made by Long (1924) and Holmboe (1943) who suggested that "pteritannic 
acid" was the tox ic  constituent. Shearer (1945) a lso suggested that a 
tannin might be the tox ic  constituent o f bracken. Wang et a l. (1976) 
iso la ted  a tannin from bracken and using intra-vesical implantation were 
ab le  to  dem onstrate i t s  c a rc in o g e n ic ity , but th is  technique is  a 
controversial one. When tested by oral administration however, they fa iled  
to induce any tumours. In the same experiment the tannin-free fraction of 
bracken induced in te s t in a l  tumours in ra ts . When adm in istered  
subcutaneously however, fibrous histiocytomas were induced by the tannin 
isolated from bracken (Pamukcu et al^, 1980a). Whether the bracken tannin 
is carcinogenic or just exhibiting a local irritant e ffect on both the skin 
and in the bladder is not certain.
Furthermore, the nature of the bracken tannin is uncertain. The term 
"tannin" re fers  to a generic term describing heterogenous polymeric 
substances which d i f fe r  from plant to plant (Kirby, 1960). Studies with 
tannin-containing fractions o f plants notably Krameria ixina and Acacia 
v illosa  demonstrated that tannin was carcinogenic via the dermal route but 
not v ia  the ora l route (O'Gara et a l., 1971, 1974).
Epidemiological evidence suggests that the oesophageal cancers of the 
people o f Curacao is  due to the high tannin content o f th e ir d iets. The 
b ete l nut Areca catechu, the cause o f oral cancers a lso has a high tannin
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content. The Luo people of Kenya who use a high tannin-containing sorghum 
for their beer have a 14-fold increase in oesophageal cancer compared to the 
rest of the population. In West Africa where a low tannin sorghum is used, 
there is  a low incidence of oesophageal cancer (Morton, 1978).
The e p id em io lo g ica l evidence notwithstanding the in a b ility  to 
demonstrate the carcinogen icity o f tannins via the oral route must cast 
doubt on the ab ility  of the bracken tannin to induce cancer in bracken-fed 
animals.
1.12.4 Shikimic Acid
Shikimic acid is a trihyaroxycyclohexene carboxylic acid which has been 
im plicated in bracken carcinogen icity (Evans and Osman, 1974). Shikimic 
acid was f i r s t  described as a natural product from the plant Illic iu m  
religiosum, Sieb. and it  was from the Japanese name of this plant, "shikimi- 
no-ki", that the name shikimic acid was derived. I t  is  a s tra teg ic  
metabolite in the formation of several aromatic compounds (Haslam, 1974).
Although i t  was reported to be carcinogenic to mice (Evans and Osman, 
1974) i t  has not been shown to  be carcinogenic to  rats (Hirono et a l . , 
1977a). In th is study however, 3 o f the 12 rats on the shikimate d ie t died 
o f pneumonia at various in terva ls  during the study, while the controls 
remained healthy throughout the 480 days of the experiment. I t  would be most 
appropriate to  feed the test compound to the tes t animals over 2 years 
before firm conclusions can be reached as regards its  carcinogenicity (DHSS,
1982).
I t  was nonmutagenic in the Ames' test (Jacobsen et a l . , 1978) but 
genotoxic in the BHK 21 c e l l  transformation test (Jones et a l., 1983). I ts  
metabolites in the rat were neither mutagenic nor genotoxic (Brewster, 1978; 
Jones et a l., 1983).
Shikimate is  widespread in nature occurring in severa l human foods 
esp ec ia lly  fru its , hence the immense in terest in i t  from a public health 
viewpoint, to determine whether i t  is a carcinogen or not and to define its  
mode of biological activity.
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1.13 The Nature of the Bracken carcinogen
The id en tity  o f the bracken carcinogen is  s t i l l  uncertain but some 
features of its  nature are known:-
( i )  i t  is soluble in water (Hirono et a l . , 1978)
( i i )  i t  is insoluble in heptane and ether (Evans, 1979)
( i i i )  i t  is soluble in methanol (Pamukcu et al., 1970a)
(iv ) i t  is soluble in ethyl acetate (Evans, 1979)
(v) i t  is  more active  at acid pH than a lkaline pH (Pamukcu et a l . , 1970a; 
Evans, 1979).
However i t  is not certain whether i t  is one toxin that ,is responsible 
for the bone marrow aplasia and the resulting haematological syndrome and 
the wide variety of tumours observed in several experimental animals.
The identity of the bracken carcinogen thus remains the central issue 
of research on bracken.
1.14 Aims of the Present Study
Of the several candidates nominated as the bracken carcinogen, 
shikimate and quercetin are deserving of closer consideration because they 
have produced cancer in experimental animals at certain times and have not 
at other times. The equivocal nature of the results of experiments on these 
isolates as well as the public health importance of these isolates make i t  
necessary to re-examine their mechanism of action based on an in itia tion - 
promotion hypothesis for the mechanism of action of these two isolates.
/ !I t  was also necessary to re-examine the factors responsible^the acute (  
tox icity o f bracken with a view to fit t in g  both acute and chronic toxicity 
into an overall mechanism of action for bracken. In this regard the role of 
the cyanogenic glycoside, prunasin was examined especially as i t  is known 
that cyanogenic glycosides cause ataxic syndromes in man and animals.
The indole and kynurenine pathways o f tryptophan metabolism were 
examined in view o f the involvement o f thiamine as a co-factor in the 
pathways of tryptophan metabolism.
30
A comparative approach was adopted, running tests  on shikimate, 
quercetin and bracken in parallel to elucidate the mechanism of action of 
these compounds.
CHAPTER TWO
THE IN IT IA T IN G  AND PROMOTING PR O PERT IES 
OF QUERCETIN  AND SH IK IM A TE
32
2.1 Introduction
These studies were undertaken to assess quercetin and shikimate as 
possible in itiators and/or promoters in bracken-induced carcinogenesis.
Both compounds had been previously screened for mutagenic, teratogenic 
and carcinogenic a c t iv ity . However, the results o f the carcinogen icity 
studies were equivocal and inconsistent giving rise to the view that neither 
may be complete carcinogens, but instead that they might be contributing to 
bracken carcinogenicity in in itia ting and/or promoting roles (Fukushima et 
a l., 1983; Hi rose et a l., 1983; Kato et a l., 1983; Jones et a l., 1983).
Although i t  was possible to demonstrate strong mutagenic activ ity  for 
quercetin in the Ames tes t using Salmonella typhimurium TA 98, TA 100, TA 
1537,and TA 1538, both with and without activation, attempts to demonstrate 
its  carcinogenicity had shown that i t  was not a carcinogen, but the work of 
Pamukcu et a l. (1980b) showing that i t  is  capable o f producing urinary 
bladder and in tes tin a l tumours in rats and those o f Erturk et a l. (1983) 
suggesting that i t  is a liver carcinogen tended to ensure renewal of e fforts 
to determine its  mode of action with respect to its  role in bracken-induced 
carcinogenicity. Specifically, the reported mutagenic activ ity  of quercetin 
was o f the same order as that o f benzo(a)pyrene, a potent carcinogen 
(Sugimura, 1982). In the ligh t o f such mutagenic a c t iv ity ,  and equivocal 
carcinogen icity  tes t resu lts , another hypothesis to explain it s  ro le  in 
bracken-induced carcinogenicity was suggested, hence the idea that i t  might 
play an in it ia t in g  (or promoting ro le ) (Fukushima et a l., 1S83; Hirose et 
a l., 1983; Kato et a l., 1983).
Shikimate, although non-mutagenic to Samonella typhimurium TA 98, TA 
100, TA 1535, TA 1537 and TA 1538 (Jacobson et a l., 1978) was genotoxic in 
the BHK 21 c e ll transformation test (Jones et al., 1983). Furthermore, its  
ab ility  to induce tumours in mice (Evans and Osman, 1974) though not in rats 
(Hirono et a l., 1977) led to the suggestion that i t  might have another 
mechanism of action probably a promoting one (Jones et a l., 1983) but an 
in itia ting role in bracken-induced carcinogenicity cannot be precluded.
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2.2 Tumour Initiation and Promotion
One o f the characteris tics  o f carcinogenesis is the la ten t period 
between contact with a carcinogen and the appearance of a malignant tumour 
or. other neoplastic characteristics. This time lag can be explained on the 
basis that carcinogenesis is a multistep process and that these steps need 
time to occur before neoplastic characteristics manifest themselves.
Early investigations id en tified  two steps in the development o f 
ep ithelia l cancers - the in itiation  phase, which required the application of 
an in itia tor and the promotion phase which required the application of an 
agent which on its  own was incapable of producing tumours but could promote 
the in it ia ted  c e lls  to form tumours. This agent was ca lled  the promoter 
(Berenblum and Shubik, 1947).
The process o f tumour in it ia t io n  and promotion was explained as a 
series of events which require the in teraction  of two d iffe ren t chemical 
agents capable of co-operative interaction to produce neoplasia (Berenblum 
and Shubik, 1947). These events were illustrated by using croton o i l  as the 
in it ia to r  and benzo(a)pyrene as the promoter with the mouse skin as the 
experimental model. The various ways in which these could in teract are 
illustrated in Figure 2.1.
Figure 2-1
The Fnicsse of Tumour Initiation and Promotion
1 U  NO TUMOURS
•?___________________________TUMOURS
3. ■  --- ------------------------ TUMOURS
& _________ ________NO TUMOURS
5.  ---------- - NO TUMOURS
6. NO TUMOURS
time (months/years)
= application of initiator
= application of promoter
I f  the in it ia to r  alone was applied, or i f  the in it ia to r  was applied 
a fte r  the tumour promoter, no tumours developed. Also, i f  the tumour
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promoter alone was applied or applied at extremely wide intervals after the 
in it ia to r  (in  th e ir  case, in terva ls  greater than four weeks) no tumours 
developed.
However, i f  the tumour promoter was applied a fte r  the in it ia to r ,  no 
matter how long a fte r  the in it ia to r  provided that the in terva l between 
successive applications was short enough, tumours developed.
2.2.1 Tumour In itia tion
An in itia ting agent is a chemical, physical or biological agent capable 
of altering the molecular structure 'of DNA This alteration may be brought 
about by covalent binding o f the DNA to the agent or it s  m etabolites, 
distortion of the DNA without covalent binding, complete deletions o f whole 
portions of DNA, scissions at various parts of the DNA chain and/or errors 
in the repair of any of the above injuries (Pitot and Sirica, 1980). These 
properties o f the in it ia t in g  agent do not imply that i t  is  the only or 
absolute requirement for neoplastic transformation.
In studying the in it ia t io n  process, various c e l l ,  organ and animal 
models have been used. As a result, some characteristics have been observed 
in some models but not in others. However* only those general features 
common to most models have been used as the basis for discussing in itiation.
The in itia ting agent exerts its  action at the genetic level by inducing 
a lte ra tion  in the DNA o f the c e l l .  A further step is  required to ensure 
establishment or*"fixation" of the in it ia l alteration. This second step is 
usually in the form of proliferation of in itiated ce lls  to create an island 
or foci or altered cells . These ce lls  d iffe r  from the surrounding ce lls  in 
the possession of properties which render them susceptible to promotion and 
eventually the formation o f neoplasia. I t  is  c lear from th is  b r ie f 
description  o f in it ia t io n  that i t  is  not a s ingle event but a multistep 
process (Farber, 1980).
There are however certain  aspects o f the in it ia t io n  process which
/remains unclear. These include the essen tia l molecular basis fo r the
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induction of the altered cells , the mechanistic role of ce ll proliferation
in in it ia t io n  and the physio logica l and/or metabolic nature o f in it ia te d  
ce lls  that enables them to act as the original progenitors for cancer.
In outline however, the in itiation  process' is irreversible. That is to 
say, that in itiated cells  have a "memory" which may be activated at a later
o f tumours, in addition, in itiation  requi ression to
neoplasia, i t  is dependent on the stage of the c e ll cycle and the metabolic 
machinery of the c e ll (p itot, 1981).
2.2.2 Tumour Promotion
A promoting agent is  one that a lters .th e  expression o f the genetic 
information o f the c e l l .  Such an agent does not react d ire c t ly  with the 
genetic m aterial o f the c e l l  but a ffe c ts  it s  expression by a va rie ty  o f 
mechanisms including in teraction  with c e l l  surface receptors or by an 
a ltera tion  of other c e llu la r  components and functions (P ito t and S irica ,
1980).
Various ce ll, organ and animal models have been used both in vivo and 
in v it ro  to study tumour promotion (Hicks, 1983). Although the exact 
details of each system or model d iffe r  in some respects to other systems or 
models, certain features are common to a ll o f them. Hence, i t  is postulated 
that tumour promoters may act by influencing the mutation rate or affecting 
the repair mechanisms o f the c e l ls  or by causing de-repression o f a
regulator gene. I t  would appear though, that the influence on the mutation
rate and the e f fe c t  on the repair mechanism belong in the realm o f tumour 
in itiation , so the more plausible possib ility is that tumour promoters may 
act by de-repression o f a regulator gene.
I t  has however, also been suggested that tumour promoters may act at a
cytoplasmic site or at the c e ll surface. Indeed, these sites appear to have 
more experimental evidence in th e ir  support than the nuclear s ite  as the 
loc i of promoter action (Berenblum and Armuth, 1981).
Whatever the s ite  o f promoter action within the c e ll, its  e ffect is to 
stimulate a number of in itiated ce lls  to develop into neoplastic cells. This 
may be done by d ifferen tia lly  inhibiting surrounding ce lls  thus allowing the
time by the appropriate stimulus, usually formation ^
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in itiated ce lls  to develop preferentially or alternatively by preferential 
stimulation of the in itiated ce lls  over the surrounding cells.
As with the in it ia t io n  process, there remain areas of in su ffic ien t 
understanding of the promotion process, i t  is not clear how the promotion 
stimulus selectively ensures the growth of in itiated cells  in preference to 
the surrounding c e lls . I t  is  also not clear whether the events o f the 
promotion stage are sufficient to provide the momentum that ultimately leads 
to fu ll neoplastic expression (Farber, 1984).
Although in itiation  and promotion exist as concurrent processes which 
follow each other in succession for the realisation of neoplasia, and whilst 
some compounds have been recognised as being in it ia to rs  under certain  
circumstances of dose and route of administration, and others as promoters 
under various circumstances, there are nevertheless, compounds which on 
th e ir own are capable o f complete carcinogenic a c t iv ity . These complete 
carcinogens may mediate th e ir actions v ia  the successive processes o f 
in it ia t io n  and promotion, but do not require action o f other compounds to 
fu l f i l l  their biological effects.
Thus, i t  is  possib le to have in it ia t io n  and promotion as a separate 
mechanism, different carcinogenesis induced by a complete carcinogen
regimen (Reddy and Fialkow, 1983).
2.3 Markers of cell Transformation
Various changes may occur in transformed cells in vivo and/or in vitro. 
These changes have b.een used as pathognomonic or diagnostic o f transformed 
c e lls . They may occur at various stages in the process o f transformation 
and with varying intensities.
These changes include a ltera tion s in the le v e l or pattern o f the 
enzymes o f the c e lls , morphological changes such as hyperplasia and 
dysplasia and a ltera tions in the metabolism o f the c e l l  resu lting in 
elevations or depressions of the levels of .some ce ll metabolites.
Some of these changes such as hyperplasia may not necessarily lead to 
neoplasia but may only be a response to external irr ita ting stimuli.
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2.3.1 Abnormal Enzymology in Neoplasia
Patients with neoplastic disease show altered profiles of glucose-6- 
phosphatase and fructose-6-phosphatase (P ito t, 1981). In addition, serum 
lacta te  dehydrogenase is  elevated in primary hepatoma and serum alkaline 
phosphatase is elevated in in tes tin a l and bladder neoplasia (Wilkinson, 
1976).
Although urinary la c ta te  dehydrogenase had been suggested as a 
screening test for urinary tract malignancies, the inconsistency of urinary 
enzyme profiles in such conditions has made them less preferable to serum 
enzyme assays.
Most of the observations in respect o f enzyme changes in neoplasia have 
been made on human subjects, but similar observations have also been made in 
experimental animals, in v ivo  and in cultured mammalian c e lls  in v it ro  
(Wilson et a l., 1978; Gadhia and Shah, 1980; Hufnagel et a l., 1980; Lehmann 
et a l., 1981).
Changes in enzyme patterns have been associated with the in it ia t io n  
phase of c e l l ’ transformation and have been demonstrated by the use of enzyme 
histochem istry in various organs in v ivo  and in v it ro  (Farber, 1980), but 
the defin itive evidence o f tumour in itiating ab ility  is the production of 
actual tumours in an animal model (p itot, 1981).
2.3.2 Metabolism in Transformed Cells
In addition' to enzymological changes, other activ ities  of transformed 
ce lls  which may be altered are the rates of plasma membrane ion transport, 
the synthesis of prostaglandins, polyamines, phospholipids, RNA, DNA, and 
plasminogen activator, a ll  o f which are elevated in transformed cells, in 
addition, thymidine uptake and the level of large external transformation 
sensitive (LETS) protein are decreased in transformed cells.
Other • changes may occur in the nature of membrane glycoproteins and a 
delay in early DNA synthesis (p itot, 1981).
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These changes are associated with the promotion phase o f c e l l  
transformation and though they have been observed mainly in cultured ce lls  
in v it ro  they are also applicable to organ systems in v ivo  (Wilson et-a l., 
1978? P ito t, 1981).
2.3.3 Morphologic Alterations in Transformed Cells
Increased c e ll division accompanied by an increase in the mutation rate 
is  an important morphologic ch aracteris tic  o f transformed c e lls . The 
increase in c e ll numbers may be triggered o ff  by a variety of factors but is 
indicative of the fact that c e ll division is no longer under ordered control 
and is an important morphologic Manifestation of neoplastic pathology.
The morphologic alterations may be in the form of hyperplasia in which 
there is  an increase in the number of c e l ls ,  or metaplasia in which c e lls  
revert to more prim itive forms such as columnar epithelia l ce lls  reverting 
to cuboid or squamous e p ith e lia l forms, or they may take the form o f 
anaplasia whereby the inter-relationships of c e ll organelles are altered.
The alterations (hyperplasia, metaplasia and anaplasia) are considered 
as part of the post-promotion phase and have been c la s s if ie d  as part o f 
tumour progression (Shabad, 1973).
2.4 Tumour Progression
Progression is  a series  o f successive events in which the c e l l  is  
transformed to  atta in  fu l l  malignant status, i t  re fers  to a series o f 
events, permanent, ir re v e rs ib le  and q u a lita tive  which transform the 
character o f a c e l l  u n til i t  is  malignant (Foulds, 1954; Shabad, 1973? 
Farber, 1984).
Progression begins with d iffu se  irregular hyperplasia progressing to 
focal nodular proliferation during which stage metaplasia and anaplasia may 
take place leading to adenomas, papillomas and other benign tumours. These 
may further progress to form malignant tumours (Foulds, 1954, 1958? Shabad, 
1973).
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Although the process of neoplasia begins from hyperplasia, hyperplasia 
is not defin itely a preneoplastic change. A hyperplastic c e ll may not revert 
to normal and sometimes do.
Some aspects of tumour progression remain unclear however. I t  is not 
clear how the process is sustained from hyperplasia to neoplasia. I t  is not 
certain  whether the impetus that sustains the process is  endogenous or 
exogenous. I t  is  also not c lear whether the impetus is  a "one-hit" 
phenomenon in which the stimulus once generated is  su ffic ie n t to achieve 
neoplasia or a "m u lti-h it" phenomenon in which continued stimulation is  
required to achieve neoplastic expression (Farber, 1984).
In recent times, evidence has been emerging o f a group o f normal 
c e llu la r  genes which may be activated  by a varie ty  o f external stim u li to 
produce an abnormal proliferation of cells. These oncogenes, i t  is thought, 
may play key or essen tia l ro les at each o f the major steps in the 
carcinogenic process. Two or more of these oncogenes may partic ipate  in 
tandem to bring about c e ll transformation (Farber, 1984).
2.5 Purpose o f Study
The roles of quercetin and shikimate in bracken-induced carcinogenesis 
have been the subject of several studies but it  would appear that neither is 
a complete carcinogen and i t  has been suggested that they might act as 
in it ia to rs  or promoters. To c la r i fy  th e ir ro les against a background o f 
possible initiation/promotion roles is the subject of this study.
Two sets of studies were carried out to c la rify  their roles in bracken- 
induced carcinogenesis. The f ir s t  of these compared quercetin and shikimate 
as complete carcinogens to the parent compound, bracken, in a chronic (24 
month study), while the second sought to define the properties o f both 
isolates as in itiators and/or promoters in a sub-acute (90-day) study.
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2.6 The Chronic Study
The aim o f th is  study was to determine the carcinogen icity o f 
quercetin, shikimate and bracken by feeding groups of rats diets containing 
the test agents and at the end of the study to determine the carcinogenicity 
o f each agent by histopathological examination.
The test agents were fed for 90 days and the rats were then returned to 
a normal d ie t fo r the rest o f the study. Although i t  is  the accepted 
protocol in carcinogen icity bioassays to feed the tes t substance fo r the 
life -sp an  o f the test animal, i t  ought to be borne in mind that th is study 
actually compared the carcinogenic properties of a ll  three compounds so that 
i t  is  important only to have id en tica l feeding regimes for a l l  the test 
substances. Therefore, although the test substances were not administered 
over the l i f e  span o f the tes t animals, that need not detract from the 
merits o f th is experimental design esp ec ia lly  in view o f the p roh ib itive  
cost o f such an experimental design that en ta ils  the feeding o f some 
expensive chemicals over an entire l i f e  span.
At the end o f the study, the experimental animals were autopsied and 
the h istopathologica l lesions in a l l  the animals assessed to determine 
whether any o f the compounds were capable o f inducing tumours or could 
induce lesions such as hyperplasia and anaplasia or a pre-neoplastic change 
such as metaplasia esp ec ia lly  in the target organs o f bracken-induced 
carcinogenicity, namely the small intestines, the bladder and bone marrow.
2.7 The Sub-Acute Study
The sub-acute study was designed to assess the in itiating and promoting 
properties o f quercetin and shikimate by feeding d iets containing these 
bracken isolates to rats in conjunction with known in itiators and promoters 
in a 90-day study. At the end o f the study various indices o f in it ia t io n  
and promotion were determined.
The bracken carcinogen(s) a ffe c t (s ) the intestinal tract, the bladder 
and the bone marrow. In this study emphasis was laid on these three target 
organs.
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The most precise index for tumour in itiation  is the ultimate production 
of a tumour but in short-term bioassays, this is not feasible and the use of 
other indices, such as biochemical lesions may provide an alternative.
Accordingly, by treating the test compounds as "in itiators", they were 
linked up with known promoters and the markers for c e ll transformation used 
were those regarded as indices o f tumour promotion, but i t  is assumed that 
these in itiators provide the in it ia l changes that make promotion possible.
Ornithine decarboxylase is  an enzyme that forms putrescine, the 
immediate precursor of spermidine. The polyamines putrescine, spermidine 
and spermine are found in large quantities in rapidly growing tissues. The 
decarboxylation of ornithine by ODC is a rate lim iting step in the formation 
of the polyamines and i t  is  thus s tra teg ica lly  s ited  in the metabolism o f 
the polyamines. Therefore in transformed c e lls  or c e lls  undergoing 
transformation, the le v e l .o f  ODC rises and i t  is  a consistent index o f 
tumour promotion (O'Brien, 1976; P itot, 1981).
The p o ss ib le  ro le  o f  plasm inogen a c t iv a to r s  in n eop la s tic  
transformation was based on. the observations that newly transformed cells  in 
culture showed dramatic increases in plasminogen activator levels (Unkless 
et a l., 1973, 1974). The precise mechanism whereby they are involved in 
neoplastic transformation is not fu lly  understood but the physiological role 
of plasminogen activators is to activate plasminogen to plasmin which has a 
fib rino lytic  role in the blood.
I t  should be emphasised however, that plasminogen activators exist as a 
wide variety of proteases of which urokinase and streptokinase are the best 
known, but other tissue and blood activators exist (Christie, 1980).
The e ffe c ts  o f quercetin and shikimate on the haematopoietic system 
were assessed by carrying out various haematological determinations 
including histopathological examination of the bone marrow at the end of the 
study. In term ittent blood sampling in the course o f a study may y ie ld  
valuable information in the understanding o f a dynamic process such as 
haematopoiesis, but with rats especially those as small as 55 - 65 g i t  may 
also lead to non-compound related  pathologies which may obscure genuine 
tox ic  e ffe c ts . The use of s a t e l l i t e  groups may be a way round the problem 
(DHSS, 1982) but i t  is an added expense.
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The tumour in it ia to rs  used in the sub-acute studies were those 
identified in previous studies as having the capability in conjuction with 
known tumour promoters of inducing characteristics of tumour in itia tion  in 
various c e ll, organ and animal models.
2.8.1 N-butyl-N-( 4-hydroxy butyl) nitrosamine (BBN)
* A carcinogen that s p e c if ic a lly  a ffe c ts  the urinary bladder, BBN, has 
been used as an in it ia t in g  agent fo r the rat at a dose rate o f 0.01% (w/v) 
in the drinking water, in conjunction with 5.0% w/w sodium saccharin in the
2.8 T u m o u r  Initiators
an in itia ting agent at dose rates of either 5 mg/kg body weight or 50 mg/kg 
body weight administered intramuscularly weekly to baboons for 2 years in 
conjunction with Schistosoma haematobium as the promoter (Hicks et_ a l.,
1980).
For these studies i t  was used at a dose rate o f 5 mg/kg body weight per 
rat per week for two weeks by gavage in conjunction with diets containing 
5.0% (w/w) saccharin or 1.0% (w/w) shikimate or 1.0% (w/w) quercetin as 
promoters.
2.8.2 Cyclophosphamide
Cyclophosphamide is  tox ic  to  the bone marrow and its  metabolite 
acrolein induces bladder tumours (Hicks, 1980? Ciplea and Mayer, 1981). At 
an intraperitoneal dose rate of 100 mg/kg body weight per day for fiv e  days 
i t  induced bone marrow damage in the mouse (Ciplea and Mayer, 1981). At 
ora l dose rates between 0.31 and 2.5 mg/kg body weight per day over a l i f e  
time, i t  induced between 12 and 37% bladder tumour incidence (Hicks, 1980).
When used at very high doses such as an in traperitoneal dose ra te.o f 
100 mg/kg body weight per month fo r  e igh teen  months or a s in g le  
in traperitoneal dose o f 200 mg/kg body weight in conjuction with methyl 
nitrosourea (MNU), no tumours were produced in the rat and it. was suggested
diet as the tumour promoter (Nakanishi et al., 1980).
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that at such high dose rates, cyclophosphamide became cytotoxic, k illin g  the 
urothelial- ce lls  rather than inducing a heritable change in the target ce lls  
(Hicks, 1980).
A lower dose rate s im ila r to  that adopted by Arai et al. (1977) was 
considered more su itable. They used a dose rate o f 10 mg/kg body, weight 
twice a week in male rats for forty weeks and fa iled to induce any'tumours, 
indicating that at this dose, cyclophosphamide was non-carcinogenic. At the 
same dose.rate i t  was capable of promoting FANFT-initiated ce lls  to produce 
tumours.
For these studies, cyclophosphamide was used at an intraperitoneal dose 
rate o f 10 mg/kg body weight per rat per week for two weeks as the 
in itia ting agent in conjunction with the same compound and dose rate, 1.0% 
(w/w) a quercetin-containing d ie t or a 1.0% (w/w) shikimate-containing 
diet, a l l  as promoters, for the studies on the haematopoietic system. The 
a b i l i t y  o f cyclophosphamide to act as a bladder carcinogen also made i t  
important to assess its  effects on the bladder.
2.8.3 N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)
MNNG is  carcinogenic to the alimentary tract. I t  has been used as an 
in itia ting agent at an intrarectal dose rate of 2.5 mg per rat, twice a week 
for two weeks in conjunction with sodium lithocholate, during which colonic 
tumours were produced (Reddy and Watanabe, 1979).
When adminstered at an ora l dose rate o f 8.3 mg/L in the water in 
conjunction with 2.0% (w/w) taurocholic acid in the d ie t tumours were 
produced in the stomach and duodenum (Salmon et al., 1984).
When administered at an oral dose rate between 100 ug/rnl and 167 ug/ml 
in the drinking water in conjunction with the bacterium, pseudomonas 
aeruginosa as promoter, gastric and small intestinal tumours were produced 
(Morishita and Shimizu, 1983).
In these studies MNNG was used at an ora l dose rate o f 7.5 mg/kg body 
weight per rat per week fo r  two weeks, with 1.0% (w/w) lithochola te , 1.0% 
(w/w) quercetin or 1.0% (w/w) shikimate as the promoters.
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2.9 T u m o u r  P r o m o t e r s
The tumour promoters used in the study were those described in various 
previous studies as capable of tumour promoting activity.
2.9.1 Saccharin
When fed to rats as a 5.0% (w/w) d ie t for a period o f 100 weeks a fte r  
0.2% (w/w) FANFT diet fed for four weeks, saccharin was shown to be capable 
o f tumour promotion in the rat urinary bladder, producing papillomas and 
carcinomas (Fukushima et al., 1981). I t  has also been administered in the 
d ie t (5% w/w) in conjunction with BBN as the in it ia to r  to induce urinary 
bladder tumours in Wistar rats (Nakanishi et al., 1980).
In these studies i t  was used as a 5.0% (w/w) diet as a tumour promoter 
in conjunction with 5 mg/kg BBN, 1.0% (w/w) shikimate d ie t and 1.0% (w/w) 
quercetin diet as in itiators.
2.9.2 Lithocholic Acid
When administered to rats at an intra-rectal dose rate of 20 mg per rat 
thrice weekly for 46 weeks after in itiation  by MNNG, lithocholic acid had a 
promoting action on colon carcinogenesis (Reddy and Watanabe, 1979).
In these studies i t  was administered in the d ie t (1% w/w) in
conjunction with MNNG, 1.0% (w/w) quercetin diet, and 1.0% (w/w) shikimate 
diet as in itiators.
2.9.3 Cyclophosphamide
Cyclophosphamide has been used as a promoting agent at an ora l dose 
rate o f 10 mg/kg body weight twice a week, in conjunction with FANFT as the
in itia ting agent (Arai et al., 1977).
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In the in itia tion -prom otion  studies however, i t  was used at an 
intraperitoneal dose rate of 10 mg/ky body weight once a week because i t  is 
cytotoxic' at high doses and its  tox ic ity  via the oral route is more rapid in 
onset than via the intraperitoneal route.
In these ■ studies i t  was used as a haematotoxic agent but its  tox ic ity  
to the urinary bladder has also been considered.
2.10 Materials and Methods
2.10.1 Experimental Animals
Male Wistar-albino (W/A) rats (University of Surrey, Animal Unit) were 
assigned twenty per group for the chronic study and fiv e  per group for the 
sub-acute study so that each group weighed on average 60.0 + 5.0 gm.
For both studies the rats were housed f iv e  per cage in p la s tic  rat 
cages on a bedding of wood chips. The cages had dimensions of 56.25 x 33.75 
x 15.0 cm with metal g r i l l  tops. For the chronic studies, the rats werG 
rehoused three per cage a fte r  s ix  months and two per cage a fte r  eighteen 
months.
2.10.2 Feedstuffs and Diets
Bracken was collected from the areas in and around Worplesdon, Surrey, 
during July and August, dried at 100°C in a dry heat oven (Department o f 
Chemical Engineering, University o f Surrey), powdered with a mortar and 
pestle, sieved and incorporated as 10% (w/w) of the diet for both studies.
Quercetin and shikimate (sigma Chemical Company Ltd., Poole, Dorset, 
England) were made up as 1.0% (w/w) diets with powdered rodent diet for both 
chronic and sub-acute studies.
The control rats received powdered rodent diet only (appendix IV). A ll 
the diets were presented in steel feeding pots placed inside the cages. In 
a l l  groups, food and water were available ad libitum.
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None o f the animals were given thiamine supplementation to their diets 
because of the added cost o f implementing adequate control groups.
The strategy o f the chronic study was to feed the test compounds in the 
d ie t for 90 days and return the rats to control d ie ts .fo r  the remainder o f 
their lives (i.e. until two years) when the study was terminated.
The sub-acute study was carried  out according to the dosing regime 
shown in Table 2.1.
2.10.3 C hem icals and Reagents
The chemicals and reagents were o f ana ly tica l reagent grade unless 
otherwise specified.
2.10.4 C lin ica l Observations
The rats were observed daily for signs of illness and weighed weekly.
2.10.5 Sam ple C o lle c tio n
A fte r  90 days, the ra ts  on the sub-acute study were l i g h t ly  
anaesthetised with anaesthetic ether (May and Baker Ltd., Manchester, 
England) and term inally bled out v ia  the posterior vena cava. Blood fo r 
h aem ato log ica l assays was c o l le c t e d  in tubes con ta in ing  EDTA as 
anticoagulant. Tissues fo r histopathology were collected in 10% buffered 
form alin and tissues fo r PA and ODC assays were washed in physio log ica l 
sa line and placed in ice cold bu ffer (2.10.6 and 2.10.8).
At the termination of the chronic study, the rats were anaesthetised as 
described above, bled out term ina lly , necropsied and the various tissues 
co llec ted  in 10% b u ffe red  n eu tra l fo rm a lin  fo r  h is to p a th o lo g ic a l 
examination.
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Dosing Regime to Study the Initiating and Promoting 
Properties o f Quercetin and Shikimate
Table 2.1
TIME (weeks)
*7 - ---%s-i ~rv ^13
IN ITIATION PROMOTION
PHASE PHASE
10% w/w bracken diet
1% w/w quercetin diet
1% w/w shikimate diet
g
control diet
control diet b
Q
control diet
1% w/w quercetin diet 5.0% w/w saccharin diet
1% w/w shikimate diet 5.0% w/w saccharin diet
1% w/w quercetin diet 10 mg/kg body weight cyclophosphamide
per week intraperitoneaily
1% w/w shikimate diet 10 mg/kg body weight cyclophosphamide
per week intraperitoneaily
1% w/w quercetin diet 1% w/w lithocholate diet
1% w/w shikimate diet 1% w/w lithocholate diet
Control diet 5.0% w/w saccharin diet
Control diet 10 mg/kg body weight cyclophosphamide
per week intraperitoneaily
Control diet 1% w/w lithocholate diet
5 mg/kg body weight BBN 1% w/w quercetin diet
per week by gavage
5 mg/kg body weight BBN 1% w/w shikimate diet
per week by gavage
Dosing Regime to Study the Initiating and Promoting 
Properties o f Quercetin and Shikimate
Table 2.1 (Continued)
TIME (weeks)
n n  .. -Xu -n. i.  > — ----- y
IN IT IATION
PHASE
PROMOTION
PHASE
7.5 mg/kg body weight 
MNNG per week by gavage
1% w/w quercetin diet
7.5 mg/kg body weight 
MNNG per week by gavage
1% w/w shikimate diet
10 mg/kg body weight 
cyclophosphamide per 
week i/p
1% w/w quercetin diet
10 mg/kg body weight 
cyclophosphamide per 
week i/p
1% w/w shikimate diet
10 mg/kg body weight 
cyclophosphamide per 
week i/p
normal rodent diet
5 mg/kg body weight BBN 
per week by gavage
normal rodent diet
7.5 mg/kg body weight 
MNNG per week by gavage
normal rodent diet
7.5 mg/kg body weight 
MNNG per week by gavage
1% w/w lithochoiate diet
10 mg/kg body weight cyclophosphamide per week i/p
5 mg/kg body weight 
BBN per week by gavage
5.0% w/w saccharin diet
K e^
a = control diet only
b = control diet plus distilled water by gavage, weekly 
c = control diet plus distilled water intraperitoneally, weekly
BBN = N-buty l-N -(4-hydroxybuty l) nitrosamine 
M NNG = N-methyi-N '-n itro-N-nitrosoguanid ine 
i/p = intraperitoneally
BBN, MNNG, cyclophosphamide and sodium lithochoiate were obtained 
from Sigma Chemical Co. Ltd., Poole, Dorset, England.
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2.10.6 Ornithine Decarboxylase Assay
Ornithine decarboxylase was determined as described by Russell and 
Snyder (1968) with the modifications as applied by Hosaka et al. (1983).
The tissue was excised, washed in physiological saline and homogenised 
in 2 volumes of an ice-cold solution of 50 mM pyridoxal phosphate buffer, pH 
7.4, containing 0.1 mM pyridoxal phosphate (Sigma Chemical Co. Ltd., Poole, 
Dorset, England) and 0.1 mM EDTA (Sigma Chemical Co. Ltd., Poole, Dorset, 
England) using a Potter-Elvehjem  glass te flon  homogeniser (three return 
strokes). The homogenate centrifuged at 2°C in an MSE Superspeed 65 
Centrifuge (MSE S c ie n tif ic  Instruments Ltd., Sussex, England) at 30,000 g 
fo r 30 minutes. From the supernatant 0.5 ml a liquots were added to 1.0 ml 
o f 50 mM sodium phosphate bu ffer, pH 7.4, containing 0.2 mM pyridoxal 
phosphate 1.0 mM EDTA, 1.0 mM d ith io th re ito l (Sigma Chemical Co. Ltd., 
Poole, Dorset, England) and 0.5 uCi o f D,L-ornithine 1 -^c  hydrochloride 
(58 mci/mmol), (Amersharn International PLC, Buckinghamshire, England) in 0.5 
mM L-ornith ine (Sigma Chemical Co. Ltd., Poole, Dorset, England). The 
reaction was carried out in flasks stoppered with self-sealing rubber caps 
fitted  with polyethylene hanging centre wells (Kontes Scientific Glassware, 
Vineland, New Jersey, USA). The centre w ells contained 0.3 ml o f a 2 : 1 
(v/v) ethanolamine : methoxyethanol mixture (May and Baker Ltd., Manchester, 
England), to absorb the ^C02 released from ornithine hydrochloride by the 
action o f ornithine decarboxylase.
The flask was incubated at 37°C for 30 minutes at the end of which the 
reaction was terminated with 0.8. ml of 50% (w/v) citric acid Chemicals 
Ltd., Poole, Dorset, England). The flask was left for 12 hours still 
stoppered to ensure complete absorption of the 1^C02.
The ethanolamine : methoxyethanol mixture was transferred to 10.0 ml of 
Optiphase 'safe' scintillant (Manufactured for LKB, Wallac, Turku, Finland 
by Fisons PLC, Loughborough, England). The amount of radioactivity was 
determined using an LKB 1217 Rackbeta Liquid scintillation Counter (LKB, 
Wallac, Turku, Finland). The counting efficiency of each sample was 
determined by adding an internal standard (glycerol trid-^C)stearate) with 
an activity of 102,500 dpm, accurate to within 0.2% of stated activity (LKB, 
Wallac, Turku, Finland), to each test sample and recounting as described 
above. The efficiency of counting of each sample was
50
(Count rate of sample + internal standard) - Count rate of sample
d.p.m. o f standard
This was multiplied by 100 to give percentage effic iency which in the 
test sample ranged between 88 -  95%. ODC activ ity  was expressed as pmole 
1 C^O2/30 min/mg protein.
2.10.7 Determination of protein Content
Samples of the supernatant were diluted 1 : 50 with d is tilled  water and 
duplicate 1.0 ml a liquots o f the d ilu ted supernatant were added to test 
tubes containing 5.0 ml copper reagent made up of 1.0 ml 1% (w/V) CuS04, 1.0 
ml o f 2% (w/v) sodium potassium ta rtra te  and 100 ml o f 2% (w/v) sodium 
carbonate in 0.1 M sodium hydroxide. A fter 10 minutes, 0.5 ml Folin and 
Ciocalteau's phenol Reagent (Sigma Chemical Co. Ltd., Poole, Dorset, 
England) d ilu ted 1 : 1 with d is t i l le d  water was added and mixed rapidly. 
After 30 minutes the absorbance was determined at 750 nm in a Cecil CE 292 
d ig ita l  UV spectrophotometer (C ecil instruments Ltd., Cambridge, England) 
using a blank which contained d is t i l le d  water instead o f the supernatant 
(Lowry et a l., 1951).
The protein standard curve was prepared with serial dilutions from a 
stock solution of 20 mg/ml bovine serum albumin (BSA). The bovine serum 
albumin was treated as the supernatant and the assay was linear over the 
range 0 - 4 0  ug/ml. The standard curve was obtained after linear regression 
analysis using a linear regression package based on the University of Surrey 
Prime Computer System.
2.10.8 Plasminogen Activator Assay
The determination of plasminogen activator was based on the amidolytic 
assay method using a chromogenic substrate as used by Whur et al. (1980) 
with some modifications.
The amidolytic assay is based on the principle that in the presence of 
excess urokinase (a plasminogen activator) a complex is formed which
catalyses the formation of p-nitroaniline from H-D-valyl-L- leucyl-L-lysine- 
p -n itroan ilid e  dihydrochloride (s-2251) (Kabi Diagnostica, Stockholm, 
Sweden). I f  the situation  is  reversed so that there is  an excess o f 
plasminogen the reaction w ill also proceed but w ill then be dependent on the 
level of urokinase.
The absorbance of the p-nitroanilide at 405 nm is proportional to the 
activ ity  of urokinase provided that plasminogen is in excess.
The standard curve was prepared by using various concentrations o f 
urokinase (Sigma Chemical Co. Ltd., Poole, Dorset, England) in 20 ul 
a liquots made up in Hanks Buffered Saline Solution (HBSS). The 20 ul 
aliquot of urokinase was added to tubes containing 200 ul of 3.0 mM, S-2251, 
400 ul HBSS, 100 ul o f 1 CU/ml plasminogen (Kabi Diagnostics, Sweden), s- 
2251 and plasminogen were made up in HBSS. I t  was incubated for 10 minutes 
at 37°C and the reaction terminated with 100 ul o f 50% acetic  acid (BDH 
Chemicals Ltd., Poole, Dorset, England). The absorbance was determined at 
405 nm in a Cecil CE 292 d ig ita l  UV spectrophotometer (C ecil Instruments 
Ltd., Cambridge, England). The blank was set up as the tests  except that 
the reaction was stopped immediately (time = zero). The assay was linear 
over the range 0.345 x 10  ^ to 27.75 x 10  ^ In ternational Units per ml. 
standard curve was the computer generated best f i t  lin e  produced a fte r  
linear regression analysis using a linear regression analysis package based 
on the University of Surrey, Prime Computer System.
The test tissues were homogenised in 10 volumes of ice-cold HBSS in a 
motor driven potter-Elvehjem  glass te flon  homogeniser (three return 
strokes). The homogenate was centrifuged at 20,000 g for 20 minutes at. 4°C 
in a Beckman J2-21 Centrifuge (Beckman-RIIC Ltd., Buckinghamshire, England).
H-D-valyl-L-leucyl-L-lysine-p-nitroanilide dihydrochloride 
(chromogenic substrate s-2251)
+
Plasminogen
h2o
Plasminogen
Urokinase
+
H-D-valyl-leucyl-lysine-OH + p-nitroanilide (yellow)
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From the supernatant, 20 ul a liquots were used for the determination o f 
plasminogen activator activ ity , described above for the standard curve. The 
blanks contained the tes t supernatant but the reaction was stopped 
immediately with acetic acid.
The protein content of the supernatant was determined as described in 
2.10.7. Plasminogen- activator activity determined as urokinase was 
expressed as International Units (IU) per mg protein.
2.10.9 Haemoglobin Assay
Haemoglobin was determined by the cyanmethaemoglobin using Drabkin's 
Reagent which was 200 mg potassium ferricyanide, 50 mg potassium cyanide and 
140 mg potassium dihydrogen phosphate up to 1 L with d is tilled  water.
The standard curve was prepared using com m ercia lly  a v a ila b le  
haemoglobin standards containing 3.0 g %, 11.5 g % and 18.0 g % o f
haemoglobin (Diagnostic Reagents Ltd., Thame, Oxon, England) using Drabkin's 
reagent as the blank. The absorbance at 540 nm was determined in a Cecil CE 
292 d ig ita l  UV spectrophotometer (C ec il Instruments Ltd., Cambridge, 
England). The standard curve was the computer generated best f i t  lin e  
obtained after linear regression analysis using a linear regression analysis 
package based on the University of Surrey Prime computer system.
The test samples in EDTA were made up as 1 : 200 solutions with 
Drabkin's Reagent and the absorbance determined at 540 nm in a Cecil CE 292 
digital UV spectrophotometer. The haemoglobin content was determined from 
the standard curve and expressed as g %.
2.10.10 Determination of packed Cell volume (PCV)
Thin capillary tubes were f i l le d  with blood containing EDTA and sealed 
at one end with plasticine and centrifuged in a microhaematocrit centrifuge 
(MSE S c ie n t if ic  Instruments Ltd., Sussex, England). The percentage 
haematocrit was determined in a microhaematocrit reader (MSE S c ie n tif ic  
Instruments Ltd., Sussex, England). Each blood sample was analysed in 
tr ip lica te .
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2.10.11 Total Erythrocyte and Leucocyte Counts
A Coulter Electronic Counter, Model Dn (coulter Electronics Ltd., 
Coldharbour Lane, Harpenden, Herts., England) was used for counting of 
erythrocyte and leucocytes in blood samples. The window setting for each 
set of blood samples was pre-aetermined with control blood samples.
2.10.12 Derived Haematological Indices
The Mean Cell Volume (MCV) was derived as follows
MCV = Packed Cell Volume (%) x 10 (fem tolitres)
Total Erythrocyte Count (million/ul)
The Mean Cell Haemoglobin was derived from the formula
MCH = Haemoglobin (g/dl) x 10 (picograms)
Total Erythrocyte Count (million/ul)
The Mean Corpuscular Haemoglobin Concentration (MCHC) was calculated as 
follows
MCHC = Haemoglobin (g/dl) x 100 (%)
Packed cell Volume (%)
These indices are derived for quality control purposes. An MCV range of 
53-69 femtolitres, an MCH range of 17-22 picograms and an MCHC range of 29- 
34% being regarded as within normal limits.
2.10.13 Platelet Counts
The manual method of Austen and Rhymes (1975) was used for the 
determination of platelet numbers in blood. Blood was diluted 1 : 100 with 
freshly prepared and filtered 1% (w/v) ammonium oxalate (BDH Chemicals Ltd., 
Poole, Dorset, England). The diluted blood sample was introduced into an 
Improved Neubauer counting Chamber making sure that there were no air bubble 
when it was covered with a coverslip.
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The Counting Chamber was l e f t  on a wet surface consisting o f paper 
towels soaked in water. A fter ten minutes, the p la te le ts  seen as highly 
re tra c t ile  bodies were counted in an area 1/5 sq.mm. (made up of sixteen 
small squares) in a phase contrast microscope with a magnification of x 400.
The ammonium oxalate lyses the erythrocytes leaving the leucocytes and 
platelets.
The platelet count per cubic millimetre = total count x 5000
2.10.14 D ifferentia l Leucocyte Counts
Thin blood films were made on glass slides, identified with a diamond 
marker on the same side as the smear, a ir  dried and fixed  in ana ly tica l 
grade methanol (May and Baker Ltd., Manchester, England) for 10 minutes.
The slides were stained for 5 .minutes in May-Grunwald stain which was 
made up o f equal parts o f the commercial stain (Raymond A. Lamb, Sunbeam 
Road, London, England), and d is t i l le d  water buffered to pH 6.5 with 
Sorensen's buffer (30 ml of 9.465 g/L disodium hydrogen phosphate and 70 ml 
o f 9.07 g/L potassium dihydrogen phosphate, pH 6.5) (BDH Chemicals Ltd., 
Poole, Dorset, England).
The s lid es  were drained o f May-Grunwald stain and stained in stain 
which was made up o f one part o f the commercial stain (Raymond A. Lamb, 
Sunbeam. Road, London, England), and nine parts o f d is tilled  water buffered 
with Sorensen's buffer pH 6.5. The slides were stained in Giemsa stain for 
10 minutes.
The slides were drained of Giemsa stain, dried, and examined under o i l  
immersion with a magnification of x 400.
One hundred leucocytes were counted and classified by moving the slide 
across the lens in a "zig-zag" fashion. The leucocytes were classified as 
eosinophils, neutrophils, basophils, monocytes and lymphocytes.
The absolute numbers of each type of leucocyte was calculated from the 
total leucocyte count.
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2.10.15 R e tic u lo c y te  Counts and H einz Body D etectio n
Three drops o f blood co llected  in EDTA were mixed in an LP3 tube 
(Luckham Ltd., Burgess H il l ,  Sussex, England) with 4 drops o f 1% B r ill ia n t  
Cresyl Blue (Raymond A. Lamb, Sunbeam Road, London, England) in c itra te  
saline. The c itra te  sa line was made up o f 1 part o f 3% (w/v) aqueous 
trisodium citrate (BDH Chemicals Ltd., poole, Dorset, England) and 4 parts 
of 0.9% (w/v) sodium chloride (BDH Chemicals Ltd., Poole, Dorset, England). 
The LP3 tubes containing blood and stain were capped, and incubated fo r 2 
minutes at 37cC. Each tube was gently agitated and thin smears were made on 
pla in  glass s lid es , a ir dried and id en tified  with a glass diamond marker. 
The film s were examined at a magnification o f x 400 under o i l  immersion. 
The number of reticu locytes in 20 f ie ld s  was determined ensuring that at 
least 100 reticulocytes were counted. The number of erythrocytes in four 
f ie ld s , the 5th, 10th, 15th and 20th fie ld s  was also determined and 
percentage reticulocytes in 20 fie ld s was determined by:
number of reticulocytes counted in 20 fie lds x 100 
5 x number o f erythrocytes in four fie lds
The absolute numbers of reticulocytes were obtained form the total 
erythrocyte counts.
2.10.16 G ross and H is to p a th o lo g ica l Exam ination
At the termination of the experiments, the rats were ether 
anaesthesised and bled to death via the posterior vena cava and all the 
major organs examined for gross pathological lesions. Where these were 
found they were noted, and tumours were measured as to diameter.
Tissues for histopathological examination were thinly cut and fixed in 
10% buffered neutral formalin and after three weeks were processed for 
histopathological examination as described by Bloom and Fawcett (1970). The 
slides were stained with haematoxylin and eosin and examined under a light 
microscope.
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2.11 R e s u l t s
The results of the chronic study are represented by the mean values of 
20 rats + standard error o f the mean (SEM), while for the sub-acute study 
they are the mean values of 5 rats + standard error o f the mean (SEM).
2.11.1 Statistical Analysis
The Students' t - te s t  was used to evaluate the data and compare the 
various groups.
Chronic Studies
2.11.2 Weight Changes
The control, quercetin- and shikimate-fed rats gained weight steadily 
throughout the study, while the bracken-fed rats had a slower rate of weight 
gain which- in the period up to week 4 differed significantly (p <0.005) and 
after week 4 (p <0.001) from the control (Figure 2.2).
2.11.3 Clinical Observations
Bracken-fed rats were v is ib ly  lis t less  from day 14 on the bracken diet. 
They had starring hair coats and by day 22 tended to tremble s lig h t ly . By 
day 26, four o f these rats developed ataxia and by day 27, three more 
developed th is c l in ic a l sign. Their re flexes  were du ll, they had an 
unsteady gait as well as to r t ico llis .
On day 28, one o f the bracken-fed rats died and was necropsied. To 
avoid the au to ly tic  changes that accompany such sudden deaths, a l l  the 
ataxic rats were- ether anaesthesised, term inally exsanguinated and 
autopsied. For comparative purposes, five  rats from the control group.were 
autopsied at this time.
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Figure 2.2 Height Gains of Rats in Chronic Study
fed (1) IS (w/w) quercetin diet (2) U  (w/w) shikimate diet 
(3) control diet (4) 10% (w/w) bracken diet
X102
0 5 10 15 20 25
Time (months)
Weights are the mean of twenty rats per group.
(A) The bracken-fed rats were statistically significantly 
different from the control, p < 0.005 up to week A 
and p ^ 0.001 up to the termination of the study.
At 8.5 months, one o f the bracken-fed rats was found dead and was 
necropsied. For comparative purposes, one each from the control, quercetin- 
fed and shikimate-fed rats were also autopsied after ether anaesthesia and
exsanguination via the posterior vena cava.
In order to avoid further sudden deaths and the d i f f ic u lt ie s  which 
could be imposed by au to ly tic  changes that would accomopany them, the 
remaining twelve bracken-fed rats were electively ether anaesthesisea, bled 
out and necropsied at 8.5 months along with four control rats.
At 24 months, nineteen rats each from the quercetin- and shikimate-fed
groups of rats and ten from the control group were autopsie'd.
During the course o f the study, none o f the rats in the control group 
or in the quercetin- and shikimate-fed groups showed any c lin ica l signs of 
illness,
2.11.4 Gross pathology
The ataxic bracken-fed rats necropsied at week 4 revealed loss o f 
subcutaneous fa t.
The bracken-fed rat that died suddenly at 8.5 months had an i le a l  
intussucception with a portion of the ileum telescoping over an ile a l tumour 
into the succeeding part up to a distance of 1.5 cm. Other polypous tumours 
were found in the ileum with diameters, 0.2 - 0.5 cm.
Of the twelve bracken-fed rats e lectively autopsied at 8 months, eleven 
had tumours of diameters 0.2 - 1.0 cm in the jejunum and ileum (Plates I I I  
and IV).
There was a roughening o f the co r t ic a l surface o f the kidneys in a l l  
rats autopsied from 8.5 months on and increasing with age.
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PLATE III - Portion of ileum of male Wistar-albino rat fed 
10% (w/w) bracken diet showing an ileal adenoma at 8.5 months.
PLATE IV - Cross section of tubulous adenoma induced in rats fed 
10% (w/w) bracken diet (x 4) H & E.
2.11.5 H i s t o p a t h o l o g y
The bracken-fed rats autopsied at week 4 had a loss o f red pulp in the 
spleen, with eosinophil in filtra tion  o f the sinusoids and increasing numbers 
of macrophages. The liver had a slight dilation of the sinusoids while the 
kidneys had a s ligh t thickening of the serosal surface o f the Bowman's 
Capsule. The predominant impression in the bone marrow was of megakaryocyte 
in filtra tion .
The bracken-fed rat that died of intussecception had an ileal tumour, 
but its histopathology was obscured by autolytic changes that had set in 
before necropsy.
The electively necropsied bracken-fed rats revealed ileal tumours which 
at histopathology were identified as tubulous adenomas (Plates V and VI). 
These tumours were characterised by increased mitoses in the epithelial 
cells, mild to severe epithelial dysplasia but in all cases they were 
sharply circumscribed and the muscularis mucosa was not penetrated.
There was increased mitoses in the hepatocytes as well as a widening of 
the sinusoids. In the spleen,, the red pulp was diminished, there was 
deposition o f golden brown pigment and the presence o f ceroid, a finding 
also present in the control. In the kidneys o f the bracken, control, 
quercetin and shikimate rats autopsied at 8.5 months, there was thickening 
of the serosal surface of the Bowman's Capsule and there were proteinaceous 
casts in the collecting ducts.
In the quercetin, shikimate and control rats autopsied at 24 months, 
the predominant impression in the spleen was of deposition o f ceroid, the 
red pulp was more diffuse and less compact and apparently diminished, there 
was golden-brown pigment both intra- and extra-corpuscular and an increase 
in the number of macrophages, in the kidney, tubular dilation was evident as 
well as tubular atrophy, there was deposition of protein casts and foci of 
mononuclear cells. In the papilla there was moderate vacuolation.
PLATE V - Section of tubulous adenoma from rat fed 
10% (w/w) bracken d iet, showing non-invasion of the 
muscularis mucosa by the benign tumour (x 50) H & E.
PLATE VI - Ile a l tubulous adenoma from rat fed 10% (w/w) bracken diet, 
showing eosinophilic paneth ce lls  and mitotic figures (x 313) H & E.
62
Sub-acute Studies
2.11.6 Weight Changes
The bracken-fed rats had a slower rate of weight gain than the control 
group (p <0.001) during the experimental period. The other test groups did 
not d iffe r  significantly from the control group (Figure 2.3).
2.11.7 Clinical Observations
The bracken-fed rats were listless and had piloerection. There were no 
clinical signs of illness in the rats in the other experimental groups.
2.11.8 Gross Pathology
The bracken-fed rats were cachetic, had little subcutaneous fat, and 
rough hairy coat.
2.11.9 Histopathology
The l iv e r  o f the bracken-fed rats revealed eosinoph ilic  hepatocytes 
with cytoplasmic and nuclear sw elling in the cen trilobu lar region 
accompanied by an increase in the number o f mitotic figures and a widening 
o f the sinusoids. The rats treated with cyclophosphamide over 11 and 13 
weeks respectively (ie. as promoter and initiator-promoter) had occasional 
single c e ll necrosis and increased m itosis..
The spleen of the quercetin, bracken, shikimate, cyclophosphamide 
(promoter and initiator-promoter), cyclophosphamide plus quercetin, cyclo­
phosphamide plus shikimate, shikimate plus cyclophosphamide, and quercetin 
plus cyclophosphamide groups revealed diminished red pulp and extra- 
follicular lymphoid hyperplasia in the central and littoral zones. 
Additionally, in these as well as in the control and saccharin groups there 
was deposition of golden-brown pigment which in the quercetin, bracken and 
shikimate groups was deposited both intra- and extra-cellular with respect 
to the increased numbers of macrophages in these groups and in the cyclo-
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Figure 2.3 Weight Gains of Rats in 90-Day Initialion-Promotion Study
fed (1) Control diet
(2) Various initiators and promoters
(3) 10? (w/w) bracken diet
X102
Time (weeks)
(1) Weights are the mean of fifteen rats from three 
groups (i.e. five per group).
(2) Weights are the mean of 115 rats from twenty-three 
groups (i.e. five per group).
(3) Weights are the mean of five rats.
Bracken-fed group was significantly different from the 
control groups, p < 0.001 throughout the studv period.
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phosphamide (initiator-promoter and promoter groups) cyclophosphamide plus 
quercetin, cyclophosphamide plus shikimate, shikimate plus cyclophosphamide 
and quercetin plus cyclophosphamide groups. There was increased splenic 
congestion in the saccharin group, while in the bracken group there was an 
increased number of mitotic figures, and foci of necrobiotic cells and 
siderophages, the latter being found in the quercetin group also. In the 
bracken group there was infiltration of eosinophils into the sinusoids.
The kidneys of the control, quercetin, bracken, dibutylnitrosamine and 
cyclophosphamide (initiator-promoter) groups revealed congestion of the vasa 
recta and in the quercetin group there was additionally focal tubular 
metachromasia, and in the shikimate group, epithelial desquamation of the 
collecting ducts.
The bone marrow of the shikimate and quercetin groups revealed slight 
fatty infiltration and the replacement of the marrow by lipocytes. The 
bracken group revealed an advanced but moderate stage of this lesion while 
the cyclophosphamide (promoter and initiator-promoter) groups represented a 
more severe stage of the lesion with increasing replacement of the marrow by 
lipocytes. The cyclophosphamide plus quercetin, cyclophosphamide plus 
shikimate ana shikimate plus cyclophosphamide groups revealed a near total 
replacement of the marrow by lipocytes.
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Table 2.2 Reproducibility3 and sensitivity*3 of the analytical methods
employed.
Assay Method Reproducibility (%) Sensitivity
Ornithine
Decarboxylase
■^ C - Liquid
Scintillation
Counting
Mean: 46 
Range: 8-93
Not
Applicable
Protein Folin and 
Ciocalteau's 
Phenol Reagent
Mean: 12 
Range: 6-18
1.2 ug/ml
Plasminogen
Activator
Chromogenic 
Substrate Assay 
using S-2251
Mean: 52 
Range: 2-149
345 IU/ml
Haemoglobin Drabkin's Reagent Mean: 14 
Range: 2-26
3 g%
Haematocrit Microhaematocrit
Centrifuge
Mean: 6 
Range: 2-11
Not
Applicable
Total
Erythrocytes
Coulter counter 
Model Dn
Mean: 9 
Range: 4-17
Not
Applicable
Total
Leucocytes
Coulter Counter 
Model Dn
Mean: 24 
Range: 4-64
Not
Applicable
Total
Platelets
Ammonium oxalate 
method of Austen 
and Rhymes (1975)
Mean: 24 
Range: 5-66
Not
Applicable
Total
Reticulocytes
Microscopic evalua­
tion o f thin smears
Mean: 0.4 
Range: 0.2-0.8
Not
Applicable
continued
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Table 2.2 Reproducibility3 and sensitivity*3 of the analytical
methods employed (continued).
Assay Method Reproducibility (%) Sensitivity
Mean Cell 
Volume
PCV x 10 = (fm) 
RBC
Mean: 4.1 
Range: 1.5-7.9
Not
Applicable
Mean ce ll 
Haemoglobin
Haemoglobin x 10 (pq) 
RBC
Mean: 4.9 
Range: 1.7-8.2
Not
Applicable
Mean Corpuscular
Haemoglobin
Concentration
Haemoglobin x 100 (%) 
PCV
Mean: 7.0 
Range: 1.7-26.4
Not
Applicable
Eosniophils Microscopic evalua­
tion of thin smears
Mean: 49 
Range: 34-70
Not
Applicable
Basophils Microscopic evalua­
tion of thin smears
Mean: 104 
Range: 71-220
Not
Applicable
Neutrophils Microscopic evalua­
tion of thin smears
Mean: 52 
Range: 9-102
Not
Applicable
Monocytes Microscopic evalua­
tion of thin smears
Mean: 59 
Range: 21-107
Not
Applicable
Lymphocytes Microscopic evalua­
tion of thin smears
Mean: 5 
Range: 3-14
Not
Applicable
a - The reproducibility of each method was assessed by determining the 
coefficient of variation by the formula (standard deviation/mean) x 100 to 
give a percentage value which is indicative of how easily reproducible 
repeated analysis with the method is. The smaller the value, the better the 
method used.
b - Sensitivity refers to the smallest quantity of the metabolite or 
substance that may be detected with the method. The smaller the value, the 
more sensitive the method is.
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2.11.10 Ornithine Decarboxylase Activ ity
The shikim ate-fed rats had s ig n ifica n tly  elevated leve ls  o f ODC 
activ ity  in the live r , intestine, spleen and kidney compared to the control, 
but the quercetin and bracken groups did not d iffe r  significantly from the 
controls in this regard (Table 2.3).
Table 2.3 Ornithine Decarboxylase (ODC) Activity at day 90, in Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets 
in the Sub-Acute Study
ODC Activity (pmole 14CO2/30 minutes/mg protein)
Group Bladder Liver Intestine Spleen Kidney
Control 151+22 3+1 14+2 1.3+2 30+6
Quercetin 125+17 3+1 10+2 15+1 32+8
Bracken 137+14 3+0 18+1 15+1 10+2
Shikimate 1026+436 119+48* 560+80* 100+5* 87+3*
Values are the means + s.E.M. of ten rats.
* - value significantly higher than control (p < 0.05) 
(Using the Student's t^test)
In the in it ia t io n  studies the quercetin plus cyclophosphamide, 
shikimate plus cyclophosphamide, the quercetin plus saccharin, shikimate 
plus saccharin, quercetin plus lithocholate and shikimate plus lithocholate 
treatments enhanced the le v e ls  o f ornithine decarboxylase in the tissues 
examined although i t  was not always consistent (Tables 2.4, 2.5 and 2.6).
Table 2.4 Ornithine Decarboxylase (ODC) A c t iv ity  at day 90, in the 
Bladder and Liver o f Rats in the In it ia t io n  Study on Quercetin and 
Shikimate using Cyclophosphamide
Group ODC Activity
(pmole -*-4CO2/30 minutes/mg protein)
In itia tor Promoter Bladder Liver
- Cyclophosphamide3 193+7 13+1
Cyclophosphamide Cyclophosphamide 149+7+ 13+1
Quercetin Cyclophosphamide 23000+9400* 113+44*
Shikimate Cyclophosphamide 1395+500* 84+33*
Values are the means + .S.E.M. of fiv e  rats.
a - control group
* - value significantly higher than control (p < 0.05)
+ - value significantly lower than control (p < 0.05)
(Using the Student's t - te s t )
Table 2.5 Ornithine Decarboxylase (ODC) A c t iv ity  at day 90, in the 
Bladder and L iver o f Rats in the In it ia t io n  Study on Quercetin and 
Shikimate using BBN and saccharin
Group ODC Activity
(pmole 14CO2/30 minutes/mg protein)
In itia tor Promoter Bladder Liver
- Saccharin3 597+101 6+1
BBN Saccharin 586+183 6+1
Quercetin Saccharin 710+196 260+100*
Shikimate Saccharin 5071+1467* 38+12*
Values are the means + S.E.M. of fiv e  rats, 
a - control group
* - value significantly higher than control (p < 0.05) 
(Using the Student's t-tes t)
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Table 2.6 Ornithine Decarboxylase (ODC) A c t iv ity  at day 90, in the 
Intestine and L iver o f Rats in the In it ia t io n  Study on Quercetin and 
Shikimate using MNNG and Lithocholate
Group ODC Activity
(pmole -^002/30 minutes/mg protein)
Initiator Promoter Intestine Liver
- Lithocholate3 3.0+2 9+3
MNNG Lithocholate 28+5* 9+1
Quercetin Lithocholate 65+19* 29+10
Shikimate Lithocholate 26+4* 6+2
Values are the means + S.E.M. of five  rats, 
a - control group
* - value significantly higher than control (p < 0.05) 
(Using the student's t-tes t)
In the promotion studies, the cyclophosphamide plus quercetin, BBN plus 
quercetin and MNNG plus quercetin elevated ODC leve ls  in the tissues 
examined though in the last-named group, i t  did not apply to the intestine 
(Tables 2.7, 2.8 and 2.9). The BBN plus shikimate treatment elevated the 
leve ls  in the l iv e r  but not in the bladder, while the MNNG plus shikimate 
treatment elevated the ODC le v e l in the in testine but not in the l iv e r  
(Tables 2.8 and 2.9).
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Table 2.7 Ornithine Decarboxylase (ODC) Activity at day 90, in the Bladder 
and L iver o f Rats in the Promotion Study on Quercetin and Shikimate using 
Cyclophosphamide
Group ODC Activity
(pmole -^co2/30 minutes/mg protein)
In itia tor Promoter Bladder Liver
Cyclophosphamide a 116+5 8+1
Cyclophosphamide Cyclophosphamide 149+7* 13+1*
Cyclophosphamide Quercetin 1100+366* 59+17*
Cyclophosphamide Shikimate 206+69 8+2
Values are the means + S.E.M. of five rats.
a - control group
* - value significantly higher than control (p < 0.05) 
(Using the Student's t-test)
Table 2.8 Ornithine Decarboxylase (ODC) Activity at day 90, in the Bladder 
and L iver o f Rats in the Promotion Study on Quercetin and Shikimate using 
BBN and Saccharin
Group ODC Activity
(pmole ^CO2/30 minutes/mg protein)
Initiator Promoter Bladder Liver
BBN a 446+18 14+2
BBN Saccharin 586+183 6+l+
BBN Quercetin 7700+3100* 86+31*
BBN Shikimate 24+4+ 2054+775*
Values are the means + S.E.M. of five rats.
a -  control group
+ -  value significantly lower than control (p < 0.05)
* -  value significantly higher than control (p < 0.05) 
(Using the Student's t-tes t)
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Table 2.9 Ornithine Decarboxylase (ODC) A c t iv ity  at day 90, in the 
In testin e and L iver o f Rats in the Promotion Study on Quercetin and 
Shikimate using MNNG and Lithochoiate
Group ODC Activity
(pmole -^002/30 minutes/mg protein)
In itia tor Promoter Intestine Liver
MNNG a 29+3 5+1
MNNG Lithochoiate 28+5 9+1*
MNNG Quercetin 26+11 177+71*
MNNG Shikimate 124+41* 7+1
Values are the means + S.E.M. of five rats.
a -  control group
* - value significantly higher than controls (p < 0.05) (Student's t-tes t)
Tab le 2.10 Comparison o f ODC values o f p o s it ive  control (BBN) with
appropriate control
Group ODC Activity (pmole •^ CO2/30 minutes/mg protein)
Bladder Liver
Control3 142+19 4+1
BBN 446+18* 14+2*
Values are the means + S.E.M. of fiv e  rats, 
a -  D istilled  water administered by gavage 
* - value significantly higher than control (p < 0.05) 
(Using the Student's t-tes t)
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Table 2.11 Comparison of ODC values of positive control (Saccharin) with
appropriate control
Group ODC Activity, (pmole 14CO2/30 minutes/mg protein)
Bladder Liver
Control3 151+22 .3+1
Saccharin 597+101* _ _ 'k 6+1
Values are the means + S.E.M. of fiv e  rats.
a - Rats fed normal rodent diet
* - value significantly higher than control (p < 0.05) 
(Using the Student's t-tes t)
Table 2.12 Comparison of ODC values of positive control (Cyclophosphamide) 
with appropriate control
Group ODC Activity (pmole 14CO2/30 minutes/mg protein)
Bladder Liver
Control3 148+18 3+1
Cyc lophosphamide*3 116+5 _ "k 8+1
Values are the means + S.E.M. of five rats.
a - D istilled  water administered intraperitoneaily 
b - Cyclophosphamide administered as in itiator 
* - value significantly higher than control (p < 0.05) 
(Using the Student's t-tes t)
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T a b l e  2.13 Comparison of ODC values of positive control (Cyclophosphamide)
with appropriate control
Group ODC Activ ity  (pmole 44CO2/30 minutes/mg protein)
Bladder Liver
Control61 148+18 3+1
Cyclophosphamide^ 193+7*
_ _ _ * 
13+1
Values are the means + S.E.M. of five  rats.
a - D istilled  water administered intraperitoneally
b - Cyclophosphamide administered as promoter
* - value significantly higher than control (p < 0.05)
(Using the Student's t - te s t )
T a b le  2.14 Comparison o f ODC values o f pos itive  control (MNNG) with 
appropriate control
Group ODC Activity (pmole 14CO2/30 minutes/mg protein)
Intestine Liver
Control3 12+2 4+1
MNNG 29+3* 5+1
Values are the means + s.E.M. of five  rats, 
a - D istilled  water administered by gavage 
* - value significantly higher than control (p < 0.05) 
(Using the Student's t-test)
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T a b l e  2.15 Comparison of ODC values of positive control (lithochoiate) with
appropriate control
Group ODC Activity (pmole -*-^ CO2/30 minutes/mg protein)
Intestine Liver
Control3 14+2 3+1
Lithochoiate 10+2 9+3
Values are the means + S.E.M. of five rats, 
a - Distilled water administered by gavage 
No statistical differences (Using the Student's t-test)
Table 2.16 Comparison of ODC values of dietary control with gavage control
Group ODC Activity (pmole 14CO2/30 minutes/mg protein)
Bladder Liver
Control (d iet) 151+22 3+1
Control (gavage) 142+19 4+1
Values are the means + S.E.M. of five  rats.
No sta tis tica l differences (Using the Student's t - te s t )
T a b le  2.17 Comparison of ODC values of gavage control with intraperitoneal
control
Group ODC Activity (pmole •^ CO2/30 minutes/mg protein)
Bladder Liver
Control (gavage) 142+19 4+1
Control (i/p) 148+18 3+1
Values are the means + S.E.M. of five rats.
No statistical differences (Using the Student's t-test)
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Table 2.18 Comparison of ODC values of dietary control with intraperitoneal
control
Group ODC Activity (pmole ^CO2/30 minutes/mg protein)
Bladder Liver
Control (d iet) 151+22 3±1
Control (i/p) 148+18 3+1
Values are the means + S.E.M. of five rats.
No statistical differences (Using the Student's t-test)
Tab le 2.19 Comparison of ODC values of dietary control with gavage control
Group ODC Activity (pmole 
Intestine
14CO2/30 minutes/mg protein) 
Liver
Control (gavage) 12+2 4+1
Control (diet) 14+? 3+1
Values are the means + S.E.M. of five rats.
No statistical differences (Using the Student's t-test)
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2.11.11 Plasminogen Activator (PA)
The quercetin-treated group had an elevated plasminogen activator level 
in the bladder only, while the le v e l o f plasminogen activa tor in the 
shikimate-treated group was lower in the live r (Table 2.20).
Table 2.20 Plasminogen Activator (PA) Activity at day 90 in Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and control Diets 
, in the Sub-Acute Study .
PA Activity (IU/mg protein) x 102
Group Bladder Liver Intestine Spleen Kidney
Control 28.0+8.1 10.2+4.2 20.4+9.2 7.0+2.6 1.1+0.4
Quercetin 50.0+4.0* 2.1+1.4 31.0+12.0 2.1+1.1' 5.3+3.0
Bracken 12.0+2.6 3.0+0.9 10.4+3.0 12.5+4.0 6.0+2.4
Shikimate 26.0+15.0 0.8+0.5+ 20.0+8.2 12.0+4.4 3.8+2.0
Values are the means + S.E.M. of fiv e  rats.
* -  value significantly higher than control (p < 0.05) 
+ -  value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
Table 2.21 Plasminogen A ctiva tor (PA) A c t iv ity  at day 90, in the 
Bladder and Liver o f Rats in the in it ia t io n  Study on Quercetin and 
Shikimate using Cyclophosphamide
Group PA Activity (IU/mg protein) x 102
In itia tor Promoter Bladder Liver
- Cyclophosphamide3 18.8+0.6 7.1+0.5
Cyclophosphamide Cyclophosphamide 21.6+1.8 9.3+0.8*
Quercetin Cyclophosphamide N.D.+ N.D.+
Shikimate Cyclophosphamide 20.3+4.2 5.9+3.8
Values are the means + S.E.M. of five  rats, 
a - control group 
N.D. - Not Detected
* -  value significantly higher than controls (p < 0.05) 
+ - value significantly lower than controls (p < 0.05) 
(Using the Student's t-tes t)
In the in itiation  studies the quercetin plus cyclophosphamide treatment 
depressed plasminogen activa tor leve ls  in the bladder and l iv e r  (Table
2.21), the quercetin plus saccharin treatment elevated the liver levels of 
plasminogen activator as did the shikimate plus saccharin treatment but in 
the bladder th is treatment depressed plasminogen activator levels (Table
2.22). However, the quercetin plus lithochoia te and shikimate plus 
lithoch oia te  treatments both elevated in tes tin a l plasminogen activa tor 
levels but while the quercetin plus lithochoiate treatment also elevated the 
live r levels, the shikimate plus lithochoiate treatment made no difference 
to the l iv e r  leve ls  (Table 2.23).
78
Table 2.22 Plasminogen Activator (PA) A c t iv ity  at day 90, in the 
Bladder and Liver o f Rats in the In it ia t io n  Study on Quercetin and 
Shikimate using BBN and Saccharin
Group PA Activity (iu/mg protein) x 102
Initiator promoter Bladder Liver
- Saccharin3 40.5+2.6 0.3+0.1
BBN Saccharin N.D.+ 2.7+0.1*
Quercetin Saccharin 62.3+27.0 6.8+1.7*
Shikimate Saccharin 9.3+0.6+ 1.0+0.1*
Values are the means + S.E.M. of five rats.
a - control group
N.D. - Not Detected
* - value significantly higher than controls (p < 0.05)
+ - value significantly lower than controls (p < 0.05)
(Using the Student's t-test)
T a b le  2.23 Plasminogen Activator 
Intestine and Liver of Rats in the 
Shikimate using MNNG and Lithocholate
(PA) Activity at day 
Initiation Study on
90, in the 
Quercetin and
Group PA Activity (IU/mg protein) x 102
Initiator Promoter Intestine Liver
- Lithocholate3 1.1+0.1 4.5+0.1
MNNG Lithocholate 31.0+21.0* 3.3+0.1+
Quercetin Lithocholate 34.8+5.4* 5.9+0.2*
Shikimate Lithocholate 40.4+5.3* 2.3+1.7
Values are the means + S.E.M. of five  rats, 
a -  control group
* - value significantly higher than controls (p < 0.05)
+ - value significantly lower than controls (p < 0.05) (Student's t-tes t)
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In the promotion studies, the bladder level of plasminogen activator in 
the BBN plus shikimate treatment was elevated but the l iv e r  le v e l was 
depressed (Table 2.24). This pattern was reversed with the cyclophosphamide 
plus shikimate treatment (Table 2.25). Both the MNNG plus quercetin and MNNG 
plus shikimate treatments depressed in testin a l and l iv e r  plasminogen 
activator levels (Table 2.26).
T a b le  2.24 Plasminogen Activator (PA) Activity in the Bladder and Liver of 
Rats in the Promotion Assay on Quercetin and Shikimate using BBN and 
Saccharin
Group PA Activity (iu/mg protein) x 102
Initiator Promoter Bladder Liver
BBN a - N.D. 7.5+0.1
BBN Saccharin N.D. 2.7+0.1+
BBN Quercetin N.D. 5.7+1.5
BBN Shikimate 127.5+78.0* 2.1+1.1+
Values are the means + S.E.M. of five  rats, 
a - control group
* - value significantly higher than controls (p < 0.05) 
+ - value significantly lower than controls (p < 0.05) 
(Using the Student's t-tes t)
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T a b le  2.25 Plasminogen Activator (PA) Activity at day 90, in the Bladder and Liver 
Rats in the Promotion Study on Quercetin  and sh ik im ate using 
Cyclophosphamide
Group
In itiator Promoter
PA Activity (IU/mg protein) x 102 
Bladder Liver
Cyclophosphami dea - 17.9+0.9 8.4+0.5
Cyclophosphamide Cyclophosphamide 21.6+1.8 9.3+0.8
Cyclophosphamide Quercetin N.D.+ 7.5+3.2
Cyclophosphamide Shikimate 0.6+0.1+ 10.2+0.1*
Values are the means + S.E.M. of five  rats, 
a - control group
* - value significantly higher than controls (p < 0.05) 
+ - value significantly lower than controls (p < 0.05) 
(Using the Student's t-tes t)
T a b le  2.26 Plasminogen Activator (PA) Activity at day 90, in the Intestine 
and L iver o f Rats in the Promotion Study on Quercetin and Shikimate using 
MNNG and Lithochoiate
Group PA Activity (IU/mg protein) x 102
In itia tor Promoter Intestine Liver
MNNG 3 - 19.8+0.2 7.1+0.2
MNNG Lithochoiate 31.0+21.0 3.3+0.1^
MNNG Quercetin N.D.+ 4.4+0.2+
MNNG Shikimate 12.5+0.17+ 4.4+0.1+
Values are the means + S.E.M. of five  rats, 
a - control group
+ - value significantly lower than controls (p < 0.05) 
(Using the Student's t-tes t)
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Table 2.27 Comparison o f Plasminogen Activator (pa ) values o f p os it iv e  
control (BBN) with appropriate control
Group PA Activity (IU/mg protein) x 102
Bladder Liver
Control3 29.4+10.9 9.3+3.3
BBN N.D. 7.5+0.1
Values are the means + S.E.M. of five  rats.
a - D istilled  water administered by gavage
N.D. - Not Detected
No sta tis tica l differences (Using the Student's t-test)
Table 2.28 Comparison o f Plasminogen Activator (PA) values o f p os itive  
control (Saccharin) with appropriate control
Group PA Activity (iu/mg protein) x 102
Bladder Liver
Control3 28.1+8.1 10.2+4.2
Sacchar in 40.5+2.6 0.3+0.1+
Values are the means + S.E.M. of five  rats, 
a - Rats 'fed normal rodent diet
+ - value significantly lower than controls (p < 0.r05) 
(Using the Student's t-tes t)
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T a b l e  2.29 Comparison of Plasminogen Activator (PA) values of positive
control (Cyclophosphamide) with appropriate control
Group PA Activity (IU/mg protein) 
Bladder
x 102 
Liver
Control3
Cyclophosphamide^
30.0+10.4
17.9+0.9
10.5+5.4 
8.4+0.5
Values are the means + S.E.M. of five  rats, 
a - D istilled  water administered intraperitoneally 
b - Cyclophosphamide administered as in itia tor
No sta tis tica l differences (Using the Student's t-test)
T a b le  2.30 Comparison of. Plasminogen Activator (PA) values o f pos itive  
control (Cyclophosphamide). with appropriate control
Group PA Activity (IU/mg protein) x 102
Bladder Liver
Cont ro la 30.0+10.4 10.5+5.4
Cyclophosphamide*3 18.8+0.6 7.1+0.5
Values are the means + S.E.M. of fiv e  rats, 
a - D istilled  water administered intraperitoneally 
b - Cyclophosphamide administered as promoter 
No sta tis tica l differences (Using the Student's t-test)
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T a b l e  2.31 Comparison of Plasminogen Activator (PA) values of positive
control (MNNG) with appropriate control
Group PA Activity (IU/mg protein) 
Intestine
x 102 
Liver
Control3 21.3+9.8 9.3+3.3
MNNG 19.8+0.2 7. 1±0.2
Values are the means + S.E.M. of five  rats, 
a - D istilled  water administered by gavage 
No sta tis tica l differences (Using the Student's t-test)
Table 2.32 Comparison o f Plasminogen Activator (PA) values o f p o s it ive  
control (Lithocholate) with appropriate control
Group PA Activity (lU/mg protein) x 102
•
Intestine Liver
Control3 20.4+9.2 10.2+4.2
Lithocholate '1.1+0.1+ 4.5+0.1
Values are the means + S.E.M. of fiv e  rats, 
a - Rats fed on normal rodent diet 
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
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T a b le  2.33 Comparison o f Plasminogen Activator (PA) values o f d ietary 
control with gavage control
Group PA Activ ity  (IU/mg protein) 
Bladder
x 102 
Liver
Control (Diet) 28.1+8.1 10.2+4.2
Control (Gavage) 29.4+10.9 9.3+3.3
Values are the means + S.E.M. of fiv e  rats.
No s ta tis tica l differences (Using the Student's t-tes t)
T a b le  2.34 Comparison o f Plasm inogen A c t iv a to r  
intraperitoneal control with gavage control
(PA) va lues o f
Group PA Activ ity  (IU/mg protein) x 102
Bladder Liver
Control (i/p) 30.0+10.4 10.5+5.4
Control (Gavage) 29.4+10.9 9.3+3.3
Values are the means + S.E.M. of fiv e  rats.
No sta tis tica l differences (Using the Student's t-tes t)
T a b le  2.35 Comparison o f Plasminogen Activator (PA) 
control with intraperitoneal control
values o f d ietary
Group PA Activity (IU/mg protein) 
Bladder
x 102 
Liver
Control (Diet) 28.1+8.1 10.2+4.2
Control (i/P) 30.0+10.4 10.5+5.4
Values are the means + S.E.M. o f five  rats.
No s ta tis tica l differences (Using the Student's t-tes t)
T a b le  2.36 Comparison o f Plasminogen Activator (PA) values o f d ietary 
control with gavage control
Group PA Activity (IU/mg protein) 
Intestine
x 102 
Liver
Control (Gavage) 21.3+9.8 9.3+3.3
Control (Diet) 20.4+9.2 10.2+4.2
Values are the means + S.E.M. of five rats.
No statistical differences (Using the Student's t-test) 
2.11.12 Haematological Parameters
Blood Films
The thin blood films were evaluated for both the differential absolute 
leucocyte counts and to gain an impression of the nature of the cell types 
for each experimental group. The control blood films had small clusters of 
platelets spread evenly throughout the film. The red cells were evaluated as 
being normochromic, normocytic cells with a few poikilocytes. No Howell- 
Jolly Bodies or other inclusions were detected, nor was Rouleaux formation 
evident.
The predominant leucocyte in the control group was the mature 
lymphocyte, identified by its large nucleus which was pushed to one side and 
a small cytoplasmic space. The immature lymphocyte was seen occasionally as 
a large cell which consisted almost entirely of nucleus. In either case the 
nuclear chromatin was clear and contained azurophilic granules but was more 
dense in the mature cells than in the immature cells.
The monocyte was seen only rarely as a large cell with an indentation 
on one side. The cytoplasm was vacuolated and contained some azurophilic 
granules.
The neutrophil had a lobed nucleus with a pale blue to colourless 
cytoplasm and small characteristic granules. A few young neutrophils were 
evident by their "doughnut" ring nucleus.
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The eosinophil had a bilobed nucleus, and contained deeply acidophilic 
staining granules. They appeared to be larger than neutrophils.
Basophils were rare but identifiable by their lobed nucleus and large 
dark granules.
In the quercetin, bracken and shikimate test groups as well as the 
cyclophosphamide (initiator, promoter and init iator-promoter), cyclophos­
phamide plus quercetin, cyclophosphamide plus shikimate and shikimate plus 
cyclophosphamide group, the degree of polychromasia was not marked, relative 
to the control group but in the quercetin plus cyclophosphamide group this 
was more marked. In all these groups except the quercetin plus cyclo­
phosphamide group the mature erythrocyte was the main red cell while in the 
quercetin plus cyclophospamide the immature erythrocyte was. more common. 
Anisocytosis was not marked in any group but the cells were generally normo­
chromic although in cyclophosphamide plus shikimate, shikimate plus cyclo­
phosphamide and the cyclophosphamide (initiator-promoter)groups there were 
some erythrocytes with only a thin ring of haemoglobin on the periphery. 
There were no Heinz bodies but in the bracken, shikimate, quercetin, cyclo­
phosphamide (initiator-promoter), cyclophosphamide plus shikimate and 
shikimate plus cyclophosphamide groups there were varying degrees of 
Rouleaux formation. In addition, platelets were few and far between in the 
test groups.
The predominant leucocyte was the mature lymphocyte in all the test 
groups. Furthermore, in the various cell types there was a predominance of 
mature cells. The polymorphonuclear cells had characteristically staining 
granules as did the monocytes.
Haemoglobin
The bracken-fed groups had a statistically significantly lower 
haemoglobin level than the control, but while the shikimate and quercetin 
treated groups were not statistically lower, they revealed a biological 
downward trend relative to the control (Table 2.37). When compared to the 
cyclophosphamide-treated group either as initiator or promoter, the 
cyclophosphamide plus quercetin or shikimate, and quercetin or shikimate
plus cyclophosphamide were not s ta tis tica lly  significantly different from 
the cyclophophamide control, but the cyclophosphamide controls were both 
lower than the control (i/p ) group (Tables 2.41, 2.44, 2.49 and 2.50).
T a b le  2.37 Some Haematological parameters at day 90, o f Rats fed 1% (w/w) 
Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets in the 
Sub-Acute Study
Group Haemoglobin 
(g %)
PCV
(%)
Erythrocytes
(Total)
mm“ 3(xl06)
Leucocytes
(Total)
-3mm J
Platelets
mm_3(xl05)
Control 15.3+1.0 44.6+0.9 7.9+0.3 7524+833 3.9+0.1
Quercetin 12.9+0.8 38.8+1.3+ 4.7+0.9+ 3742+613+ 3.0+0.2+
Bracken 11.5+0.9+ 42.6+0.7 5.1+0.1+ 5739+368 3.0+0.3+
Shikimate 14.4+0.5 44.6+1.3 3.9+0.3+ 2977+239+ 3.1+0.3+
Values are the means + S.E.M. o f ten rats.
+ - value significantly lower than controls a and b (p < 0.05) 
(Using the Student's t-tes t)
T a b le  2.38 Derived Haematological Indices at day 90, o f Rats fed 1% (w/w) 
Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets in the 
Sub-Acute Study
Mean Cell Mean Cell Mean Corpuscular
Volume Haemoglobin Haemoglobin
Concentration
Groups MCV (fm) MCH (pg) MCHC (%)
Control 56.2+0.5 18.7+0.3 33.0+1.0
Quercetin 78.0+1.5 26.0+0.9 33.0+0.4
Bracken 84.3+0.6 23.5+0.9 27.0+1.5
Shikimate 112.5+2.5 35.5+0.3 31.0+0.3
Values are the means + S.E.M. o f ten rats.
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Table 2.39 Total Reticulocyte Counts at day 90, of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Groups Reticulocytes
Control 88000+88
Quercetin 65000+130+
Bracken 76500+306+
Shikimate 48000+96+
Values are the means + S.E.M. of five  rats.
+ = values s ta tis tica lly  lower than control (p<0.05) 
(Using the Student's t-tes t)
Table 2.40 Absolute D ifferential Leucocyte Counts at day 90, of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets 
in the Sub-Acute Study
Groups Eosinophils Basophils Neutrophils Monocytes Lymphocytes
Control 226+68 45+15. 1053+45 45+15 6170+75
Quercetin 165+39 15+7 636+150+ 75+11 2844+187+
Bracken 80+11 34+11 976+80 172+17* 4476+57+
Shikimate 71+12 6+6+ 536+30+ 48+6 2292+30 +
Values are the means + S.E.M. of five  rats.
*  - value significantly higher than control (p < 0.05) 
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
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T a b le  2.41 Some haematological parameters at day 90, o f Rats in the 
In itiation  Study on Quercetin and Shikimate using Cyclophosphamide
Group 
Initiator promoter Haemoglobin 
(9 %)
PCV
(%)
Erythrocytes 
(Total) 
mnf2 (xlO^)
Leucocytes
(Total)
-3mm J
- CPa 11.5+0.8 33.2+1.2 5.1+0.2 2966+51
CP CP 9.8+0.8 35.2+1.8 4.6+0.1 2601+121
Quercetin CP 11.5+1.1 40.2+0.3* 4.7+0.3 2420+252
Shikimate CP 13.4+1.6 38.0+0.3+ 3.8+0.3+' 3362+987
Values- are the means + S.E.M. of five  rats.
CP - Cyclophosphamide 
a - Control group
*  - value significantly higher than control (p < 0.05) 
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
T a b le  2.42 Derived Haematological parameters at day 90, o f Rats in the 
In itiation  Study on Quercetin and Shikimate using Cyclophosphamide
Mean Cell Mean Cell Mean Corpuscular
Group V o l u m e H a e m o g l o b i n Haemoglobin
(MCV) (MCH) Concentration
Initiator promoter (fin) (pg) (MCHC) (%)
- CP 64.7+0.6 22.5+0.2 36.0+0.4
CP CP 70.0+2.0 21.3+0.8 28.0+0.4
Quercetin CP 80.0+1.2 24.4+0.5* 30.0+3.6
Shikimate CP 100.0+3.6 35.2+0.6+ 34.0+1.8
Values are the means + S.E.M. o f five  rats.- 
CP - Cyclophosphamide
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Table 2.43 Total P la te le ts  and Reticulocytes at day 90, o f Rats in the 
In itiation  Study on Quercetin and Shikimate using Cyclophosphamide
Group
Initiator Promoter Platelets 
mnf2 (xlO^)
Reticulocytes
- Cyclophosphamide3 3.5+0.8 71400+142
Cyclophosphamide Cyclophosphamide 3.0+0.3 60000+180+
Quercetin Cyclophosphamide 3.7+0.5 125000^250*
Shikimate Cyclophosphamide 3.0+0.4+ 38000+38+
Values are the means + S.E.M. of five  rats, 
a - control group
* - value significantly higher than control (p < 0.05)
+ - value significantly lower than control (p < 0.05)
(Using the Student's t-test)
Table 2.44 Some Haematological parameters at day 90, o f Rats in the 
Promotion Study on Quercetin and Shikimate using Cyclophosphamide
Group
In itia tor Promoter. Haemoglobin PCV Erythrocytes Leucocytes
(%) (%) (Total) (Total)
mm( x l O^ )  mm~2
CP 3 13.6+0.4 34.6+1.2 5.9+0.3 2604+149
CP CP 9.8+0.8+ 35.2+1.8 4.6+0.1+ 2601+121
CP Quercetin 13.8+0.4 39.6+0.7* 4.9+0.5 2635+146
CP Shikimate 13.4+0.7 39.6+1.1* 4.5+0.2+ 3822+928
Values are the means + S.E.M. of five rats.
CP - Cyclophosphamide 
a - Control group
* -  value significantly higher than control (p < 0.05) 
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-test)
90
Table 2.45 Some Derived Haematological parameters at day 90, of Rats in the 
Promotion Study on Quercetin and Shikimate using Cyclophosphamide
Mean Cell Mean - Cell Mean Corpuscular
Group V o l u m e H a e m o g l o b i  n Haemoglobin
(MCV) (MCH) Concentration
Initiator Promoter (fm) (pg) (MCHC) (%)
CP 53.3+2.0 23.0+0.4 39.3+0.3
CP CP 70.0+2.0 21.3+0.8 27.8+0.4
CP Quercetin 80.0+1.5 28.1+0.8 34.8+0.6
CP Shikimate 88.8+1.0 29.1+0.7 33.0+0.7
Values are the means + S.E.M. of five rats.
CP - Cyclophosphamide
Table 2.46 Total P la te le ts  and Reticulocytes at day 90, o f Rats in the 
Promotion Study on Quercetin and Shikimate using Cyclophosphamide
Group
Initiator Promoter Platelets 
mnf2 (xlO^)
Reticulocytes
Cyclophosphamide3 - 3.5+0.1 84000+84
Cyclophosphamide Cyclophosphamide 3.0+0.3+ 60000+180+
Cyclophosphamide Quercetin 3.2+0.3+ 80000+160*
Cyclophosphamide Shikimate 3.2+0.4+ 67500+135+
Values are the means + S.E.M. of five  rats, 
a - Control group
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
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TABLE 2.47 Differential Absolute Leucocyte Counts at Day 90, of Rats in the 
Initiation Study on Quercetin and Shikimate Using Cyclophosphamide
GROUP
Initiator Promoter Eosinophil Basophil Neutrophil Monocyte Lymphocyte
- Cyclophosphamide3 47 + 15 17 + 6 189 + 85 47 + 23 2669 + 89
Cyclophosphamide Cyclophosphamide 31 + 5 10 + 5 182 + 79 52 + 17 2340 + 78+
Quercetin Cyclophosphami d e 29 + 5 10 + 5 266 + 24 48 + 8 2057 + 24+
Skikimate Cyclophosphamide 67 +  U 20 + 7 369 + 67 73 + 27 2824 + 33
Results are the mean + S.E.M. of five rats 
a = Control Group
+  = Values significantly lower than control p<0.05 (student's t-test).
TABLE 2.48 Differential Absolute Leucocyte Counts at Day 90, of Rats in the 
Promotion Study on Quercetin and Shikimate Using Cyclophosphamide
GROUP
Initiator Promoter Eosinophil Basophil Neutrophil Monocyte Lymphocyte
Cyclophosphamide3 - 36 + 11 1 0 + 5 218 + 85 57 + 21 2343 + 80
Cyclophosphamide Cyclophosphamide 31 +  5 10 + 5 182 + 79 52 + 17 2340 + 78
Cyclophosphamide Quercetin 3 2 + 5 11 + 6 169 + 79 53 + 9 2240 + 26
Cyclophosphamide Shikimate 122 + 42 53 + 18* 420 + 88 84 + 3l 3134 + 114*
Results are the mean + S.E.M. of five rats, 
a = Control Group
* = Values significantly higher than control, p<0.05 (Student's t-test)
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T a b l e  2.50 Comparison of Derived Haematological parameters of positive
control (Cyclophosphamide - initiator) with appropriate control
Mean Cell Mean Cell Mean Corpuscular
Group V o l u m e H a e m o g l o b i n Haemoglobin
(MCV) (MCH) Concentration
(fm) (pg) (MCHC) (%)
Control3 61.6+2.0 20.5+2.0 33.1+0.1
Cyclophosphamide*3 58.3+2.0 23.0+0.4 39.3+0.3
Values are the means + S.E.M. of five rats, 
a - Distilled water administered intraperitoneally 
b - Cyclophosphamide administered as initiator
H aem atocrit
The quercetin-treated group had a statistically significantly lower PCV 
than the control group (Table 2.37), but the quercetin plus cyclo­
phosphamide, shikimate plus cyclophosphamide, cyclophosphamide plus 
quercetin and cyclophosphamide plus shikimate groups all had statistically 
significantly higher PCV than the appropriate cyclophosphamide controls 
(Tables 2.41 and 2.44). The cyclophoaphamide controls were statistically 
lower than the intraperitoneally treated control group (Table 2.49 and 
2.50).
T o ta l E ry th ro cy te  Counts
The quercetin, bracken and shikimate groups (Table 2.37) as well as the 
cyclophosphamide (in itia to r-p rom oter), cyclophosphamide plus quercetin, 
cyclophosphamide plus shikimate and shikimate plus cyclophosphamide groups 
had lower to ta l erythrocyte counts re la t iv e  to the respective controls 
(Tables 2.41, 2.44, 2.49 and 2.50).
94
T o t a l  Leucocyte counts
The quercetin and shikimate groups had a statistically lower leucocyte 
count, and the bracken group showed a biological downward trend (Table
2.37). The cyclophosphamide (initiator and promoter) groups had a 
statistically significant leucopenia compared to the control (i/p) group 
(Tables 2.49 and 2.50).
T o ta l P la te le ts
The quercetin, bracken and shikimate groups had a thrombocytopenia 
(Table 2.37) as did cyclophosphamide (initiator-promoter), cyclophosphamide 
plus quercetin, and cyclophosphamide plus shikimate groups (Table 2.46). 
With the exception of the quercetin plus cyclophosphamide group, the 
cyclophosphamide plus cyclophosphamide, and shikimate plus cyclophosphamide 
groups had a biological downward trend in their platelet counts (Table
2.43).
R e tic u lo cy te s
With the exception of the quercetin plus cyclophosphamide group (Table
2.43), all other test groups had a statistically significantly lower 
reticulocyte count relative to the control groups (Tables 2.43 and 2.46).
D erived  H aem ato log ica l In d ice s
The Mean Cell Volume (MCV) calculated for the quercetin, bracken and 
shikimate groups (Table 2.38) as well as the cyclophosphamide (initiator- 
promoter), quercetin plus cyclophosphamide, shikimate plus cyclophosphamide, 
cyclophosphamide plus quercetin, and cyclophosphamide plus shikimate groups 
indicate a macrocytic anaemia (Tables 2.38, 2.42 and 2.45), and the Mean 
Cell Haemoglobin (MCH) correlates well with the MCV in these groups, the 
Mean Corpuscular Haemoglobin Concentration (MCHC) however indicates a 
normochromasia in each of these groups.
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D i f f e r e n t i a l  L e u c o c y t e  coun t s
The quercetin, bracken and shikimate groups revealed a b io lo g ica l 
downward trend in the granulocytes and lymphocytes (Table 2.40), but in 
conjunction with cyclophosphamide this trend was not consistently maintained 
especially in the shikimate plus cyclophosphamide and cyclophosphamide plus 
shikimate groups (Tables 2.47 and 2.48).
Table 2.52 Comparison o f Derived Haematological parameters of p os itive  
c o n tro l (Cyclophosphamide ~ prom oter) w ith  appropria te  c o n tro l
Mean Cell Mean Cell Mean Corpuscular
Group Volume Haemoglobin H a e m o g l o b i n
(MCV) (MCH) Concentration
(fm) (pg) (MCHC) (%)
Control3 61.6+2.0 20.5+2.0 33,1+0.1
Cyclophosphamide*3 64.7+0.6 22.5+0.2 36.0+0.4
Values are the means + S.E.M. of five  rats, 
a - D istilled  water administered intraperitoneally 
b - Cyclophosphamide administered as promoter
T a b le  2.53 Comparison of Absolute D ifferential Leucocyte Counts of positive 
control (Cyclophosphamide - in itia tor) with appropriate control
Groups Eosinophils Basophils Neutrophils Monocytes Lymphocytes
Control3 280+35 25+13 957+191 50+13 4977+64
CP b 36+11+ 10+5 218+85+ 57+21 2343+80+
Values are the means + S.E.M. of five  rats.
CP - Cyclophosphamide
a -  D istilled  water administered intraperitoneally 
b -  Cyclophosphamide administered as in itiator 
+ -  value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
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Table 2.54 Comparison of Absolute Differential Leucocyte Counts of positive 
control (Cyclophosphamide - promoter) with appropriate control
Groups Eosinophils Basophils Neutrophils Monocytes Lymphocytes
Control3 280+35 25+13 957+191 50+13 4977+64
CP b 47+15+ 17+6 189+85+ 47+23 2669+89+
Values are the means + S.E.M. of fiv e  rats.
CP - Cyclophosphamide
a - D istilled  water administered intraperitoneaily 
b - Cyclophosphamide administered as promoter 
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)

Table 2.56 Comparison o f Derived Haematological parameters o f Dietary 
Control with Intraperitoneal Control
Group
Mean Cell 
Volume 
(MCV) 
(fm)
Mean Cell 
H aem oglobin  
(MCH)
(pg)
Mean corpuscular 
Haemoglobin 
Concentration 
(MCHC) (%)
Control (d iet) 
Control (i/p)
56.2+0.5
61.6+2.0
18.7+0.3
20.5+2.0
33.0+1.0
33.1+0.1
Values are the means + S.E.M. of five  rats.
Table 2.57 Comparison of Absolute D ifferential Leucocyte Counts of Dietary 
Control with Intraperitoneal Control
Groups Eosinophils Basophils Neutrophils Monocytes Lymphocytes
Control 226+68 
(d iet)
45+15 1053+45 45+15 6170+75
Control 2U0+35 
(i/p)
25+13 957+191 50+13 4977+64+
Values are the means + s.E.M. of five rats.
+ - value significantly lower than control (p < 0.05) 
(Using the Student's t-tes t)
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2.12 Discussion
2.12.1 Chronic Study
The objective of the chronic study was to determine if shikimate and/or 
quercetin, both compounds isolated from bracken were responsible for the 
carcinogenicity of bracken. Although it is the accepted strategy and method 
in these studies to feed the compound over the entire life span of the 
animal (in this case, two years), this practice has not been followed here 
because it is more a comparative study of the carcinogenic properties of 
shikimate and quercetin with those of bracken rather than an empirical 
determination of the independent carcinogenic properties of shikimate and 
quercetin. Hence the two test compounds, quercetin and shikimate, were fed 
only for as long as the parent composite, bracken. In addition, the expense 
of life-time feeding fore closed that option in this study.
The 1.0% (w/w) levels used for quercetin and shikimatfe are higher than 
the levels normally obtained in bracken. Shikimate is estimated to occur at 
a l e v e l  o f  1.44 mg/g dry w eigh t o f  bracken (I.A . Evans, persona l 
communication to Hirono et a l., 1977a), equ/alent to 0.14%. However, th is  
dose level had been previously employed without any tumours developing even 
when fed for 142 days/the use o f a ten -fo ld  increase ought, i f  there is  a 
dose-related carcinogenic e f fe c t ,  to produce tumours in some o f the 
experimental rats. As i t  is there were no tumours in any of the shikimate- 
fed rats up to two years old. The amount o f quercetin. in bracken has been 
estimated at 0.57 g per kg dry weight of bracken or 0.057% (Pamukcu et a l., 
1980b). However, various quantities of quercetin have been used and only one 
report o f quercetin carcinogen icity has so far been recorded (pamukcu et 
al., 1980b) and the failure to reproduce i t  elsewhere has cast doubt on the 
real carcinogenic activ ity  of quercetin.
There were however certain histopathological lesions in some of the 
quercetin- and shikimate-fed rats which deserve a mention with regard to the 
age of the rats rather than as evidence of compound related toxic effects. 
In this regard, the foci of mononuclear cells in the kidneys of both groups 
as well as in the control rats are indicative of a chronic 
glomerulonephritis which is commonly observed in rats of this age and has 
been termed "rat nephropathy". The ceroid which was deposited in the spleen
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may be a product o f l ip id  peroxidation, but may also be found along with 
golden brown pigment and/or lipo fu scin  in organs undergoing cachexia or 
sen ile  atrophy.
The bracken-induced ataxia which occurred in some rats at week 4, had 
been observed in other studies and attributed to the actions of the enzyme 
thiaminase (Weswi<j et al., 1946? Evans and Evans, 1949). This phenomenon! is 
further examined in chapter Three.
The intussuception which led to the sudden death of one o f the bracken- 
fed rats was the main factor that led to the premature termination o f this 
aspect of the Chronic Study at 8.5 months rather than at 24 months.
Intussuceptions were found in previous studies on bracken carcinogeni­
c ity  (Evans and Mason, 1965; Pamukcu et a l . , 1980b). Intussuceptions occur 
as a resu lt o f abnormal p e r is ta ls is  in on.e part o f the gut so that 
successive portions are moving more slowly than preceeding portions and the 
former then telescope into the latter. Bracken-induced tumours tend to occur 
in those parts of the gut where the gut is more prone to stagnation (Hirono 
et al., 1977b). These may suggest the presence of an "antim otility agent" in 
the bracken or may suggest that the fibrous content o f bracken induces 
greater than usual catharsis.
The implication of intussuception that might occur in the course of a 
long-term carcinogenicity test ought to be borne in mind in the adoption o f 
tox icity testing schedules and the need for f le x ib il ity  in these studies, in 
th is study, the 10% (w/w) bracken d ie t is  already low compared to other 
studies where 15-70% (w/w) bracken d iets have been used (Appendix I ) .  
Another measure might be to implement additional or s a te llite  groups to take 
account o f such an even tua lity , but the additional cost, must be borne *in 
mind.
The resu lt o f the term ination o f the study at 8.5 months was that 
benign tumours only, were induced in the experimental rats. These may 
progress to malignancy i f  le f t  for a longer period. However, the ab ility  of 
bracken to induce tumours has been demonstrated but the a b il i t y  is  not 
attributable to either quercetin or shikimate.
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2.12.2 Sub-Acute Study
The studies on ornithine decarboxylase and plasminogen activator were 
carried out to determine the tumour promoting activ ities  of quercetin and 
shikimate. The enzyme orn ith ine decarboxylase (ODC; EC 4.1.1.17) catalyses 
the formation o f the polyamine putrescine which is  the precursor o f 
spermidine. The polyamines are found in very high concentrations in those 
tissues with very high rates o f b iosynthetic activity, rapid ly growing 
tissues, embryonic tissues and neoplasms (Russell and Snyder, 1968). The 
decarboxylation of ornithine to form putrescine is a rate-lim iting step in 
the formation of polyamines and the determination of ornithine decarboxylase 
has been used as a sen s itive  and consistent index in the determination o f 
tumour promoting a c t iv ity  by various chemicals (O'Brien, 1976; Hosaka et 
a l . , 1983) because the tumour prom otion phase o f the tw o-stage
carcinogenesis model is  the phase o f rapid c e l l  d if fe r e t ia t io n  and 
proliferation. k
"Plasminogen activa tor" is  a term which re fers  to a wide va rie ty  o f 
proteases whose ultim ate b io lo g ica l a c t iv ity  is  the opening o f peptide 
linkages in fibrin  and fibrinogen and clot lysis. Plasminogen activator is 
found.in  high le v e ls  in transform ed c e l l s ,  but un like o rn ith in e  
decarboxylase i t  is not an obligatory or consistent finding in transformed 
ce lls  (P ito t, 1981).
In these studies the techniques used for the determination of ornithine 
decarboxylase is the sensitive liquid scin tillation  technique based on ^4C. 
In applying it ,  a coeffic ient of variation (reproducibility) was an average 
of 46%, ranging from 8-93% in comparison to the range of 16-244% obtained by 
Ball and Balis (1976). Other studies indicate a high degree o f individual 
v a r ia b il it y  in the application  o f the method in the determination o f ODC 
(Hosaka et a l . , 1983). In determining plasminogen activa tor, the use o f a 
chromogenic substrate is  convenient, but its  rep rodu cib ility  is highly 
dependent on the type o f tissue or c e l l  system to which i t  is  applied. In 
primary c e l l  cultures a c o e ff ic ie n t  o f varia tion  o f 35% was obtained 
compared to 0.25% in metastasizing Lewis Lung Carcinoma Cells (Whur et al.,
1980). This is  in contrast to a reprodu cib ility  o f 52% (range 2-149%) in 
this study,. but these were whole organs with the greater potential for the 
presence of potential plasminogen activator inhibitors such as antiplasmin 
and <*i2-macroglobulin (Richards et al., 1983).
The shikimate-fed rats had a consistently elevated ODC level in all the 
tissues examined with the exception of the bladder where it was not a 
statistically significant change. This is indicative of tumour promoting 
ability on the part of shikimate. In conjunction with other test compounds 
which have been used as tumour promoters and initiators, there was an 
inconsistent elevation of ODC in some organs but not in others. In 
conjunction with cyclophosphamide and saccharin, shikimate administered as 
an initiator demonstrated an ability to enhance ODC levels in both the 
bladder and liver, and in conjunction with lithocholate in the intestine but 
not in the liver. While it was envisaged to evaluate shikimate as an 
initiator in these studies, the fact that shikimate was not administered as 
a single dose would invalidate that criterion for evaluation of shikimate, 
but this strategy was adopted as a result of the need to achieve adequate 
doses of shikimate before the promoter was administered. This in turn 
suggests that it may be more valid to discuss these results not on the basis 
of "initiators" and "promoters" but on the basis of "cell transformation" as 
an umbrella term for initiation and promotion. To further buttress this is 
the emergent idea that initiation and promotion may not be such clearcut 
phenomena as hitherto thought (Bannasch, 1984), some promoters being 
considered as weak carcinogens. Therefore the crucial issues would appear 
not to be classification of compounds but on their mechanisms of actions, 
interactions with various other compounds and their target organs. Another 
development which has a bearing on this area of work is that more recent 
evidence points to two classes of promoters - the first stage promoter which 
may alter the genetic material of initiated cells in such a way that only 
one application would have an obligatory effect for promotion, whereas a 
second stage promoter would require repeated applications for the same 
effect. In addition to the foregoing is the concept of co-carcinogenesis in 
which two carcinogens may act co-operatively to induce cancer but each on 
its own cannot. It has been shown that papillomas induced by the initiation- 
promotion model- differ from those induced by the application of carcinogen 
alone (Reddy and Fialkow, 1983).
These various concepts may be at play individually or in concert in any 
process o f carcinogenesis. Thus the a b il i t y  o f shikimate on it s  own to  
enhance ODC production in various organs (Table 2.3) is indicative of tumour 
promoting ab ility  but its  interactions with cyclophosphamide, saccharin and 
lithochola te  need not necessarily re fer to the same process, pertinent to
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the above is the induction o f glandular gastric neoplasia and leukaemia in 
TFI mice by shikimate. Those results, achieved by a single intraperitoneal 
in jec tion  or oro-gastric  gavage o f shikimate show that shikimate is  
carcinogenic to mice (Evans and Osman, 1974) but in the ligh t o f the ODC 
resu lts in rats i t  may also be in ferred  that i t  is  probably a stage one 
promoter in rats but in another species (mice) acts as a carcinogen.
The rest of the results of shikimate administered as a promoter may 
then be viewed against the background of the foregoing, considered as a 
promoter, it does not enhance ODC activity, relative to the cyclophosphamide 
(initiator) control (Table 2.7). When considered with aibutyl nitrosamine 
(BBN) as an initiator however, it enhanced ODC activity in the liver but not 
in the bladder. While the bladder may be a target organ for BBN it is 
noteworthy that shikimate did not enhance ODC activity in the bladder in a 
statistically significant way (Table 2.3). With MNNG the level of intestinal 
ODC was enhanced but not the liver suggesting a target organ effect probably 
due in the main to MNNG.
The results o f shikimate with regard to plasminogen activator levels 
show a lowered effect on the liver of shikimate treated rats but this may be 
attributed to the possible action o f plasminogen activa tor inh ib itors 
already mentioned above. Otherwise the plasminogen activator resu lts in 
Table 2.20 were largely non-statistically significant. Whereas shikimate (as 
in itia tor) in conjunction with cyclophosphamide enhanced ODC levels in the 
bladder and l iv e r ,  i t  did not achieve the same with regard to plasminogen 
activator, but with saccharin i t  enhanced liver plasminogen activator levels 
but not bladder le v e ls  (Table 2.22). With lithochoia te  i t  enhanced 
in te s tin a l le v e ls  o f plasminogen activator but not l iv e r  leve ls . These 
results may illustrate the ab ility  of shikimate to act synergistically or 
a d d itive ly  with some o f the tes t compounds, or i t  may il lu s tra te  the 
p red ilection  of shikimate and the tes t compounds concerned fo r certain  
target organs, but i t  must also be seen as the d ifferen ce in response to a 
set o f te s t substances by two markers o f tumour promotion - orn ith ine 
decarboxylase and plasminogen activa tor. On these resu lts , the greater 
r e l ia b l i l i t y  o f ornith ine decarboxylase as a marker would tend to be 
confirmed. When administered as a promoter, shikimate tended to act more 
compatibly with cyclophosphamide than when administered as an in it ia to r  
(Tables 2.21 vs 2.25) with respect to the liver. The same, however, does not 
hold true when MNNG and lithochoiate were used (Tables 2.23 vs 2.26).
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The results of ODC activ ity  as affected by quercetin show that on its  
own quercetin did not enhance ODC a c t iv ity  in any o f the organs examined 
(Table 2.3). However, in conjunction with cyclophosphamide i t  enhanced ODC 
activ ity  in the bladder and the liver regardless of whether i t  was applied 
before or after cyclophosphamide. In conjunction with saccharin, however, i t  
elevated liver but not bladder ODC and in conjunction with lithocholate it  
enhanced in tes tin a l but not l iv e r  ODC a c t iv ity . With dibutyl nitrosamine 
(BBN) i t  enhanced both liver and bladder ODC activ ity  but with MNNG, liver 
but not in tes tin a l ODC a c t iv ity  was enhanced. These resu lts may be 
in terpreted as re fle c t in g  the a b i l i t y  o f quercetin to  act as a tumour 
promoter in certain organs and in conjunction with certain compounds. This 
view may be further buttressed by some o f the plasminogen activa tor data 
such as the enhanced a c t iv ity  o f the bladder plasminogen activator by 
quercetin (Table 2.20), quercetin plus saccharin ( l iv e r )  (Table 2.22), and 
quercetin plus lithochola te  (Table 2.23). These resu lts take on added 
significance in view of the carcinogenicity test results which showed that 
quercetin could act as a carcinogen in the rat (Pamukcu et a l., 1980b). The 
issues raised ea r lie r  with the shikimate resu lts and the p os itive  mouse 
carcinogenicity study are raised here again. That is , the possib ility that 
quercetin may be a stage one promoter capable under certain conditions of 
inducing cancer.
While the above issues remain, the results of previous, studies on 
quercetin should be recalled as these are relevant at this stage. Other 
studies in various animal models using varying levels of quercetin showed 
that quercetin is not a carcinogen (Ambrose et al., 1952; Morino et al., 
1982; Takanashi et al., 1983). It was suggested that the rapid
detoxification was the reason for its non-carcinogenicity (Ueno et al., 
1983). Apart from its non-carcinogenicity it lacks tumour promotion 
capability (Fukushima efc al., 1983; Kato et al., 1983; 1984). It was 
postulated that this effect was mediated via inhibition of lipoxygenase, an 
enzyme responsible for facilitating the insertion of oxygen into free fatty 
acids and considered to be a pre-oxidant (Kato et al., 198'3). It was 
suggested that lipoxygenase products are essential for tumour promotion 
(Fischer et al., 1982). This action of quercetin is part of its inhibitory 
action on several enzymes like cycloxygenase, hyaluronidase, histidine- 
decarboxylase, xanthine oxidase, mitochondrial bound hexokinase, ATPase and 
aldolase reductase amongst others (Gschwendt et al., 1983). In addition to
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these, quercetin in h ib its  DNA, RNA and protein synthesis (Graziani and 
Chayoth, 1979), but tumour promoters increase DNA and RNA synthesis (P itot,
1981).
These reports are strongly  ind icative o.f quercetin as lacking both 
tumour promoter and carcinogenic potential. The results of its  enhancement
of ODC activ ity  in conjunction with other test compounds already adumbrated/...
above may therefore not be a ttribu tab le to any rea l contributions by! 
quercetin because when tested on it s  own i t  did not produce th is enhanced 
e ffe c t  (Table 2.3). Furthermore, its  e ffe c t  on the plasminogen activa tor 
le v e l o f the bladder may be seen as an iso lated  e ffe c t  and plasminogen 
activa tor is  a less re lia b le  index o f tumour promotion than ornithine 
decarboxylase. The weight o f evidence would on balance be in favour o f 
qu erce tin  as lack in g  prom oter c a p a b il ity ,  but the is o la te d  and 
uncorroborated report of its  carcinogenicity in rats (Pamukcu et al., 1980b) 
remains to be c larified .
In proceeding with further studies on the b io lo g ica l e ffe c ts  o f 
quercetin, i t  may be instructive to study its  interaction with shikimate, a * 
compound along with whicfo i t  is a co-constituent of bracken and which has 
shown promoting action in th is  study. I t  is  noteworthy tHat quercetin is  
mutagenic, and it  would be interesting to see how this activ ity  is related 
to shikimate's promoting capab ility  in the context o f bracken carcino­
gen ic ity . In th is regard the ro le  of ptaquiloside may also be examined 
alongside these two isolates and candidate carcinogens.
The haematological studies were carried out to examine the roles o f 
shikimate and quercetin in the production of the haematological syndrome in 
bracken to x ic ity . The study was a 90-day sub-acute study with the 
determination o f various haematological indices at the end o f the study.
This is  perhaps the most important lim ita tion  o f th is  study in that so 
dynamic a process as haemopoiesis requires continuous monitoring over 
several time points in the course of the study. This strategy may be adopted 
by bleeding the experimental animals from the t a i l  vein for example, and 
determining the various indices required. This approach is  however not 
without hazard espec ia lly  where very young rats are used in startin g  the 
experiment as very small volumes o f blood may be a l l  that can be sa fe ly  
obtained from them. The use of sa te llite  groups reserved for this purpose is 
a way round the problem but is an added expense.
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The o vera ll impression o f the e ffe c t  o f quercetin, shikimate and the 
parent composite, bracken, o f which they are consituents is  a depressant 
e ffect on haemopoiesis. This is evidenced by the fatty in filtra tion  of the 
bone marrow. This was more marked in the bracken-fed rats and less so in the 
quercetin- and shikimate-fed rats. The resultant e ffe c t  o f th is is  the 
reduction in the numbers of erythrocytes, leucocytes and platelets in these 
three groups compared to the control (Table 2.37). Although the bracken-fed 
rats did not reveal a s ta tis tica lly  significantly lower number of leucocytes 
than the control, the overall numbers were numerically lower indicating a 
b io lo g ic a lly  downward trend. The lower numbers o f re ticu locytes in these 
three test groups compared to the control (Table 2.39) would indicate a non- 
regenerative bone-marrow damage, but it  is important to view this conclusion 
with caution especially as this was a single time-point observation. I t  is 
not at a l l  evident from such an observation what the events preceeding or 
succeeding this particular observation are and in a dynamic process such as 
haemopoiesis i t  is  important or perhaps even imperative that such a 
continuous picture should be taken into account in considering the effects 
of a particular compound in the process of haemopoiesis.
These lim ita tion s notwithstanding, the test compounds quercetin and 
shikimate and their parent composite, bracken, induce in male Wistar-Albino 
rats, a macrocytic, normochromic non-regenerative anaemia (Tables 2.37 and
2.38) with bone-marrow hypoplasia.
The erythrocyte count which gave the indication of anaemia was 
determined in a Coulter Counter (Model Dn), with a reproducibility of 9% 
which is less accurate than the estimated +2% suggested for such instruments 
(Mitruka and Rawnsley, 1977). The Mean Cell Volume (MCV) in each of the test 
groups was higher than the control, but the value of 112.5 fm for shikimate 
is extremely high and although the impression of a macrocytic anaemia may 
not be in doubt, the value may reflect errors in the estimation of the 
erythrocyte count or the packed cell volume or both. The reproducibility of 
6% for the microhaematocrit method for determination of the packed cell 
volume is within the range of 2.25 -  8% estimated for this method (Mitruka 
and Rawnsley, 1977), ana it may therefore be correct to attribute any errors 
of estimation to the total erythrocyte count.
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The bone-marrow hypoplasia is  also re flec ted  in the accompanying 
agranulocytopenia which was a feature of the leucopenia o f the quercetin-, 
bracken- and shikimate-fed rats, along with a lymphocytopenia. Although the 
granulocytes did not always show a s ta t is t ic a l ly  s ign ifica n t d ifferen ce  
compared to the control (Table 2.40) the numerical values were lower and 
reveal a b io lo g ica l trend. However, the monocytes o f the bracken-fed rats 
were s ta tis tica lly  significantly higher than the control. This may reflect a 
response to the agranulocytopenia which was evident in the bracken-fed rats. 
In the absence of the polymorphonuclear cells , the monocytes may step in and 
take up the defence functions o f the body. However, monocytosis is  a very 
rare phenomenon in  the ra t and i t  may be more apparent than re a l 
representing a "sympathetic d r ift"  rather than a genuine biological effect.
The other features of this hypoplasia are the accompanying thrombo­
cytopenia which had been observed and reported in other cases of bracken 
toxicity and its nonregenerative nature. However, the method of Austen and 
Rhymes (1975) suffers from the fact that too few platelets are used for the 
estimation because of the small area of the counting chamber which is used. 
This may be a source of errors. The lower numbers of reticulocytes is 
indicative of a failure to produce enough red cells and get them into the 
peripheral circulation. This is however only valid in the context of the 
time-point (ie. at day 90) when this observation was made. Whether this is a 
part of a trend can only be fully determined by having a continuous picture 
of the events.
When either shikimate or quercetin was used in conjunction with 
cyclophosphamide as an initiator or as a promoter, there was a reduction in 
the number of erythrocytes compared to the appropriate positive control 
(Tables 2.41 and 2.44), but not in the leucocytes. Although the shikimate 
plus cyclophosphamide group had a thrombocytopenia and a reduction in the 
number of reticulocytes (Table 2.43) the quercetin plus cyclophosphamide 
group had a higher number of platelets than the cyclophophamide (promoter) 
control and a reticulocytosis (Table 2.43). Although these groups had bone 
marrow hypoplasia, it is not clear whether these effects can be attributed 
to the effect of cyclophosphamide alone or quercetin alone or shikimate 
alone or an effect of both chemicals. This is because when used as a 
promoter, cyclophosphamide on its own induced a macrocytic normochromic 
anaemia compared to the control group (Table 2.52). In addition there was a 
leucopenia. This may indicate that with hindsight the dose of
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cyclophosphamide used was too high. Cyclophosphamide is  one o f the known 
causes of macrocytic anaemia (Richards et al., 1983).
The quercetin plus cyclophosphamide group had a reticulocytosis (Table
2.43) which was evident as a burst o f immature erythrocytes in the thin 
smears and an accompanying high Mean C e ll volume (MCV) o f 80.0+1.2 (Table 
2.42). Such a burst o f re ticu locytes may occur i f  one or two m itotic  steps 
are missed, and the c e l l  is  prematurely thrust into the c ircu lation . Such 
re ticu locy tes w i l l  boost the absolute re ticu locyte  count but are not 
re flective  of the true state of erthropoiesis in the bone marrow. A trigger 
fo r such a phenomenon is the rapid drop in haemoglobin le v e ls  which then 
results in a failure of the mechanism whereby iron and erythropoietin act as 
the regulators o f red c e l l  synthesis. I t  is  therefore more in form ative-to 
think in terms of the corrected reticulocyte count which takes into account 
the 2 - 3  day re ticu locy te  maturation time, rather than the absolute 
reticulocyte count.
When used as promoter, both quercetin and shikimate induced, in 
conjunction with cyclophosphamide, a macrocytic, normochromic, non- 
regenerative anaemia with hypoplasia, and thrombocytopenia. I t  would appear 
that the two test compounds, quercetin and shikimate are capable in their 
own right of inducing bone marrow damage although to a lesser degree than 
bracken, at day 90, in male Wistar-Albino Rats.
However certain  aspects o f the haematology o f bracken-induced bone 
marrow aplasia remain to be clarified . Specifically at what stage of haemo­
poiesis is the aplasia induced? In order to determine this, various aspects 
o f c e l l  k inetics w i l l  need to  be investigated using some cytochemical 
techniques" not routinely employed in haematology but which enable the c e ll 
to  be studied in d e ta il. Some o f these w i l l  provide information on DNA 
synthesis within the c e ll and w ill  enable a more accurate classification of 
the c e ll based not only on morphological features but also on histochemical 
properties. In addition the bone marrow damage may be induced via immuno­
logica l mechanisms. In order to study this, immunofluorescence techniques 
may need to be employed. These could show what sort of immunoglobulins are 
present on the c e l l  surface, and how these change q u a lita t iv e ly  and 
qu an tita tive ly  over a period o f time in the course o f feeding these tes t 
compounds.
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Conclusion
The chronic study was able to confirm the w e ll established carcino­
genicity of bracken in rats even though the study was prematurely terminated 
consequent upon the intussuception which occurred in one rat at 8.5 months. 
The carcinogenic properties o f quercetin and shikimate could not be 
established at 24 months.
The sub-acute study showed that shikimate could act as a tumour 
promoter due to the enhanced ornithine decarboxylase activity in the various 
tissues of rats fed shikimate. Quercetin did not elevate ornithine 
decarboxylase activity in the tissues of rats and its role in bracken 
carcinogenicity remains unclear.
F ina lly , quercetin and shikimate could induce in male W istar-Albino 
Rats at day 90, a macrocytic, normochromic, non-regenerative anaemia with 
thrombocytopenia and granulocytopenia.
111.
CHAPTER THREE
INVESTIGATION OF THE BRACKEN-INDUCED 
ATAXIA IN RATS
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In tro d u c tio n
During the chronic studies described in chapter two , seven o f the 
twenty bracken-fed rats developed an ataxia from the 26th - 28th day after 
in itia ting bracken feeding. previous studies had identified this c lin ica l 
sign in bracken-fed rats (Evans and Evans, 1949) and horses (Roberts et al., 
1949; Evans et a l., 1951), and i t  was attributed to the presence o f "an 
enzymic antithiamine factor" which upon bracken in ges tion  induced 
avitaminosis and an associated ataxia. This view was confirmed by the 
positive response of affected animals to thiamine therapy. In addition, the 
presence of a thermolabile factor in an aqueous extract o f bracken capable 
o f inactiva tin g thiamine was demonstrated (Evans et a l., 1950). These 
observations led to the widely held view that the neurologic ataxia observed 
in bracken-intoxicated animals was due to the action of this enzyme known as 
thiaminase.
However, due cognisance may not have been taken o f the presence in 
bracken o f the cyanogenic glycoside prunasin which upon hydrolysis w i l l  
y ie ld  cyanide, which is also capable of inducing neurological ataxia in man 
and animals (Osuntokun, 1968; 1969; 1970; Blood et a l., 1979; Ballantyne,
1983). I t  was decided therefore to investigate the role o f the cyanogenic 
glycoside, prunasin, in bracken-induced neurologic ataxia in rats.
The influence of nitrite, a known antidote of cyanide was also 
examined.
The metabolism of cyanide by the enzyme rhodanese was examined and the 
influence of the bracken isolates, quercetin and shikimate on the metabolism 
of cyanide was also examined.
It is not however being suggested that either quercetin or shikimate is 
responsible for the bracken-induced ataxia of monogastrics.
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3.2 Anti-Thiamine Factors
3.2.1 Thiaminase I  (thiamine: base, 2-methyl-4-amidopyrimidine-5methyl 
transferase, EC. 2.5.1.2)
Thiaminase I is an enzyme that catalyses the decomposition of thiamine 
by a base exchange reaction involving a nucleophilic displacement on the 
methylene group of the pyrimidine moiety. This reaction requires co- 
substrates which may be primary or secondary amines, a sulphydryl group or 
sulphinic acid. In addition, depending on the nature of the predominant co­
substrate which participates in the reaction, the thiamine analogue formed 
could act as a thiamine antagonist thus exacerbating the onset of thiamine 
deficiency (Evans, 1976).
3.2.2. T h iam in ase  I I  (thiamine hydrolase, EC. 3.5.99.2)
Thiaminase II has a narrower distribution in nature, occuring mainly in 
micro-organisms and is not considered important with regard to bracken.
3.2.3. O ther A nti-Th iam ine Fac to rs
Other anti-thiamine factors found in bracken are rutin, iso-quercitrin 
and astragalin -type flavonol glucosides (Hasegawa et a l., 1956, 1957), 
c a ffe ic  acid (3,4-dihydroxy-cinnamic acid) (Somogyi and Beruter, 1967; 
Somogyi, 1971), and caffeoylshikimic acid (Fukuoka, 1982). These are thought 
to be active only in v itro .
These have been designated "thermostable anti-thiamine factors". 
Bracken dried at 100°C in dry-heat still retains anti-thiamine activity 
(Evans et al., 1950) and it is quite probable that these thermostable anti­
thiamine factors also contribute to the anti-thiamine activity of bracken, 
and the bracken-induced ataxia of monogastrics. One of these thermostable 
anti-thiamine factors called "the SF Factor" is active in vivo (Konishi,
1984).
The finding of other anti-thiamine factors in bracken reinforces the 
need to determine the role of other factors in the bracken in the context of
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Figure 3.1 Mechanism of Action of Thiaminase
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(After Evans, 1976)
bracken-induced ataxia and hence the investigation into the role of the 
cyanogenic glycoside, prunasin.
3.3 The Anti-Thiamine Activ ity  o f Bracken
The anti-thiamine activity of bracken is mainly attributable to 
thiaminase I and is manifested in rats and horses by ataxia, as inappetence, 
listlessness and unthriftiness in pigs and as cerebro-cortical necrosis in 
sheep and cattle.
The enzyme attains highest levels in the bracken rhizome in winter, 
drops during the spring and rises again in May reaching its peak level in 
the autumn. The frond however has very high activity in April dropping in 
May and remains low during the autumn.
The clinical signs of avitaminosis Bj_ are due to the role of thiamine 
in the biochemical, pathways of the cell. The enzymes, pyruvate 
decarboxylase and <>c-ketoglutarate decarboxylase both require thiamine 
pyrophosphate (TPP) as a co-factor for their actions. The biochemical 
lesions of low tissue thiamine levels, high blood pyruvate, increased 
pyruvate kinase and enhanced thiamine pyrophosphate effect in the blood 
transketolase reaction.are manifested clinically as ataxia, anorexia, 
opisthotonus and clonic spasms.
The mechanism by which the biochemical lesions are translated into 
clinical signs is not certain but some suggestions have been made - a 
failure to supply adequate energy to the cell which is starved of TPP, or a 
failure to produce an essential intermediate necessary for the nervous 
system and cardiovascular functions in thiamine deficiency. This later 
explanation is more plausible because of the observation that pigeon brains 
suspended in pyruvic acid utilised oxygen far more rapidly when thiamine was 
added than when it was not (Peters, 1936). This has been called the 
"catatorulin effect". The third explanation is that the inactivation of 
thiamine may result in one or more reaction sequences being inhibited 
leading to an accumulation of toxic factors leaaing to ataxia (Handler, 
1958).
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Although the avitaminosis Bp due to the anti-thiamine factors has been 
reported in both ruminants and monogastrics, the c lin ica l signs in ruminants 
tend to be less dramatic than in monogastrics. Whereas in monogastrics, 
ataxia, inappetence and listlessness are the principal signs, in ruminants, 
ataxia occurs only terminally. Furthermore, in order to induce avitaminosis 
in sheep very high levels of thiaminase are required as evidenced by the 
use o f the rhizome which has 20-30 times more thiaminase than the fronds 
(Evans et a l., 1975).
The ataxia which is observed as a terminal sign in sheep is probably a 
consequence of the induced cerebro-cortical necrosis. The pathogenesis of 
avitaminosis B-^  in ruminants is chronic because of the ab ility  o f the rumen 
microflora to generate thiamine, consequently, whereas thiamine levels in 
intoxicated monogastrics may drop rapidly, the levels in ruminants drop less 
rapidly.
3.4 The Cyanogenic Glycoside Content o f Bracken
Following the observation o f Greshoff (1908) that the fronds o f ferns 
were cyanophoric, the cyanogenic glycoside, prunasin, was iso la ted  from 
bracken (Kofod and Eyjolfsson, 1966). I t  was estimated that in some cases 
the le v e l o f hydrocyanic acid was as high as 50mg per lOOg dried bracken 
(Moon and Rafaat, 1951b). I t  was suggested that its  role might be to protect 
bracken from predators (Cooper-Driver and Swain, 1976).
Cyanogenic glycosides yield  cyanide upon hydrolysis.
Figure 3.2 The Hydrolysis of cyanogenic Glycosides
+ HCN
Hydrogen
cyanide
R1. o -S u g a r  . R1 OH R1
\ X  Fn7vmQticaUvr\  ^Enzymatically <>r_,>c_ , 
\ CsN +H,0 R, /  Xnonenzym atic^/
Aldehyde
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3.5 The Toxicology of cyanide
Cyanide toxicity in farm animals normally occurs as a result of the 
ingestion of plants containing cyanogenic glycosides, usually at times of 
drought when normal forage is scarce. Such plants include sorghums (Johnson 
grass, Sudan grass and milo), arrow grass (Triglochin spp.), elderberry 
(Sambucus spp.), wild cherry (Prunus spp) and the pits of apple, peach and 
apricot (Oehme, 1977).
In humans, cyanide to x ic ity  resu lts from d ietary sources such as 
cassava (Manihot utilissima) (Osuntokun, 1968), c iga re tte  smoking (Wilson, 
1965a) or therapeutical preparations such as nitroprusside, a potent 
hypotensive, and succinonitrile, an antidepressant.
Other sources of exposure are insecticides based on organic 
thiocyanates, industrial processes for the manufacture of steel, paint and 
aluminium, as well as coal gasification and electroplating (Solomonson, 
1981; Way, 1981).
3.5.1 cyanide Toxicity in Farm Animals
Acute cyanide intoxication causes tissue asphyxia, a histotoxic anoxia, 
dyspnoea, cerebral anoxia, tremors and convulsions, a course of events 
lasting 1-2 hours.
Affected sheep and cattle moan, are anxious, restless and terminally, 
develop chronic convulsions. The mucosa is bright red, the pupils dilate 
and there is nystagmus.
In sub-acute cases, sheep may develop go itre  (Blood et a l., 1979) but 
chronic cyanide to x ic ity  has not been reported in these species (H ill ,  
1973).
Pigs fed a cassava diet rich in cyanide had a lower rate of weight gain 
than the controls (peixoto, 1965) due perhaps to the competition by cyanide 
for sulphur-containing amino acids with the body tissues (Tewe, 1985). A 
previous report however reported no ill-effects from feeding pigs on a 
cyanide-containing diet (Alba, 1937).
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Young chicks show decreased growth rate when fed a 10-15% cassava meal 
but adult hens show no ill effects and continue to lay eggs normally (Vogt 
and Penner, 1963; Jalaluain and Yin, 1972).
3.5.2 Cyanide T o x ic ity  in  Experim ental Anim als
The clinical signs of cyanide toxicity in dogs and rats are 
excitability, ataxia, capillary congestion, and cyanosis. Histologically 
there is demyelination of the oligodendroglial cells (Rose et al., 1954; 
Ibrahim et al., 1963; Smith et al., 1963; Osuntokun, 1970). Goitre has also 
been reported in rats (Ekpechi et al., 1966).
3.5.3 Cyanide T o x ic ity  in  Humans
Acute toxicity in humans is characterised by anoxia, convulsions and if 
untreated, death rapidly supervenes.
Chronic toxicity is the more common form of cyanide toxicity caused 
usually through the repeated consumption of cyanide-rich foodstuffs like 
cassava (Manihot utilissima), or inhalation of cigarette smoke or cyanide- 
containing fumes from industrial processes.
The clinico-pathologic signs are neuropathologic, goitre and osteo- 
pathologic. patients may exhibit one or more of these symptoms.
The neuropathologic symptoms include ataxia, b ilatera l optic atrophy, 
b ilatera l nerve deafness, posterior column myelopathy, muscular wasting and 
weakness. This syndrome was described as Tropical Ataxia Neuropathy 
(Osuntokun, 1968).
In some parts of eastern Nigeria where cassava is the staple diet a 
goitre incidence of 41.0% was related to the small quantities of cyanide 
ingested in their diet over long periods (Ekpechi et al., 1966). The 
goitrogenic potential of cassava has also been experimentally demonstrated 
in rats (Ekpechi, 1973).
120
The osteopathologic symptoms of chronic cyanide tox icity in humans have 
been reported as kyphosis, kyphoscoliosis, osetoarthritis and osteoporosis. 
The mechanism o f this syndrome was thought to be due to cyanide inhibiting 
the enzyme ascorbic acid oxidase, an enzyme important in bone metabolism 
(Wilson, 1965a).
3.6 The Detoxification of Cyanide
Cyanide may be detox ified  in the thyroid, through a reaction with 
cystine and/or through reaction with vitamin B-^ 2, but the most important 
mechanism accounting for 80%*of cyanide detoxification is by conversion to 
thiocyanate, a reaction which is  catalysed by the enzyme rhodanese 
(thiosulphate sulphur transferase) which is  w idely d istributed in the 
mammalian body but has its  highest concentration in the liver. Its  optimum 
pH is  7.4 and the reaction is :
HCN + Na2S203 HSCN + Na2S03
(Himwich and Saunders, 1948; Cosby and Sumner, 1945; Wood and Cooley, 1956; 
Osuntokun, 1970).
3.7 The Treatment of Cyanide Toxicity
The f ir s t  line of approach in the treatment of poisoning by cyanide is 
the maintenance of v ita l functions such as respiratory and cardiovascular 
functions in so that the body can detoxify and excrete cyanide through the 
normal processes. Often however, supportive therapy is not enough and 
specific antidotes have to be used.
Various cobalt-containing compounds - cobalt n itra te , hydroxy- 
cobalamine, cobalt h is tid in e , cobalt ch loride and d icobalt EDTA were 
o r ig in a lly  used fo r trea tin g cyanide posioning, based on the a b il it y  o f 
cobalt to form stable complexes with cyanide. The to x ic ity  o f cobalt has 
however rendered the ir use obsolete in favour o f methaemoglobin forming 
substances. Methaemoglobin reacts with cyanide to form cyanmethaemoglobin, 
in which form cyanide is rendered inert. N itrite  has also been used in this 
respect as a methaemoglobin-forming substance.
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Fl9Ure 3 ’3 The Detoxification, of Cyanide by Hydroxncnhal.min
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3.7.1 The Treatment of Cyanide poisoning in Humans
First-aid treatment of affected subjects is the inhalation of one 
ampoule of amyl nitrite every five minutes. Hospital therapy usually 
consists of intravenous administration of 10 ml, 3% sodium nitrite, followed 
by slow intravenous administration of 50% sodium thiosulphate {25 ml). In 
severe, life threatening situations, 600 mg of dicobalt EDTA may be given 
over one minute followed by another 300 mg if there is no immediate recovery 
(Vale and Meredith, 1983; Volans, 1983). The use of oxygen inhalation in 
conjunction with the nitrite-thiosulphate therapy has been recommended to 
alleviate the toxicity of nitrite (Way, 1981).
3.7.2 The Treatment o f Cyanide Poisoning in Domestic Animals
Cyanide toxicity in the dog has been treated by intravenous 
administration of 25 mg/kg body weight of sodium nitrite and 2.5 mg/kg 
sodium thiosulphate (Rose et al., 1954).
In cattle, 3 g of sodium nitrite plus 15 g of sodium thiosulphate in 
200 ml of water administered intravenously is the preferred therapeutic 
measure.
In sheep, a combination of 1 g sodium nitrite, plus 2.5 g sodium 
thiosulphate in 50 ml of water administered intravenously is the preferred 
therapy.
The regime adopted for horses is similar to that for cattle (Brander 
and Pugh, 1971; Blood et al., 1979). In all cases it may be necessary to 
repeat the therapy if symptoms recur.
3.8 Strategy o f the Study
The levels of cyanide and its detoxification product thiocyanate as 
well as the enzyme rhodanese responsible for the detoxification and the 
levels of the antidote of cyanide, nitrite were determined in rats fed a 10% 
bracken diet for 28 days. This was the length of time before ataxia was 
observed in the chronic study (2.11.3).
The haematology of the rats was evaluated to provide information which 
could complement the data obtained in the 90-day study (2.11.14).
A comparative approach was adopted by feeding two groups of rats with 
the bracken iso la tes , shikimate and quercetin and assaying for the 
biochemical and haematological parameters described fo r the bracken-fed 
rats.
Upon termination of the experiment, fu ll necropsies were carried out on 
a ll  rats to assess any relevant pathologic and histopathologic lesions.
3.9 Materials and Methods
3.9.1 Animals
Forty male Wistar-albino (W/A) rats (University of Surrey, Animal Unit) 
were assigned to four groups, so that each group had equivalent mean weights 
to each other (60.0 + 5.0 gm). The rats were housed f iv e  per cage as 
previously described (2.10.1), and fed a 10% (w/w) bracken d ie t, a 1% (w/w) 
shikimate d ie t, a 1% (w/w) quercetin d iet and a control d iet. They we re 
weighed weekly and observed for c lin ica l appearance.
3.9.2 Feedstuffs and Diets
The control, bracken, quercetin and shikimate d iets  were made up as 
previously described (2.10.2).
3.9.3 Sample Collection
Urine was co llec ted  by putting the rats into metabole cages and 
collecting urine over a 24 hour period. This was filte red  and stored at -12 
°C and analysed within three days.
The rats were ether anaesthesised and terminally bled via the posterior 
vena cava. Blood was collected in EDTA-containing tubes for haematology and 
in plain glass tubes for serum, which was also stored as the urine samples.
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Each rat was autopsied, tissues for histopathology were fixed  in 10% 
buffered neutral form alin, and tissues for rhodanese assay ( l iv e r  and 
intestine) were washed in physiological saline and collected in beakers in 
an ice box for the rhodanese assay.
3.9.4 Chemicals and Reagents
A ll  chemicals and reagents were o f ana ly tica l reagent grade except 
where otherwise specified.
3.9.5 Determination o f Thiocyanate
A modification of the method of powell (1945) was used for determining 
serum and urinary thiocyanate.
Potassium thiocyanate (sigma Chemical company, Poole, Dorset, England) 
was made up in d is tilled  water as a 2 g/L solution and titrated against 20 
ml o f 2.924 g/L s ilver nitrate solution (BDH Chemicals Ltd., Poole, Dorset, 
England) plus 5.0 ml, 12 M n it r ic  acid (May and Baker Ltd., Manchester, 
England), using 1.0 ml o f saturated ferr ic  ammonium sulphate solution (BDH 
Chemicals Ltd., Poole, Dorset, England) as indicator. Serial dilutions of 
th is standardised stock solution were used for the preparation o f the 
standard curve by mixing 1.0 ml solutions of the potassium thiocyanate with 
8.0 ml d is t i l le d  water and 1.0 ml o f fe r r ic  n itra te  (BDH Chemicals Ltd., 
Poole, Dorset, England) made up o f 50 g fe r r ic  n itra te  in 500 ml o f water 
plus 25 ml, 12 M n it r ic  acid and made up to 1 L with d is t i l le d  water. The 
blank solution was 25 ml, 12 M n itr ic  acid made up to 1 L with d is t i l le d  
water. Absorbance was determined in a Cecil CE 292 UV d ig ita l spectro­
photometer (Cecil Instruments Ltd., Cambridge, England) at 540 nm.
The assay was lin ear over the range 1.0 ug/ml to  1.0 mg/ml and the 
standard curve was the computer-generated b e s t - f it  lin e  obtained a fte r  
lin ear regression analysis using a s ta t is t ic a l  package based on the 
University of surrey, Prime Computer System.
For the tes t serum and test urine, 0.5 ml o f the serum or urine was 
added, in duplicate, to 4.0 ml o f d is t i l le d  water. These were regarded as 
the tes ts , while another set, in duplicate, were s im ila r ly  set up and 
regarded as blanks. To the tests was added 0.5 ml ferric  nitrate and to the 
blanks, 0.5 ml of the blank solution. The absorbance was determined at 540 
nm in a Cecil CE 292 UV d ig ita l  spectrophotometer. The absorbance o f the 
blank was subtracted from the absorbance o f the tes t and the actual 
concentration of thiocyanate read from the calibration curve. Thiocyanate 
was expressed as ug per ml serum or ug per mg creatinine for urine samples.
3.9.6 Determination o f Cyanide
A modification of the method of Hanker et al., (1958) was used for the 
determination of cyanide in serum and urine. A potassium cyanide solution 
(Sigma Chemical Company Lt., Poole, Dorset, England) was standardised by 
argentometric titration against silver nitrate as previously described 
(3.9.5).
The standard curve was prepared by adding to 1.0 ml o f 1 M sodium 
hydroxide in succession, 1.0 ul potassium cyanide, 1.0 ml g lycine buffer 
made up o f 77.4 g g lycine and 58.6 g sodium ch loride (BDH Chemicals Ltd., 
Poole, Dorset, England) in 1 L o f d is t i l le d  water, 1.0 ml, 0.01 g/L 
palladium chelate solution, and 1.0 ml of 1 g/L magnesium chloride solution 
(BDH Chemicals Ltd., Poole, Dorset, England). A fter eight minutes, the 
fluorescence was determined in a Perkin-Elmer Fluorescence Spectrophotometer 
model LS-5 (Perkin-Elmer Ltd., Bucks., England) with the excita tion  
wavelength at 358 nm and the emission wavelength at 496 nm. The assay was 
linear over the range 0.087 ug/ml to 3.50 ug/ml. The standard curve was the 
computer-generated best-fit line obtained after linear regression analysis 
on a sta tis tica l package based on the University of Surrey, Prime Computer 
System. Recovery studies were carried out by adding varying concentrations 
o f potassium cyanide to the serum samples and trea tin g as above. Recovery 
ranged from 79 to 151% and the values determined from the calibration graph 
were corrected accordingly.
For the determination o f cyanide in urine and serum, 1.0 ul aliquots 
were used. In the blank, d is t i l le d  water was substituted for urine or 
serum.
The palladium chelate was prepared by adding 0,02 M 8-hydroxy-5- 
quinoline sulphonic acid (Sigma Chemical Company Ltd., Poole, Dorset, 
England) to a 0.01 M solution o f palladium ch loride in 300 ml of 5% (v/v) 
sulphonic acid (May and Baker Ltd., Manchester, England). The solution was 
heated to b o ilin g  and cooled to room temperature. Saturated potassium 
carbonate (BDH Chemicals Ltd., Poole, Dorset, England) was added until the 
evolution of carbon dioxide ceased. The chelate was washed repeatedly over 
a f i l t e r  with 10% carbonate, water, ethanol and ether in succession and 
f in a lly  a ir  dried. The resu lting yellow  powder is the chelate and a. 1.0% 
solution in d is tilled  water was used in the assay for cyanide.
The method is based on the demasking of 8-hydroxy-5-quinoline sulphonic 
acid by cyanide from the non-fluorescent potassium bis ( 5-sulphoxino) 
palladium ( I I )  which is the palladium chelate. The liberated 8-hydroxy-5- 
quinoline sulphonic acid co-ordinates with magnesium to form a fluorescent 
chelate whose fluorescence is a measure of the cyanide present.
Figure 3,5 Principles of the Determination of Cyanide Concentration
by the Demasking of Palladium Chelates
so 3k
+ 4CN
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3.9.7 Determination o f Rhodanese Activ ity
The method of Wilson (1965b) was used with some modifications.
The liver and intestine we re separately homogenized in ice-cold acetone 
using 10 ml acetone per mg tissue in a Potter-Elvehjem glass teflon 
homogenizer (three return strokes). The homogenate was left at 0°C for 30 
minutes and centrifuged at 3,000 g for 5 minutes using a bench-top 
centrifuge.
The supernatant was decanted, the centrifugate resuspended in acetone 
and centifuged again at 3,000 g for 5 minutes. The supernatant was decanted 
and the centrifugate dried in a dessicator over anhydrous calcium chloride 
and a shallow beaker o f sulphuric acid for 24 hours. The acetone dried 
powder was ground in a mortar and made up as a 10 mg/ml suspension in 0.0125 
M sodium thiosulphate (BDH Chemicals Ltd., Poole, Dorset, England). I t  was 
thoroughly mixed and le ft  for 15 minutes at 0°C and centrifuged at 0°C for 
30 minutes at 12,000 g in a Beckmann JZ-21 Centrifuge (Beckmann-RIIC Ltd., 
Bucks., England). The clear supernatant was decanted, i t s  protein content 
determined (2.10.7), and the rhodanese activ ity  determined by adding 250 ul 
o f the to a mixture o f 5.75 ml t r is  HCl and 5.0 ml o f 0.125 M sodium 
thiosulphate and thoroughly s tirred . A fter 30 seconds, 1.25 ml o f 1.0 M 
potassium cyanide as substrate was added and 0.2 ml aliquots withdrawn at 30 
seconds, 1.0 minute, and every 1.0 minute thereafter fo r 10 minutes and 
added to  0.2 ml, 40% formaldehyde (BDH Chemicals Ltd., poole, Dorset, 
England) which was used to stop the reaction. 1.0 ml fe r r ic  n itra te  
co lorim etric  reagent made up o f 200 g fe r r ic  n itra te  added to 200 ml 65% 
n it r ic  acid and made up to 1L with d is t i l le d  water, was added and the 
absorbance determ ined at 460 nm in a C e c il CE 292 d ig i t a l  UV 
spectrophotometer (Cecil Instruments Ltd., Cambridge, England).
The blank was the reaction mixture at time zero, the 0.2 ml, 40% 
formaldehyde being used to stop the reaction. The readings were obtained 
against distilled water which was used to 'zero' the spectrophotometer.
The standard curve was prepared using argentometrically standardised 
potassium thiocyanate. The assay was linear over the range 1 ug/ml to 150 
ug/ml potassium thiocyanate and the standard curve was the computer
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generated best f i t  lin e  obtained a fte r  linear regression analysis in a 
sta tis tica l package on the University of Surrey Prime Computer System.
Rhodanese activ ity  was determined from the standard curve and expressed 
as umole thiocyanate per minute per mg protein. These determinations were 
carried out at 20°C rather than 37°C used by Wilson (1965b).
3.9.8 Determination of Nitrite
Urinary nitrite was determined by a modification of the of Montgomery 
and Dymock (1961) which was more sensitive than the Greiss-ilosvay method.
The standard curve was prepared by adding varying concentrations o f 
sodium n itr ite  (BDH Chemicals Ltd., Poole, Dorset, England) as 20 ul to 2.5 
ml sulphanilic acid solution made up of 27.2 g potassium hydrogen sulphate 
(Hopkin and Williams Ltd., Essex, England) and 3.46 g sulphanilic acid (BDH 
Chemicals Ltd., Poole, England) made up to 1 L with d is tilled  water. After 
10 minutes, 2.5 ml o f 0.04% (w/v) NEDH added and a fte r  20 minutes, the 
absorbance was determ ined at 550 nm in a C e c il CE 292 d ig i t a l  UV 
spectrophotometer (Cecil Instruments Ltd., Cambridge, England).
The assay was linear over the range 0.3 ug/ml to 20 ug/ml and the 
standard curve was the computer generated best fit line obtained after 
linear regression analysis on a>statistical package in the University of 
Surrey Prime Computer System. For the determination of urinary nitrite, 20 
ul urine aliquots were treated as described above. Urinary nitrite was 
determined from the standard curve and expressed as ug per mg creatinine.
This method is based on the principle of diazotization of nitrite by 
sulphanilic acid and the coupling of the diazonium salt to NEDH to produce 
the pink colour, the intensity of which is a measure of the nitrite in the 
sample.
The Montgomery and Dymock (1961) method employs potassium hydrogen 
sulphate as the buffering agent rather than acetic acid which is used in the 
Greiss-ilosvay method. The buffering capacity of potassium hydrogen 
sulphate is better, the intensity of the colour developed is 13% greater 
than in the Greiss-ilosvay method and the blank values in the Montgomery and
129
Dymock method are less than half those obtained by the Greiss-llosvay 
method. As a result, only small quantities of urine were required for the 
determination of nitrite, 20 ul aliquots being used in this assay.
3.9.9 Determination of Urinary Creatinine
A kit assay method was used for the determination of urinary creatinine 
(Sigma Chemical Company Ltd., Poole, Dorset, England).
Five sets o f tubes were set up in duplicate containing 0, 0.05, 0.10, 
0.15 and 0.20 ml of 15 mg/100 ml creatinine standard solution. To the tubes 
were added 0.30, 0.25, 0.20, 0.15 and 0.10 ml d is t i l le d  water To each tube 
was added 3.0 ml alkaline picrate and after 5 minutes the absorbance at 500 
nm was determined in a Cecil CE 292 d ig ita l UV spectrophotometer (C ecil 
Instruments Ltd., Cambridge, England) using the tube containing no 
creatinine as the reference.
The standard curve was the computer-generated best fit line obtained 
after linear regression analysis using a statistical package on the 
University of Surrey prime computer System. The assay was between 0.25 and 
10 ug/ml creatinine.
For the determination o f creatin ine in the urine samples, four tubes 
were set up for each sample, a blank, standard and two tests. To the blank 
was added 0.3 ml o f water, to  the standard 0.3 ml o f a 3 mg/100 ml 
creatin ine solution , and to the tests  0.3 ml o f the urine sample. To a l l  
tubes was added 3.0 ml of alkaline picrate solution and after 10 minutes the 
in it ia l absorbance of tests and standard were determined at 500 nm against 
the blank in a Cecil CE 292 d ig ita l UV spectrophotometer (Cecil Instruments 
Ltd., Cambridge, England).
To each tube was added 0.1 ml acid reagent and after thorough mixing 
and leaving for 5 minutes, the final absorbance was determined at 500 nm.
Creatinine concentration was calculated as follows:
In it ia l absorbance of test - fina l absorbance of test x 3 = ug/ml
In it ia l absorbance of standard - fina l absorbance o f standard
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3.9.10 Haematological Evaluations
The evaluations for haemoglobin, packed cell volume, total erythrocyte 
and leucocyte counts, total platelet counts, total reticulocyte counts, the 
differential leucocyte counts as well as the derived indices (MCV, MCR and 
MCHC) were carried out as previously described (2.10.9 - 2.10.15).
Heinz body examinations were undertaken using the same slides as for 
the reticulocyte counts..
Determination of methaemoglobin was done by lysing 0.2 ml of blood in a 
solution o f 4.0 ml, 0.1 M phosphate bu ffer, pH 6.8 and 6.0 Nonidet P40, 10 
ml/L, as detergent (Sigma Chemical Company Ltd., Poole, Dorset, England). 
The lysate was divided into two portions labelled a and b. The absorbance 
of a was measured in a Cecil CE 292 d ig ita l UV spectrophotometer at 630 nm 
before and after addition of one drop of 50 g/L potassium cyanide solution. 
One drop o f potassium ferricyan ide was added to b and the absorbance 
determined at 630 nm, a fte r 5 minutes. One drop o f potassium cyanide, 50 
g/L, was added to b and the absorbance determined at 630 nm. The blank for 
a l l  determinations consisted of buffer and detergent in the same proportion 
as for the tests. The result was calculated as follows:
Methaemoglobin = In it ia l absorbance of a -  second absorbance of a
Initial absorbance of b - Second absorbance of b
The value was multiplied by 100 to give the percentage value.
Although i t  is advisable to carry out methaemoglobin analysis within 1 
hour of collecting blood, the lysate, once prepared, could be stored for up 
to 24 hours at 2-4°C.
Since the samples had to be transported to the laboratory from the 
experimental unit the lysate was prepared immediately and used for all 
analyses.
3.9.11 Histopathological Evaluations
These were done as previously described (2.10.17).
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3.10 Results
The results are presented as the mean values obtained from ten rats for 
each dietary group + standard error of the mean after statistical analysis 
using the Student's t-test.
3.10.1 Weight Changes
The bracken-fed rats had a lower rate o f weight gain in comparison with 
the control, shikimate- and quercetin-fed rats (p < 0.001) (Figure 3.4).
3.10.2 Clinical Observations
There were no signs of illness in the control, quercetin- and 
shikimate-fed rats, but the bracken-fed rats had piloerection. Ataxia was 
not observed in any of the animals.
3.10.3 Gross Pathology
The main gross pathological finding was the lack of the subcutaneous 
fat in the bracken-treated rats. The other groups were generally in good 
condition at necropsy.
Two of the bracken-fed rats had urinary calculi in their bladders.
3.10.4 Histopathology
The liver of the bracken-fed rats had occasional foci of areas of peri­
portal necrosis with mononuclear cell infiltration although there were 
occasional polymorphs. In these areas, the liver cell architecture was 
completely disorganised. The liver of the control, quercetin- and shikimate- 
fed rats were normal.
The lungs of the rats in all the groups had eosinophilic-staining 
exudate in the bronchioles accompanied in some cases by detachment of the
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Figure 3.6 Weight Gains of Rats in 28-Day Ataxia Study
fed (1) 1% (w/w) quercetin diet (2) 1% (w/w) shikimate diet 
(3) control diet and (4) 10% (w/w) bracken diet
X10
Time (weeks)
Weights are the aean o f  ten r a t s  in each group.
ra t s  were s t a t i s t i c a l l y  s i g n i f i c a n t l y  
i f f e r e n t  from the c o n t r o l  group,  p < 0.001 
throughout the study p e r i o d .
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cuboidal epithelial lining of the bronchioles. The bracken, shikimate and 
control groups had an accompanying pneumonitis and alveolitis, while in the 
bracken group there were areas of red hepatisation with eosinophil 
infiltration.
The bone marrow of the various groups was filled with red marrow, with 
little or no fat spaces. The predominant cell type was the megakaryocyte and 
in the bracken-fed rats they were especially numerous. Occasional 
multinucleated "giant" cells were also observed especially in the bracken- 
fed rats.
In the spleen, the red pulp was consistently diminished only in the 
bracken-treated group, while in the quercetin and shikimate-treated group 
there was a variation with some revealing diminished red pulp and others 
showing plentiful red pulp. In the quercetin-, shikimate- and bracken- 
treated groups there was extra-corpuscular lymphoid hyperplasia with 
encroachment into the littoral macrophage zone, occasional necrobiotic cells 
and generally increased numbers of megakaryocytes especially in the 
shikimate- and bracken-treated groups. Extramedullary haemopoiesis was 
judged to be increased only in the bracken-treated group. The capsule, 
trabeculae and germinal centres were normal and the splenic nodules were 
absent. Other lesions include the increased numbers of the mitotic figures 
of the quercetin group and eosinophil infiltration in the bracken group.
In the kidneys there was a wide measure of inter-individual variation 
within groups. While some revealed no histopathological lesions, others 
revealed lesions ranging from hydropic change in the proximal tubules to 
nephro-calcinosis in the collecting ducts, along the cortico-medullary 
junction. Other lesions include the occasional dilated proximal tubule, 
occasional focal tubular nephritis, and in the bracken-treated group, slight 
thickening of the parietal surface of the Bowman's Capsule affecting some 
glomeruli. These lesions were common to all the various groups.
3.10.5 Cyanide Levels
The serum cyanide level of the quercetin-fed rats was too low to be 
detectable as was the urinary level.
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The bracken-fed rats had significantly higher levels of cyanide in the 
serum than the controls, but the urinary levels were undetectable.
The shikimate-fed rats had undetectable urinary levels of cyanide' but 
the serum level of cyanide did not differ significantly from the control 
level.
3.10.6 Rhodanese Activity
The liver rhodanese activity of the quercetin-fed rats was 
significantly higher than the control, the bracken-fed rats had 
significantly lower rhodanese activity in the liver than the control, while 
the shikimate-fed rats did not differ significantly from the control.
The intestinal rhodanese activity was undetectable in all the groups.
Table 3.2 Cyanide, Rhodanese and Thiocyanate levels after 28 days, of Rats 
fed 1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control 
Diets
Groups
Serum
Cyanide
(ug/ml)
Liver 
Rhodanese 
(umole thiocyanate/ 
min/mg protein)
Serum 
Thiocyanate 
(ug/ml)
Urinary 
Thiocyanate 
(ug/mg 
creatinine)
Control 0.125+0.003 0.33+0.01 4.2+2.0 1.6+0.1
Quercetin N.D.+ 0.88+0.08* 9.0+1.4 10.8+1.1*
Bracken 0.257+0.006* N.D. 6.3+2.9 - 1.5+0.1
Shikimate 0.097+0.002 0.44+0.08 3.3+1.0 4.7+0.1*
Coeff. of
Variation(V) 7.i% 26.6% 110.2% 0.2%
Sensitivity 0.087 0.21 1.0 1.0
Values are the means + S.E.M. o f ten rats.
N.D. = Not detected
* -  value significantly higher than controls (p < 0.05)
+ - value significantly lower than controls (p < 0.05) (Student's t-test)
135
3.10.7 Thiocyanate Levels
The serum thiocyanate levels were not significantly different from each 
other, but the urinary thiocyanate levels of the quercetin- and shikimate- 
fed rats were s ig n ific a n tly  higher than the control le v e l. The urinary 
thiocyanate level of the bracken-fed rats was not s ig n ifica n tly  d iffe ren t 
from the control.
3.10.8 Urinary Nitrite Levels
The urinary n itr ite  levels of the quercetin- and bracken-fed rats were 
higher than the control le v e l but in the shikimate-fed rats i t  was 
undetectable.
Table 3.3 Urinary N itrite  Levels after 28 days, of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Groups Urinary N itrite  
(ug/mg creatinine)
Control 0.3+0.0
Quercetin 3.0+0.2*
Bracken 13.5+0.3*
Shikimate N.D.
Coefficient of variation (V) 1.1%
Sensitivity 0.3 ug/ml
Values are the means + S.E.M. o f ten rats.
N.D. = Not detected
* = values s ta tis tica lly  higher than control (p<0.05) 
(Using the Student's t-tes t)
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T a b l e  3.4 Urinary Creatinine of Rats fed 1% (w/w) Quercetin,
10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets for 28 days.
Groups Urinary Creatinine 
(ug/ml)
Control 1.51+0.04
Quercetin 1.82+0.02*
Bracken 1.21+0.01
Shikimate 2.03+0.03*
Coefficient of variation (V) 4.7%
Sensitivity 0.25 ug/ml
Values are the means + S.E.M. o f ten rats.
*  - value significantly higher than control (p < 0.05) 
(Using the Student's t-tes t)
3.10.9 Haematological parameters
There were no Heinz bodies in any of the experimental groups.
The attempt at methaemoglobin analysis yielded unreliable results and 
these have been omitted.
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Table 3.5 Some Haematological parameters after 28 days, of Rats fed
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and control Diets
Groups Haemoglobin 
(g %)
PCV
(%)
Erythrocytes/mm3 
(x 106)
Leucocytes/mm3
Control3 15.0+1.0 43.0+0.5 5.3+0,0 15000+271
Control*3 14.6+0.0 47.4+0.1 8.9+0.1 9920+759
Quercetin 11.5+0.2+ 34.0+0.7+ 4.1+0.0+ 6701+242+
Bracken 14.0+0.1 43.0+0.4 5.5+0.0 6215+187+
Shikimate 12.0+0.3+ 44.0+0.7 6.0+0.0 14000+347
Values are the means + S.E.M. o f ten rats, 
a - Experimental control from 28 day study 
b -  Historical control from Mitruka and Rawnsley (1977).
+ - values significantly lower than controls a and b (p < 0.05) 
(Using the Student's t-tes t)
Table 3.6 Platelet and Reticulocyte Counts after 28 days, of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets
Groups Platelets/mm3 (x 105) Reticulocytes
Control3 4.0+0.3 58500+583
Control b 3.4+0.5 223750+2237
Quercetin 3.1+0.1+ 73800+738+
Bracken 2.3+0.0+ 55000+550+
Shikimate 3.6+0.2 204000+2040
Values are the means + S.E.M. of ten rats.
a - Experimental control from 28 day study 
b - Historical control from Mitruka and Rawnsley (1977).
+ - value significantly lower than controls a and b (p < 0.05) 
(Using the Student's t-test)
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The resu lts o f the mean c e l l  volume (MCV) and mean c e l l  haemoglobin 
(MCH) are above normal h is to r ica l values and may indicate errors in the 
estimation of the tota l erythrocyte counts, and therefore the reticulocyte 
counts derived from them. Although presented in Table 3.6 no conclusions are 
drawn from them.
The total leucocyte counts are also presented but intrusive pathology
(3.10.4) renders the control group redundant and the shikimate group has 
been abandoned for comparative purposes.
The quercetin-fed rats had reduced haemoglobin and packed ce ll volume, 
leucopenia, and thrombocytopenia.
Table 3.7 Mean Cell Volume (MCV), Mean Cell Haemoglobin (MCH), and Mean 
Corpuscular Haemoglobin Concentration (MCHC) after 28 days, of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets
Groups MCV (fm) MCH (pg) MCHC (%)
Control3 81.1+0.1 28.3+0.2 34.0+0.2
Control*3 53.8+0.1 16.3+0.1 30.8+0.1
Quercetin 82.9+0.7 28.0+0.1 33.8+0.2
Bracken 78.1+0.4 25.4+0.1 32.5+0.2
Shikimate 73.3+0.7 20.0+0.3 27.2+0.4
Values are the means + S.E.M. of ten rats, 
a - Experimental control from 28 day study 
b -  Historical control from Mitruka and Rawnsley (1977).
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Table 3.8 Absolute D ifferential Leucocyte Counts after 28 days, of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) shikimate and control Diets
Groups Eosinophils Basophils Neutrophils Monocytes Lymphocytes
Control a 180+60 75+30 1500+180 105+30 13200+150
Control b 350+11 200+15 2420+20 230+20 7540+826
Quercetin 120+47 26+13 281+87+ 46+13 6231+134
Bracken 932+186* 80+25 2113+229 249+62 2734+248+
Shikimate 378+70 70+28 896+210 140+28 12460+280
Values are the means + S.E.M. of ten rats, 
a - Experimental control from 28 day study 
b - Historical control from Mitruka and Rawnsley (1977).
* - value significantly higher than controls a and b (p < 0.05)
+ -va lues significantly lower than controls a and b (p < 0.05)
(Using the Student's t-test)
The bracken-fed rats had leucopenia and thrombocytopenia, while the 
shikimate group had reduced haemoglobin.
The d ifferen tia l absolute leucocyte counts revealed an eosinophilia and 
leucopenia for the bracken-fed rats and a neutropenia for the quercetin-fed 
rats.
Examination of the blood films revealed that in the control group there 
was a mild anisochromasia, mild anisocytosis and small platelet clumps seen 
occasionally across the film . The erythrocytes contained no inclusion 
bodies.
The predominant leucocyte was the mature lymphocyte, identified by the 
large nucleus and the corresponding small cytoplasm. There were occasional 
immature lymphocytes with a large nucleus and practically no cytoplasmic 
space.
The monocyte was rare, but was kidney-shaped and had a vacuolated 
cytoplasm.
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The neutrophil was evident as a cell with a pale blue to colourless 
cytoplasm containing small granules, which were few in number. The nucleus 
was lobed but less clearly defined than in the eosinophil.- A few young 
neutrophils were identified by the presence of "doughnut" ring nuclei.
The eosinophils were larger than neutrophils, had a bilobed nucleus, 
and contained deeply acidophilic-staining granules.
The basophils were very rare but identifiable by their dark-staining 
granules.
The blood film of the quercetin-fed rats revealed a marked 
polychromasia, with clusters of small platelets seen throughout the film. 
The predominant leucocyte was the mature lymphocyte. The other leucocytes 
were identified but revealed no striking features different from the normal.
The shikimate-fed rats showed increased polychromasia, increased 
microcytosis, anisocytosis and hypochromasia. The dominant leucocyte was the 
lymphocyte. There was an increase in the number immature neutrophils. The 
platelets were larger than in the control films.
The polychromasia of the bracken-fed rats was less marked than in the 
shikimate group. There was microcytosis and hypochromasia with an 
accompanying anisocytosis and poikilocytosis. There was a predominance of 
small erythrocytes. Rouleaux formation was evident, the platelets were small 
sized and the predominant leucocyte was the mature lymphocyte.
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3.11 Discussion
The investigation of the bracken-induced ataxia in rats was carried out 
on the premise that other consituents of bracken apart from but probably in 
addition to thiaminase may play a ro le in the induction o f the ataxic 
syndrome. The main bracken constituent thought to induce this was cyanide 
derived from the cyanogenic g lycoside, prunasin which in some bracken 
samples may be as high as 50 mg per 100 g dry weight o f bracken {Moon and 
Raafat, 1951b). The other bracken constituents, shikimate and quercetin are 
not thought to induce ataxia but the in vivo ataxic a c t iv ity  o f the "SF 
Factor" (Konishi, 1984) in the equine suggests that thermostable factors 
capable o f inducing ataxia also ex is t in bracken. Quercetin and shikimate 
were studied for comparative purposes.
To this end a sensitive fluorimetric assay method. (Hanker et al., 1958) 
was used to determine the serum and urinary levels in the various test and 
control groups. It has the advantage of not using benzidine which is a 
bladder carcinogen employed in the method of Aldridge (1944), it has a 
comparable sensitivity (Pettigrew and Fell, 1972), and the use of serum 
rather than whole blood ensures that the cyanide so determined is the active 
fraction of cyanide as against whole blood where erythrocytic enzyme, 
thiocyanate oxidase may reconvert some thiocyanate into cyanide (Goldstein 
and Reiders, 1953). The activity of thiocyanate oxidase is probably 
responsible for the presence of cyanide in the serum of control animals and 
human subjects not ingesting cyanide directly. Thiocyanate is a normal 
constituent of human saliva and may be converted to cyanide by thiocyanate 
oxidase (Smith et al., 1963; Wells et al., 1972). The method used here is 
however less sensitive than the chloramine-T method of Boxer and Rickards 
(1960) which showed linearity over the range 0.005 to 0.40 ug/ml cyanide 
with a coefficient of variation of 1.5%. The possibility of interfering 
substances has been corrected for by the recovery studies, but in contrast 
to the method of Aldridge (1944) where the coefficient of variation as 
applied tojoy other workers (Osuntokun, 1973) ranged from 32.2% to 375.4% it 
may be considered a comparatively sensitive method. Furthermore, by using 
the excitation and emission wavelengths specified in 3.9.6 the specificity 
of the method has been improved.
3.11.1 The Metabolism of Cyanide
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The bracken-fed rats had significantly higher cyanide levels in their 
sera and this may be a direct consequence of the failure of rhodanese enzyme 
to convert cyanide to thiocyanate. Cyanide retention by bracken-fed animals 
had been previously reported by Moon and Raafat (1951b) in sheep and 
bullocks but they concluded that cyanide was not a significant constituent 
o f bracken, probably due to d i f f ic u lt ie s  with estim ating the amount o f 
cyanide exhaled in the breath, and also probably due to the fact that 
ga s troen te r it is  which is  a consistent feature o f bracken to x ic ity  is  not 
usually found in cyanide to x ic ity . However these rats had s ig n ific a n tly  
higher cyanide le v e ls , due in the main to the fa ilu re  o f the rhodanese 
enzyme in the bracken-fed rats. The rhodanese activ ity  of the control rats 
at 0.33 umols thiocyanate/min/mg protein is comparable to the value o f 0.49 
umols thiocyanate/min/mg protein determined by Osuntokun (1970) although his 
rats ranged in age from 6 to 18 months. The coefficient of variation in this 
study is  to be compared to  the range o f 32.0% to 57% for various organs 
determined by Osuntokun (1970).
The factors responsible for the impaired activity of rhodanese may 
include the reduced availability of sulphur donor compounds such as 
methionine which occurs in cyanide toxicity (Tewe, 1985). Also the 
thiaminase enzyme may contribute by destroying thiamine, but the overall 
effect would be to limit the availability of co-factors or sources of 
sulphur for the operation of rhodanese. In addition to being a substrate for 
rhodanese, cyanide may also act as an inhibitor of rhodanese, an inhibition 
which may also be brought about by other substrates such as nicotine 
(Schievelbein et al., 1969).
The effect of the failure to detoxify cyanide is the accumulation of 
cyanide which then contributes to the ataxic syndrome.
In addition, the m y e l o p e r o x i d a s e  e n z y m e  (MPO) found in 
polymorphonuclear cells (PMNs) may play a role in the production of cyanide. 
In an inflammatory response as occurred in the liver of bracken-fed rats
(3.10.4) and which is discussed later (3.11.4), the azurophil granules of 
the PMNs may release MPO, which in combination with hydrogen peroxide and 
chloride may react with some amino acids like glycine to yield hydrogen 
cyanide (Stelmaszynska and zgliczynski, 1981). The hydrogen peroxide may be 
produced as part of a free-radical component of bracken toxicity which is
commented upon later (3.11.4). However, this additional source of cyanide 
generation in bracken-intoxicated.rats must be viewed against the background 
that in bracken-intoxicated animals a wide range of amino acids is depleted 
(Tewe, 1985), and glycine may not necessarily be available.
The main product of cyanide detoxification is thiocyanate. The enhanced 
activity of rhodanese in the shikimate- and quercetin-fed rats is reflected 
in the higher levels of urinary thiocyanate in these two groups. The serum 
levels of thiocyanate were not significantly different and this may be 
explained in part by the non-linear pattern of thiocyanate biotransformation 
in the rat. Thiocyanate is absorbed from the small intestine into the blood, 
where some may be converted into cyanide by the erythrocytic thiocyanate 
oxidase. Thiocyanate is then secreted from the blood into the stomach where 
some may be sequestered depending on the amount of food available in the 
stomach, and where it may enter into various reactions, including the 
catalysis of N-nitrosation. Any thiocyanate left may be transported down the 
gut and be absorbed from the small intestine and the cycle goes on. In the 
rat there is a gastro-intestinal re-circulation of thiocyanate and unlike in 
the human, the rat salivary gland does not secrete thiocyanate 
(Logothetopoulos and Myant, 1956; Okoh,. 1978). This non-linear 
biotransformation of thiocyanate causes wide variability in serum 
thiocyanate levels. This notwithstanding the value of 4.2 ug/ml for the 
control rats is comparable to the value of 5.3 ug/ml obtained by Ermans et 
al. (1973) for rats on a six-week experiment. In addition to the non-linear 
biotransformation, the diet of the rats also affects the serum thiocyanate 
levels. Dams on a rat chow diet had a serum thiocyanate value of 8.17 ug/ml 
to 9.46 ug/ml while those on a Remington diet had values of 2.49 ug/ml to 
2.51 ug/ml (Kreutler et al., 1978).
The urinary levels of thiocyanate were considered more representative 
of the body load. The urinary thiocyanate level of 1.6 ug/mg creatinine ( = 
2.4 ug/ml) is lower than the value of 5.8 ug/ml determined by Smith and 
Foulkes (1966) but the rats in this study had various kidney lesions which 
may have influenced this (see 3.11.4) although these are considered to be 
related to the ad libitum pattern of feeding.
These differences are reflected in the differing coefficients of 
variation between thiocyanate determined in the two biological fluids. 
Indeed when determined by other methods by other workers the differences
between the two were also remarkable. For human plasma the technique of 
Pettigrew and Fell (1972) gave a coefficient of variation of 69% (Gardner et 
al., 1984) while the method of Aldridge (1944) gave a coefficient of 
variation of 34% for human urinary thiocyanate (Osuntokun, 1973).
Although this method is an improvement on previous methods using ferric 
chloride, it nevertheless suffers the disadvantage of a reduced specificity 
due to other compounds such as cyanide.
It ought, in addition to the foregoing, be borne in mind that other 
pathways involving cyanide detoxification apart from the rhodanese- 
thiocyanate pathway exist, although they are less important (Oke, 1973). 
Some cyanide may also be exhaled as hydrocyanic acid and carbon dioxide, and 
nitrite also has an influence in reducing the available body pool of cyanide 
(Johnson and Isom, 1985).
3.11.2 Nitrite Levels
The nitrite levels were determined because of the ability of nitrite to 
act as an antidote of cyanide toxicity. However, when the level of nitrite 
in the system gets too high it may induce ataxic syndromes and abnormalities 
in the brain activity of rats (Behroozi et al., 1972). The bracken-fed rats 
and the quercetin-fed rats had significantly high urinary levels of nitrite.
The method of Montgomery and Dymock (1961) is very sensitive and easily 
reproducible. The application of the method by Bassir and Maduagwu (1978) 
was more sensitive but had a higher coefficient of variation due to the 
nature of the crude mixtures they were analysing. They had a sensitivity of
0.2 ug/ml compared to 0.3 ug/ml in this study, but their coefficients of 
variation ranged from 20 to 58%. However, recovery of added nitrite was as 
high as 98.3 + 0.7%.
The origin of the significantly high levels of nitrite in the urine of 
the quercetin- and bracken-fed rats may be due to the reduction of nitrate, 
a reaction catalysed by micro-organisms in the mammalian alimentary tract or 
by tissue nitrate reductase enzyme (Ayanaba and Alexander, 1973? Omura, 
1959).
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Nitrate is an ubiquitous component of foods being present in fruits, 
vegetables and potable water (Hill et al., 1973; White, 1975). The nitrate 
content of the bracken and quercetin diets was not determined, neither was 
the amount in the local water supply. Although the diet is the most probable 
source of nitrate and hence nitrite, it is by no means the only one. The in 
vivo synthesis of nitrate appears to be a normal mammalian process as rats 
on a low nitrate diet excreted more urinary nitrate than could be accounted 
for by ingested nitrate alone (Green et al., 1981). The metabolism of 
quercetin (a constituent of bracken) is dependent in part on the nature of 
the gut flora and it is possible that the gut flora is transformed in such a 
way as to promote the growth of nitrite-yielding bacteria in the gut of 
quercetin- and bracken-fed rats. This does not exclude the role of tissue 
nitrate reductase or the possibility that the nitrite so produced may be a 
breakdown product of N-nitroso compounds. The bacterial breakdown of N- 
nitroso compounds may yield nitrite as one of its products (Rowland and 
Grasso, 1975).
Although the origin of n itr ite  is open to speculation, its  significance 
is clear. I t  could be implicated along with cyanide in the ataxic syndrome 
observed in bracken-fed rats. Furthermore, i t  may play a ro le  in the 
n itrosation  o f various secondary and te r t ia ry  amines to  form N-nitroso 
compounds, but this is further examined in Chapter Four. Clinical evidence 
supports the view that n it r i t e  may induce symptoms s im ilar to those o f 
cyanide in domestic animals (Blood et al., 1979).
The bracken-induced ataxia of rats may therefore be a multifactorial 
phenomenon, of which cyanide and nitrite are two of the possible 
aetiological factors, including the thiaminase enzyme which may act to 
predispose the animals to the-toxic effects of cyanide.
3.11.3 Haematology
The haematological indices are suggestive of the ability of the test 
substances, shikimate and quercetin arid bracken the composite from which 
they are isolated to inflict toxic injury on the erythropoietic system. The 
haemoglobin levels and the haematocrit were depressed relative to the 
experimental and historical controls. In addition there was a 
thrombocytopenia in all the three test groups but even though in the
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shikimate group i t  was not s ta t is t ic a l ly  lower than the control, i t  
nevertheless revealed a biological downward trend. These are indicative of 
bone marrow depression by these tes t compounds. However, the MCV and MCH 
values calculated from the observed data were higher than the h is to r ica l 
values and may indicate errors in the estimation of the erythrocyte number 
and therefore of the reticulocyte numbers estimated from them. Therefore the 
comments here do not include any references to or any inferences from these 
indices.
The polychromasia observed from the smears is  in d ica tive  o f the 
presence of ce lls  of varying ages and i t  may thus be inferred that there is 
a regenerative process in these three groups. This view is  further 
buttressed by the large number o f megakaryocytes which are the precursor 
c e l ls  o f p la te le ts  esp ec ia lly  in the bone-marrow o f the bracken-treated 
rats. In addition the bone marrow in the three test groups revealed red 
f i l le d  cavities and l i t t l e  or no fat spaces and it  may be inferred that this 
is regenerative. This inference must however be viewed with caution as i t  is 
based on a single time-point observation of what is essentially a dynamic 
process. However, i t  is pertinent to draw attention to the extramedullary 
haemopoiesis which was particularly prominent in the spleen of the bracken- 
fed rats. Though this process was going on in the quercetin- and shikimate- 
fed rats, they were judged to be no more than would be expected in a normal 
(control) rat. Thus i t  may be that at the time of sampling, the bracken-fed 
rats were at a further stage of regeneration than the two isolates.
The resu lts fo r the bracken-fed rats are in accordance with the 
previously published observations on bracken to x ic ity , but in the case o f 
the quercetin -treated rats, they are at variance with a previous study in 
which a 1% (w/w) quercetin diet did not induce any. haematological changes in 
albino rats at 70, 250 and 410 days respectively (Ambrose et al., 1952).
The Rouleaux formation observed in the bracken-fed rats is evidence of 
the c l in ic a l illn ess  which was observed before the experiment was 
terminated, and may indicate a greater tendency o f the blood to c lo t  more 
easily in these rats.
The d if fe r e n t ia l leucocyte counts indicate an eosinoph ilia  and 
lymphocytopenia in the bracken-fed rats. These conclusions were reached 
because in comparison with both experimental and historical controls, these
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changes were s t i l l  va lid . To further buttress the view that these changes 
were geniune is the in filtra tion  of eosinophils into the lungs and spleen of 
the bracken-fed rats. This may be as a result o f a hypersensitiv ity  
response. The absence of an accompanying monocytosis , however, renders this 
assertion questionable, but monocytosis in the rat is  a very rare 
phenomenon. Recently, two glucuronyl pyranosides called braxin and braxin 
A2 capable of e lic it in g  the release of vasoactive amines from rat peritoneal 
mast c e l ls  were iso lated  from bracken (Saito and Mochizuki, 1986). The 
vasoactive amine, histamine is a mediator of immune responses in animals. 
The release of histamine and heparin in bracken-intoxicated cattle had been 
previously reported as part o f a possib le immune response in bracken 
to x ic ity  (Evans, 1968; Leach and Evans, unpublished data). This ra ises the 
issue o f the type o f immune reaction which th is might be. Eosinophils are 
usually mobilised in type I (anaphylactic) reactions where as a resu lt o f 
re-exposure to a particular antigen, igE attached to mast ce lls  causes them 
to release mediators like histamine, bradykinin and Slow Reacting Substance 
of Anaphylaxis (SRS-A) whose main actions are on the smooth muscle, vascular 
endothelium and on mucus secretion. As a resu lt,oedema o f the nose and 
throat are observed as c l in ic a l signs. The eosinophils are attracted by 
Eosinophil Chemotactic Factor A (ECF-A) and the eosinophils release 
histaminase and other inhibitors which neutralise the anaphylactic response. 
That this explanation might be plausible is reflected in the earlier studies 
o f Fletcher (1944) who reported a la ryn g itic  form o f bracken poisoning in 
c a t t le  characterised by sw elling o f the throat region and roaring (1.3.1). 
This might be the f i r s t  recognised report o f an anaphylactic response in 
bracken tox ic ity .
In considering the presence o f eosinophils and the v a lid ity  o f the 
immunological in terpretation , i t  is  pertinent to bear in mind that no 
previous contact with bracken was observed before the feeding of bracken in 
' the 28 day study, and these rats besides had an intrusive pathology, so that 
the eosinoph ilia  may be considered as part o f a "sympathetic response" by 
the eosinophils. Their presence in the spleen, however, would tend to rule 
this possib ility out.
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3.11.4 Histopathology
The histopathological lesions in the lungs of both the control and test 
animals are evidence of intrusive pathology not related to compound 
treatment. The control and shikimate test groups have reacted most markedly 
as shown by the lymphocyte counts, hence they were considered untenable for 
comparative purposes and while the shikimate group was abandoned for that 
reason, historical controls have been substituted for the experimental 
controls.
The kidneys showed evidence of deposits in the collecting ducts in the 
cortico-medullary zone which may be diagnosed as nephro-calcinosis. This 
change is probably responsible for the other changes such as hydropic change 
and focal tubular nephritis in the proximal tubules, and occasional 
thickening of the parietal surface of the Bowman's Capsule. These being 
observed in both test and control groups of rats were not attributable to 
intrusive pathology, but are rather a consequence of the ad lib, feeding 
method in these'essentially young rats, with a resulting imbalance in 
calcium : phosphorus ratio and the deposition of calcium in the collecting 
ducts. This feature had been observed in the Univeristy of Surrey strain of 
Wistar Albino rats. However, this may be reflected in the lower urinary 
thiocyanate levels of the control group compared to literature values. Their 
generalised occurrence is, however, thought to indicate a particular pattern 
of metabolism for this age of rats rather than a compound-related pathology.
The liver lesions in the bracken-fed group are however thought to be a 
compound-related e ffect which may have arisen as a result of free-radical 
damage o f the hepatocytes resu lting in the. invasion o f the l iv e r  by 
inflammatory c e l ls ,  both polymorphonuclear c e lls  and mononuclear c e lls , 
although the o vera ll p icture was o f predominantly mononuclear c e l l  
in filt ra t io n *  Bracken to x ic ity  a ffe c tin g  the l iv e r  had been reported 
previously (Hirono et al., 1984a) but this was an isolated report.
The predominance of round cells would suggest a chronic inflammatory 
response to free-radical induced damage. It may also represent a delayed 
hypersensitivity (or type. IV) immune response to cells which now damaged are 
recognised as foreign. The interpretation is buttressed by the low 
lymphocyte numbers in the differential absolute counts of the bracken- 
treated group, which perhaps suggests that these cells are sequestered in
the tissues as, for example, in the liver. That bracken toxicity is mediated 
via free-radicals has been suggested by the studies of Pamucku et al. (1970) 
and Evans (1985). Apart from free-radicals, however, lymphokines released 
from macrophages may cause local tissue ischaemia and necrosis. The pattern 
of periportal tissue necrosis in the liver of the bracken-fed rats is in 
accordance with this interpretation. It is probably a general hepatic 
response to toxic injury rather than a specific toxic lesion of bracken. 
This sort of response by the liver has been observed in rats poisoned by the 
pyrolliziaine alkaloids of crotalaria, aflatoxins B and G and dimethyl- 
nitrosamine (McLean et al., 1965).
The other possible consequence of the involvement of free-radicals has 
been briefly mentioned earlier. The polymorphonuclear cells released in the 
early part of the immune response release myeloperoxidase which may play a 
role in the generation of cyanide (vide supra).
3.11.5 Conclusion
In conclusion therfore, the picture that emerges from these studies is 
o f a fa ilu re  by bracken-intoxicated rats to detox ify  cyanide mainly as a 
resu lt o f the fa ilu re  o f the rhodanese enzyme, a fa ilu re  which may be 
brought about by a shortage o f sulphur-donor compounds or even as a result 
of poisoning by the cyanide which acts as its  substrate. The consequence of 
th is  fa ilu re  is the accumulation o f cyanide which is  a cause of ataxia in 
animals, and humans. In addition, though n it r i t e  may act as an antidote o f 
cyanide, i t s  to x ic ity  is s im ila r to that o f cyanide i f  i t  accumulates to 
very high leve ls  as was the case in the bracken-intoxicated rats. In the 
event, i t  would appear that there is  a substantial case fo r im plicating 
nitrate and n itr ite  in b i^jcken toxicity. Almost uniformly, gastro-enteritis 
is  found in a l l  cases o f  n it r a te -n it r ite  toxicoses but not in cyanide 
toxicoses (Hibbs, 1979). The pattern in bracken-intoxicated ca tt le  shows 
that ga s tro -en te r it is  is  a consistent feature o f bracken to x ic ity . While 
cyanide and n itr ite  may be causes of bracken-induced ataxia in animals, the 
role o f thiaminase as a cause is s t i l l  valid.
On the other hand, the detoxification of cyanide in quercetin- and 
shikimate-fed rats was enhanced resulting in very high levels of thiocyanate 
in the urine of these rats.
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The haematological observations reveal a bone marrow depressant effect 
by bracken and its constituent isolates, quercetin and shikimate, while the 
liver lesion in the bracken-intoxicated rats was attributable to an 
immunologically induced injury probably in response to free-radical attack 
on the hepatocytes.
The implications of high nitrite and thiocyanate in the toxicology of 
bracken with specific reference to N-nitrosation will be examined in the 
next Chapter.
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CHAPTER POUR
N-NITROSATION STUDIES ON BRACKEN, 
QUERCETIN AND SHIKIM ATE
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4.1 Introduction
The studies described in this chapter were designed to investigate the 
possible role of N-nitrosation in bracken-induced carcinogenesis.
In the previous experiments (chapter Three), bracken-fed, and to a 
lesser extent quercetin-fed rats excreted in their urine, large amounts of 
n itr ite . The n itr ite , together with cyanide derived from prunasin could be 
responsible for the bracken-induced ataxia observed in bracken-fed rats, in 
addition, n itr ite  and other oxides of nitrogen are known to form very toxic 
and carcinogenic N-nitroso compounds with a group of nitrosatable compounds 
which include secondary and te r t ia ry  amines, amides, N-alkylureas, N- 
alkylcarbamates, cyanamides, guanidines, amidines, hydrazines, hydrazones, 
hydrazides, 3-methylindole (skato le ), indole-3acetic acid and N-acetyl 
tryptophan (M irvish, 1975). I t  is  essen tia l to d iffe re n t ia te  between N- 
nitroso compounds and C-nitroso compounds which are formed by the reaction 
of n itrites  and some phenols and are generally non-carcinogenic or only very 
weak carcinogens (Mirvish, 1975).
4.2 The Toxicology of N-Nitroso Compounds
N-nitroso compounds have a wide spectrum of toxicological effects, 
including acute and chronic cellular injury, mutagenesis, teratogenesis and 
carcinogenesis (Magee and Swann, 1969; Shank, 1975).
Their toxic effects depend on their chemical nature - the nitrosamines 
are usually activated metabolically in the liver to a reactive species whose 
toxic effects are usually in the liver with a few exceptions such as 
dibutylnitrosamine which selectively and specifically attacks the urinary 
bladder. The nitrosamides on the other hand tend to decompose to species 
which attack the organs of rapid cell turnover such as the lymphoid tissue, 
the haematopoietic tissue and the gastro-intestinal tract (Magee and Swann, 
1969; Lobl,1972; Shank, 1975).
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4.3 Sources of Nitrosatable Compounds
Various chemical compounds are capable o f reacting with n itr ite  to form 
N-nitroso compounds (Section 4.1). With sp ec ific  regard to bracken, 
bracken-intoxicated calves had increased leve ls  o f c ircu la tin g  heparin, 
histamine and serotonin (Evans and Howell, 1962; Mason, 1965; Leach and 
Evans, unpublished data, c ited  by Evans, 1970). In addition, pterolactam, 
isolated from bracken contains a nitrosatable group. These provide a source 
of nitrosatable compounds. The n itrosatability of serotonin, a tryptophan 
metabolite, has been demonstrated (Gatehouse and Wedd, 1983).
This raises the issue o f the ro le  o f tryptophan metabolites and 
tryptophan metabolism in bracken toxicity. Some tryptophan metabolites like 
indole, indoleacetic acid, 8-hydroxyquinaldic acid and xanthurenic acid are 
tumour prom oters, w h ile  o thers l ik e  3-hydrox.ykynurenine and 3- 
hydroxyanthranilic acid are bladder tumour promoters and are also mutagenic 
(Hill, 1980).
I t  may therefore be o f interest to examine tryptophan metabolism in the 
tox ico logy o f bracken in view o f the n itro s a ta b ility  o f metabolites lik e  
serotonin and the tumour promoting abilty of others like xanthurenic acid.
The work of Dalgleish (1955) showed that thiamine is required as a co­
factor for the enzyme tryptophan pyrrolase responsible for the conversion of 
tryptophan to N-formylkynurenine, which is the fir s t  step in the kynurenine 
pathway o f tryptophan metabolism. I t  may thus be possib le to envisage a 
situation such as occurs in bracken tox ic ity  where avitaminosis occurs, 
and the kynurenine pathway is  impaired in favour of the indole pathway o f 
tryptophan metabolism, leading to the production of potentially nitrosatable 
compounds.
Although tryptophan metabolism had been inconclusively studied in 
bracken-intoxicated cows (Pamukcu et al., 1959; Pamukcu and Bryan, 1979) the 
use of a different animal model in the form of a monogastric provides an 
opportunity to re-examine an old subject.
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4.4 Factors A f f e c t i n g  N - N i t r o s a t i o n
The formation o f N-nitroso compounds requires that n it r i t e  and a 
n itrosatab le compound be present together at the same s ite , in addition, 
acid pH fa c i l i t a te s  the ir formation as do thiocyanate, halide ions, 
kaempferol, quercetin, catechin, and naringenin which are catalysts of N- 
n itrosation  (Wogan and Tannenbaum, 1975; Mirvish, 1975; Boyland et a l., 
1971; Mirvish et a l., 1975; P ig n a te lli e t  a l . ,  1980, 1982).
Conversely, a lka line or neutral pH w i l l  in h ib it the formation o f N- 
n itroso compounds except in the presence o f formaldehyde (Shank, 1975) as 
w ill  ca ffe ic , feru lic, and chlorogenic acids, ga llic  acid, fise tin , trolox, 
butylated hydroxyanisole, ascorbate, butylated hydroxytoluene and tert-butyl 
hydroquinone (Wogan and Tannenbaum, 1975; Mirvish et a l., 1975; A s t il l and 
Mulligan, 1977; Kuenzig et a l., 1984).
In addition to  these chemical factors, some bacteria enhance N- 
nitrosation even at neutral pH. Thus in the human achlorhydric stomach, in 
the in fected  urinary bladder and in the colon, bacteria play a ro le  in in 
vivo N-nitrosation (El-Merzabani et al., 1979; H ill, 1979).
4.5 Objectives of the Study
The objectives of this study are to determine:
i )  the possible role of N-nit.rosation in bracken-induced carcinogenicity.
•ii) what contributions ( i f  any) quercetin and shikimate might make to such a 
process.
i i i )  i f  there is an alteration of tryptophan metabolism in bracken-fed rats.
iv ) i f  quercetin and shikimate may also induce such a ltera tion s in 
tryptophan metabolism.
v) i f  such alteration may be implicated in bracken carcinogenicity.
4.6 The Strategy of the Study
Some of the factors affecting N-nitrosation were determined in a 90-day 
study. These include n it r i t e  le ve ls  in the urine o f rats fed 10% (w/w) 
bracken, 1% (w/w) quercetin, 1% (w/w) shikimate or control d iets, in.
addition, thiocyanate, a cata lyst o f N-nitrosation was determined in the 
urine and terminally in the serum of these rats.
Tryptophan metabolites like xanthurenic acid which is known to be an 
intermediate in the kynurenine pathway o f tryptophan metabolism and is  a 
known bladder carcinogen (Allen et al., 1957) as well as kynurenic acid were 
determined in the urine of these rats.
The indole pathway was examined by assaying for tota l 5-hydroxy indole 
using 5-hydroxytryptamine as a marker (Udenfriend et a l., 1955; Varley et 
a l., 1976).
The comparison of the shikimate- and quercetin-fed rats to bracken-fed 
rats is important not only on the basis of a need for determining how they, 
as bracken isolates compare with the parent compound, but in its own right 
quercetin is a catalyst of N-nitrosation. In addition, as a mutagen it may 
enhance the growth of intestinal microflora which could influence in vivo N- 
nitrosation. The role of shikimate in N-nitrosation is not yet explored but 
its metabolism is carried out in part by the gut flora (Brewster et al.,
1978) hence the need to determine how this may influence N-nitrosation.
4.7 Materials and Methods
4.7.1 Animals
Forty male Wistar-albino (W/A) rats (University of Surrey Animal Unit) 
were divided into four groups of 10 per group as previously described.
4.7.2 F e e d stu ffs  and D ie ts
Bracken (10% w/w), quercetin (1% w/w) and shikimate (1% w/w) diets were 
prepared as previously described.
4.7.3 Chemicals and Reagents
These were of analytical reagent grade, unless otherwise stated.
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4.7.4 S a m p l e  col l e c t i o n
Urinary samples were co llec ted  at weeks 4, 8, and 13 by putting the 
rats into metabole cages and collecting 24 hour urine. The volume and pH of 
each urine sample were noted and the urine sample from each group divided 
in to three. One portion was used for the determination o f creatin ine, 
n itr ite , thiocyanate and tota l 5-hydroxyindoles,
The second portion was a c id ified  with sulphamic acid and used for N- 
n itroso compound studies. The sulphamic acid s ta b ilis e s  the urine by 
suppressing bacterial growth, inactivates nitrosating agents, and prevents 
decomposition of N-nitroso compounds. The third portion was acidified with 
2M hydrochloric acid (2 ml per 10 ml urine aliquot) for the determination of 
xanthurenic and kynurenic acids.
At week 13 when the study was terminated each rat was anaesthesised 
with anaesthetic ether. (May and Baker Ltd., England) and term inally 
exsanguinated via the posterior vena cava. The blood collected was le f t  to 
clot in plain glass tubes for the collection of serum which was used for the 
determination of thiocyanate.
The gut contents were co llec ted  by separately tying o f f  the stomach, 
intestine and caecum and flushing out with d is tilled  water. Each portion was 
thoroughly dried on f i l t e r  paper and weighed out in 1 g portions. Sulphamic 
acid was added to each portion. A ll the samples were stored at -12°C until 
analysed usually within three days.
4.7.5 D eterm in ation  o f C re a tin in e
Urinary creatinine was determined as described in 3.9.9.
4.7.6 D eterm in ation  o f U rin a ry  N it r it e
Urinary n itr ite  was determined as described in 3.9.8.
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Urinary and serum thiocyanate were determined as described in 3.9.5.
4.7.8 D eterm in ation  o f N -N itroso  Compounds in  U rin e  and Gut Contents
The urine sample containing sulphamic acid was f i l t e r e d , sodium 
ch loride (BDH Chemicals Ltd., Poole, Dorset, England) was added (10% w/v) 
and the solution exhaustively extracted with ethyl acetate (May and Baker 
Ltd., Manchester, England) using 10.0 ml ethyl acetate per ml urine on each 
occasions using fla t  bottomed flasks. The gut contents were extracted with 
100 ml ethyl acetate per 1 g o f gut content by shaking in f la t  bottomed 
flasks.
To each ethyl acetate extract o f either the gut content or urine 
sample, an equal volume of 3% hydrogen bromide (BDH Chemicals Ltd., Poole, 
England) in g la c ia l acetic  acid (BDH Chemicals Ltd., Poole, England) was 
added and le f t  at room temperature for 15 minutes. A 20 ul a liquot was 
added to  2.5 ml su lphanilic acid made up o f 27.2 g potassium hydrogen 
sulphate (Hopkin and Williams Ltd., Essex, England) and 3.46 g sulphanilic 
acid (BDH Chemicals Ltd., Poole, Dorset, England) made up to  1 L with 
d is tilled  water. After 10 minutes, 2.5 ml of NEDH, 0.04% (w/v) in d is tilled  
water was added. The pink colour was allowed to develop for 20 minutes and 
the absorbance was determ ined using a C e c il CE 292 d ig i t a l  UV 
spectrophotometer (C ec il Instruments Ltd., Cambridge, England) at 550 nm. 
To ensure that residual n itr ite  was not mistaken for N-nitroso compounds the 
blank was made up o f extract minus the hydrogen bromide (Eisenbrand and 
Preussmann, 1970).
The standard curve was prepared by using sodium n itr ite  in d is tilled  
water according to the method of Montgomery and Dymock (1961) as described 
in section 3.9.8. The assay was linear between 1.00 x 10”  ^ and 2.00 x 10~2 
mg/ml.
4.7.9 The N itro s a tio n  A ssay Procedure (NAP)
The NAP was carried out as described by Coulston (1980) and modified by 
G illa tt  e t  a l . (1984).
4.7.7. Determination of Urinary and Serum Thiocyanate
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To each 1 ml o f urine, or 1 g o f gut content a c id ifie d  with sulphamic 
acid, were added sodium ch loride, 0.5 mg, plus su ffic ien t 0.05 M KCl-HCl 
bu ffer containing 10 mM potassium thiocyanate to bring the pH to pH 3 
Sodium n it r it e  was added to g ive a concentration o f 40 mM in the fin a l 
volume, i t  was incubated at 37oC for 3 hours, and at the end excess 
sulphamic acid was added to remove residual n itr ite  which could give false 
p o s it ive  resu lts. Extraction o f N-nitroso compounds was done with ethyl 
acetate and determined as already described.
The determination of N-nitroso compounds was based on the method of 
Eisenbrand and Preussmann (1970) with the modification that the method of 
Montgomery and Dymock (1961) was used for the detection of nitrite rather 
than the Greiss-ilosvay reagent.
The method is  rapid, sen s itive  and sp ec ific  for N-nitroso compounds. 
I t  does not detect related compounds such as N-nitramines, N-nitramides, C- 
n itro  and C-nitroso compounds, oximes and a lkyl n itra tes  (Johnson and 
Walters, 1971).
The reaction is based on the cleavage of the N-nitroso group by 
hydrogen bromide in the presence of glacial acetic acid.
Figure 4.3 Cleavage of the N-Nitroso Bond by Hydrogen Bromide
(The principle of the determination of N-nitroso compounds, Eisenbrand
and Preussman, 1970)
N—N = 0  + HB r
R2^
Glacial Br" + 0= N -B r N0+ +  Br
acetic acid rV "
The NO+ thus released is captured by diazotization of sulphanilamide and the 
diazonium ion which resu lts is  coupled with NEDH and can be measured 
spectrophotometrically at 550 nm.
For the assay system to work w e ll, i t  has to be as anhydrous as 
possible, and an average recovery of 99.5% could be obtained, so that in the 
determination o f N-nitroso compounds each n it r i t e  molecule could be 
considered equivalent to one molecule of N-nitroso compound (Newton, 1978).
4.7.10 Determination o f Xanthurenic and Kynurenic Acids
The portion of urine acid ified with hydrochloric acid was diluted 1 : 5 
with d is t i l le d  water and 4.0 ml a liquots were used fo r the duplicate 
determination of xanthurenic acid and kynurenic acid by pouring the urine 
samples down a 3.0 cm column of Dowex 50-W ion exchange, acid form resin in 
a bedding o f cotton wool. The resin column was prepared prior to use by 
washing successively with 5.0 ml 2 M hydrochloric acid and 10.0 ml d is tilled  
water. The eluate and the f ir s t  10.0 ml portion of d is tilled  water from the 
column were discarded. The last 25.0 ml portion was used fo r the 
determination of xanthurenic acid and kynurenic acid.
Xanthurenic acid was determined by adding 1.0 ml saturated sodium 
hydroxide to 1.0 ml o f the eluate and centrifuged at 3,000 g for 5 minutes 
in a bench top cen trifuge to g ive  a c lear solution whose fluorescence was 
determined in a Perkin-Elmer fluorescence spectrophotometer, Model LS-5 
(Perkin-Elmer Ltd., Bucks., England), with the excitation wavelength at 370 
nm and the emission wavelength at 515 nm.
Kynurenic acid was determined by adding 1.0 ml 18 M sulphuric acid to
1.5 ml of the eluate. After leaving to cool the fluorescence was determined 
at an excitation wavelength of 365 nm and an emission wavelength of 440 nm 
using a Perkin-Elmer fluorescence spectrophometer, Model LS-5 (Perkin-Elmer 
Ltd., Bucks., England).
The blank in each case was made up o f d is t i l le d  water passed through 
the column and treated as above (Bender et al,, 1977).
Xanthurenic and kynurenic acids (Sigma Chemical Company Ltd., Poole, 
Dorset, England) were used fo r the preparation o f the standard curve. The
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xanthurenic acid assay was linear over the range 1.0 x 10 to 1.0 x 10  ^
mg/ml while the kynurenic acid assay was linear over the range 1.0 xlO-5 to
1.0 mg/ml. Recovery studies were carried out by adding quantities o f
jcommercial xanthurenic acid and kynurenic acid to aliquots of various urine 
samples and processing them as described above. The percentage recovery 
determined in each case ranged from 96% to 104% for xanthurenic acid and 
from 91% to 103% for kynurenic acid.
4.7.11 Determination of Total 5-Hydroxyindoles
To duplicate 1.0 ml aliquots of urine were added in succession, 1.0 ml 
d is t i l le d  water, 1.0 ml 1 g/L l-nitroso2naphthol in ethanol and 1.0 ml 
nitrous acid reagent made up o f 0.2 ml 25 g/L sodium n it r it e  in d is t i l le d  
water and 5.0 ml 1 M sulphuric acid. The nitrous acid reagent was always 
freshly prepared. After 10 minutes, i t  was shaken twice with ethyl acetate,
5.0 ml on each occasion. The ethyl acetate layers were discarded and the 
aqueous layer was centrifuged at 3,000 g for 5 minutes in a bench-top 
centrifuge. The absorbance of the supernatant was determined in a Cecil CE 
292 d ig ita l  UV spectrophotometer (C ecil Instruments Ltd., Cambridge, 
England) at 540 nm against a blank containing water instead o f urine 
(Udenfriend ejt a l., 1955; Varley et_ a l., 1976).
The standard curve for to ta l 5-hydroxyindoles was prepared with 5- 
hydroxytryptamine (sigma Chemical company Ltd., Poole, Dorset, England). 
The assay was lin ear between 2.2 x 10~3 and 17.6 x 10~3 mg/ml. Recovery 
studies were carried out by adding commercially obtained 5-hydroxytryptamine 
to aliquots of the various urine samples and processing them as described 
for the test samples. Recovery for total 5-hydroxyindoles ranged from 99.5% 
to  119%.
4.8 Results
The results are presented as the mean values obtained from ten rats for 
each dietary group + standard error of the mean (S.E.M.).
4.8.1 Statistics
The student's t-test was used to compare the means of each test group 
to the control group and the significance was determined at p<0.05.
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4.8.2 Weight Changes
The bracken-fed rats had a slower rate of weight gain compared to the 
control, shikimate- and quercetin-fed rats (p<0.05) using the Student's t -  
test (Figure 4.3).
4.8.3 Clinical Signs
There were no overt signs of illness in any of the experimental groups 
except as described above for the bracken-fed rats.
4.8.4 Urinary pH
The urine was basic in a l l  the groups during the experimental period 
(Table 4.1).
Table 4.1 Urinary pH of Rats fed 1% (w/w) Quercetin, 10% (w/w) Bracken,
1% (w/w) Shikimate and Control Diets.
Time (weeks) 
Groups
4 8 13
Control 8+0 8+0 8+2
Quercetin 9+0 8+1 9+0
Bracken 8+0 8+1 8+0
Shikimate 8+0 8+1 8+1
Values are the means + S.E.M. o f ten rats.
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Figure 4.3 Weight Gains of Rats in 90-Pay N-Xitrosation Study
fed (1) IX (w/w) shikimate diet (2) control diet
(3) IX (w/w) quercetin diet (4) 10T (w/w) bracken diet
xi e2
Time (weeks)
/eights are the means of ten rats per group.
(4) The bracken-fed rats were statistically
®i8 ^ificantly different from the control group, 
p < 0.001 throughout the study period.
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4.8.5 Urinary Nitrite
At week 4, urinary n it r i t e  leve ls  in the quercetin- and bracken fed 
rats were higher than the control, while the shikimate-fed rats had a lower 
level. These levels dropped dramatically in the bracken-fed rats, steadily 
in the quercetin-fed rats and remained constant in the shikimate-fed rats.
In the three test groups there was a decrease in urinary n itr ite  with 
time, but in the control group i t  rose at week 8 and dropped at week 13 
(Table 4.2).
Table 4.2 Urinary Nitrite Concentration in Rats fed 1% (w/w) Quercetin, 
10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Urinary Nitrite (ug/mg creatinine)
Time (weeks) 
Groups
4 8 13
Control 0.5+0.0 1.0+0.4 0.3+0.0
Quercetin 3.0+0.2* 1.7+0.3 0.2+0.0+
Bracken 14.0+0.3* 2.3+0.0* 0.1+0.0+
Shikimate 0.1+0.0+ 0.1+0.0+ 0.1+0.0+
Values are the means + S.E.M. of ten rats.
* ~ values statistically higher than control (p<0.05) 
+ = values statistically lower than control (p<0.05) 
(Using the Student's t-test)
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4.8.6 Urinary Thiocyanate
The urinary thiocyanate levels for the quercetin-fed rats were higher 
than the control values throughout the experimental period. In the bracken- 
fed rats, i t  was lower at week 8 and higher at week 13. In the shikimate-fed 
rats i t  was higher at week 4, lower at week 8 and higher at week 13 (Table 
4.3).
Table 4.3 Urinary Thiocyanate Concentration of Rats fed 1% (w/w) Quercetin, 
10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Urinary Thiocyanate (ug/mg creatinine)
Time (weeks) 
Groups
4 8 13
Control 2.2+0.0 1.8+0.0 12.2+0.3
Quercetin 13.5+1.0* 5.2+0.1* 21.7+0.7*
Bracken 2.1+0.0 1.4+0.0+ 20.4+0.3*
Shikimate 5.5+0.1* 2.4+0.1* 14.4+0.4*
Values are the means + S.E.M. o f ten rats.
* = values s ta tis tica lly  higher than control (p<0.05) 
+ = values sta tis tica lly  lower than control (p<0.05) 
(Using the student's t-test)
4.8.7 Serum Thiocyanate
The bracken-fed rats had a s ig n ific a n tly  higher le v e l o f serum 
thiocyanate than the control group while the shikimate-fed rats.had a 
significantly lower level than the control group (Table 4.4).
Table 4.4 Serum Thiocyanate Concentration at week 13 in Rats fed 1% (w/w) 
Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Groups Serum Thiocyanate
(ug/ml)
Control 5.0+0.1
Quercetin 5.0+0.3
Bracken 6.9+0.2*
Shikimate 2.5+0.2+
Values are the means + S.E.M. of ten rats.
* = values statistically higher than control (p<0.05) 
+ = values statistically lower than control (p<0.05) 
(Using the Student's t-test)
4.8.8 D eterm in ation  o f N -N itroso  Compounds in  th e U rin e  and Gut Contents
The determination of N-nitroso compounds in the urine and gut yielded 
negative results. N-nitroso compounds were not found in the gut contents or 
urine of any of the experimental groups.
1 6 8
4.8.9 The Nitrosation Assay Procedure on the Gut Contents
Consequent upon the NAP, the intestinal contents of the quercetin-fed 
ra ts  showed the g rea te s t  s u s c e p t ib il ity  to N-n itrosation fo llow ed 
successively in decreasing order by the stomach contents of the bracken-fed 
rats, the intestinal contents of the shikimate-fed rats, the caecal contents 
o f the bracken-fed rats, the in te s tin a l contents o f the bracken-fed rats, 
the caecal contents of the quercetin-fed rats and. the caecal contents of the 
shikimate-fed rats. In regional terms, the intestinal contents were most 
read ily  susceptible to N-n itrosation . The stomach contents o f the 
quercetin- and shikimate-fed rats were not susceptible to N-nitrosation, nor 
were the stomach, intestinal and caecal contents of the control group (Table
4.5).
Table 4.5 N-N itrosatable Compounds in the Gut at week 13 o f Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate 
and Control Diets post Nitrosation Assay Procedure.
N-Nitrosatable Compounds (ug N02 /g ingesta)
Groups
Stomach Contents In testinal Contents Caecal Contents
Control N.D. N.D. N.D.
Quercetin N.D. 345+46* 7+1*
Bracken 160±15* 61+3* 78+25*
Shikimate N.D. 79+4* 4+1*
Values are the means + S.E.M. o f ten rats.
* = values s ta tis tica lly  higher than control (p<0.05) 
(Using the Student's t-tes t)
N.D. = Not Detected
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4.8.10 Nitrosation Assay Procedure o n  the Urine
The urine of the shikimate-fed rats was not susceptible to nitrosation, 
while the urine of quercetin-fed rats at weeks 4 and 8, and the bracken-fed 
rats at week 4, were significantly more susceptible to nitrosation than the 
control group. At week 13 however, the three tes t groups were less 
susceptible to nitrosation than the control group (Table 4.6).
Table 4.6 N-Nitrosatable Compounds in the Urine at week 13 of Rats fed 
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate 
and Control Diets post Nitrosation Assay Procedure.
N-Nitrosatable Compounds (ug N02 /mg creatinine)
Time (weeks) 
Groups
4 8 13
Control N.D. 1.00+0.03 2.00+0.07
Quercetin 2.70+0.20* 3.00+0.06* 0.10+0.02+
Bracken 1.20+0.02* N.D.+ 0.70+0.01+
Shikimate N.D. N.D.+ . N.D.+
Values are the means + S.E.M. o f ten rats.
■* = values s ta tis tica lly  higher than control (p<0.05) 
+ = values s ta tis tica lly  lower than control (p<0.05) 
(Using the Student's t-tes t)
4.8.11 Urinary Xanthurenic Acid
The three test groups had lower xanthurenic acid levels at week 4, the 
shikimate group a higher level at week 8, while the quercetin and shikimate 
groups had lower levels at week 13 (Table 4.7).
Table 4.7 Urinary Xanthurenic Acid Concentration o f Rats fed
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Xanthurenic Acid (ug/mg creatinine)
Time (weeks) 
Groups
4 8 13
Control 2.60+0.47 0.35+0.06 0.21+0.01
Quercetin 0.33+0.02+ 0.35+0.07 0.11+0.01+
Bracken 1.00+0.13+ 0.26+0.03 0.21+0.01
Shikimate 0.75+0.07+ 0.73+0.17* 0.16+0.01+
Values are the means + S.E.M. o f ten rats.
* = values s ta tis tica lly  higher than control (p<0.05) 
+ = values s ta tis tica lly  lower than control (p<0.05) 
(Using the Student's t-tes t)
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The three test groups had lower kynurenic acid le ve ls  at week 4 than 
the control group, while at week 8, the quercetin and bracken groups had 
lower kynurenic acid levels. At week 13, there were no differences between 
the test and control groups (Table 4.8).
4.8.12 Urinary Kynurenic Acid
Table 4 . 8  Urinary Kynurenic Acid Concentration o f Rats fed
1% (w/w) Quercetin, 10% (w/w) Bracken, 1% (w/w) Shikimate and control Diets.
Kynurenic Acid (ug/mg creatinine)
Time (weeks) 
Groups
4 8 13
Control 0.92+0.02 0.27+0.04 0.07+0.01
Quercetin 0.13+0.01+ 0.14+0.01+ 0.08+0.01
Bracken 0.30+0.01+ 0.13+0.01+ 0.07+0.00
Shikimate 0.22+0.01+ 0.39+0.10 0.06+0.00
Values are the means + S.E.M. o f ten rats.
+ = values s ta tis tica lly  lower than control (p<0.05) 
(Using the Student's t-tes t)
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4.8.13 Urinary Total 5-Hydroxyindoles
The shikimate-fed rats had a s ig n ific a n tly  lower le v e l o f to ta l 5- 
hydroxyindoles at week 4 but otherwise there were no significant differences 
(Table 4.9).
Table 4.9 Urinary Total 5-Hydroxyindoles of Rats fed 1% (w/w) Quercetin,
10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Total 5-Hyd roxyindoles (ug/mg creatinine)
Time (weeks) 4 8 13
Groups
Control 75+25 35+12 23+7
Quercetin 68+23 71+24 34+11
Bracken 45+15 20+7 38+13
Shikimate 21+5+ 47+16 30+10
Values are the means + S.E.M. o f ten rats.
+ = values s ta tis tica lly  lower than control (p<0.05)
(S tatistica l analysis based on comparison of test values to control for each 
week, using the Student's t-tes t)
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4.8.14 Urinary Creatinine Values
These were determined for each urine sample ,and metabolites determined 
in the urine were expressed per m g ' creatinine to take into account 
variations due to volume of urine output and dilution factors. These are 
presented in Table 4.10.
T a b le  4.10 Urinary Creatinine of Rats fed 1% (w/w) Quercetin, 
10% (w/w) Bracken, 1% (w/w) Shikimate and Control Diets.
Urinary Creatinine (ug/ml)
Time (weeks) 
Groups
4 8 13
Control 0.8+0.1 1.4+0.1 2.0+0.2
Quercetin 1.6+0.2 1.5+0.1 2.0+0.2
Bracken 1.5+0.1 2.5+0.2 2.6+0.2
Shikimate 2.1+0.1 1.1+0.1 2.1+0.1
Values are the means + S.E.M. of ten rats.
4.9 Discussion
The hypothesis tested by these studies was that N-nitrosation was a 
possible mechanism for the mediation of bracken-induced carcinogenicity.
To th is end the urinary n it r i t e  leve ls  were monitored over a 90-day 
experimental period by measuring at th ree tim e po in ts  during the 
experimental period. The progressive decline of n itr ite  levels in the urine 
of the quercetin- and bracken-fed rats may be suggestive of the utilisation  
of n itr ite  for the formation of N-nitroso compounds, but may also indicate 
impairment of the nitrate reductase responsible for the reduction of nitrate 
to n it r ite .  Cyanide which may be produced upon enzymatic hydrolysis o f 
cyanogenic glycosides, is  a potent in h ib ito r  o f  n it r a te  reductase 
(Solomonson, 1981). The a c t iv ity  o f the enzyme is  enhanced by hydrogen 
donors such as malate, succinate and glutamate. Another mechanism that might
impair its  activ ity  in bracken-intoxicated animals is via the anti-thiamine 
e f fe c t  which deprives the animal o f an essentia l co -factor (thiamine 
pyrophosphate) fo r the enzymes pyruvate dehydrogenase and <*-glutamate 
dehydrogenase responsible for the metabolism of these hydrogen donors via 
the c itr ic  acid cycle.
The determination o f the le v e ls  o f thiocyanate in the urine at three 
time points over the experimental period and in the serum at the end of the 
experiment would suggest that the conditions for in vivo N-nitrosation exist 
in the three experimental groups. However, no N-nitroso compounds were 
detected until the application of the Nitrosation Assay procedure when some 
N-nitrosatable material was detected in the test groups.
Some explanations which may be advanced for this are, the insufficient 
sensitivity of the colorimetric method o f Eisenbrand and Preussmann (1970). 
Although this method is described as sensitive, i t  cannot be compared to the 
newer methods based on selective gas-liqu id  chromatography and linked to 
mass spectrometers (Fiddler, 1975; Webb et al., 1979). The other.possible 
explanation could be the ro le  o f the blocking agents lik e  c a ffe ic  and 
fe ru lic  acids which occur in bracken and could block N-nitrosation in the 
bracken-fed rats. Thus a study o f the k inetics of the process o f N- 
nitrosation in the bracken-fed rats may help to delineate the relative roles 
of the factors that favour N-nitrosation and balance them against those that 
block N-nitrosation.
The situation with quercetin and shikimate is interesting in view of 
the n itro s a ta b ility  o f the gut contents o f rats fed these bracken 
constituents, as shown by the NAP. I t  may be explained on the basis, of 
their ab ility  to alter the composition of the gut microflora in such a way 
that the growth o f bacteria capable o f enhancing N-nitrosation is  
preferentially promoted in the gut of animals fed these compounds (Sander, 
1968). The a b i l i t y  o f quercetin to  act as a cata lyst of. N -n itrosation 
(P ig n a te lli et a l., 1980) must be a further important factor in the very 
high le v e ls  o f N-n itrosatable compounds found in the in testine o f the 
quercetin -fed rats a fte r  the NAP. In addition the urinary le v e ls  o f 
thiocyanate, a potent catalyst o f N-nitrosation, in the quercetin-fed rats, 
r ises  very rapidly at week 4 and must be another important factor 
responsible for the susceptibility of the intestinal contents o f the rats to 
N-nitrosation. This in it ia lly  very high leve ls  o f thiocyanate is  probably
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due to the enhanced activity of rhodanese (3.10.5). The levels of
a phenomenon previously observed in rats on chronic cyanide ingestion and 
attributed to substrate saturation (Smith and Foulkes, 1966). However, the 
levels in the control group also drop at week 8 and although the decrease is 
less remarkable than in the test groups it perhaps represents a natural 
pattern of thiocyanate excretion in rats reflective of gastro-intestinal 
recirculation of thiocyanate as the animals increase in size and the amount 
of space available for thiocyanate recirculation increases, and the amount 
excreted drops (Kreutler et al., 1978; Okoh, 1978). The thiocyanate levels 
rise at week 13 and this may be reflective of saturation re-absorption in 
the renal tubules (Kreutler et al., 1978).
The scenario provided by in it ia l high n itr ite  and thiocyanate levels is 
idea l fo r N -nitrosation to occur. I t  may be concluded therefore that th is 
occurs early in the course o f feeding the test compounds. Indeed N- 
nitrosatable compounds were detected in the urine as early as week 4 (Table
4.6).
The detection of N-nitrosatable compounds in the stomach of the 
bracken-fed rats only, but not in the quercetin- and shikimate-fed rats may 
be attributed to two factors, namely, the absence of any nitrosatable 
compounds (e.g. amines or amides) in the stomach of the quercetin- and 
shikimate-fed rats and the absence of bacteria capable of promoting the 
process of nitrosation in the stomach. Thus although there is nitrite and 
the catalyst thiocyanate is available and the acidic pH of the stomach is 
ideal for nitrosation, the absence of an amine or amide makes it impossible 
for the process to take place in the stomach of these rats. Bracken on the 
other hand contains a primary amide, pterolactam and upon ingestion of 
bracken, this compound is readily available in the stomach to be nitrosated.
In contrast, the intestinal and caecal contents of the three test 
groups are susceptible to N-nitrosation due to the presence of the 
nitrosatable compounds produced in part as a result of bacterial metabolism 
as well as other factors such as the presence of thiocyanate and in the case 
of bracken, the potentially nitrosatable compound, pterolactam. It is 
possible then to envisage a balance of factors in each of the three test 
groups which promote or inhibit N-nitrosation. In the three test groups 
there are common factors like the presence of nitrite and thiocyante.
thiocyanate quercetin, bracken and shikimate groups at week 8
However, while quercetin is able to produce more thiocyanate than the others 
i t  lacks the presence of N-nitrosatable compounds, but may produce these via 
the metabolism of gut flora. On the other hand, while bracken contains the 
potentially nitrosatable compound pterolactam, i t  also contains cafeic acid 
and feru lic  acid, both blockers of N-nitrosation. In the shikimate-fed rats, 
i t  is  probably the metabolism o f gut flo ra  that, is  most important with 
regards to the production of N-nitrosatable compouJ'5
The possib le ro le  o f tryptophan metabolism  in bracken-induced 
carcinogenesis' was investigated to determine i f  any of the metabolites might 
be considered significant in the process.
The lower levels of xanthurenic and kynurenic acids in the bracken-fed 
rats are in agreement with the resu lts o f Dalgleish (1955) who reported 
decreased urinary excretion of the metabolites of the kynurenine pathway in 
thiamine deficient rats.
The quercetin- and shikim ate-fed rats also had lower le v e ls  o f both 
m etabolites in the urine compared to the control group except fo r  the 
shikimate-fed group at week 8. I t  is thus pertinent to consider whether the 
e ffect is related to or mediated via an anti-thiamine mechanism. I t  had been 
suggested that some thermostable anti-thiam ine factors such as is o - 
quercitrin and caffeoyl-shikimic acid are only active in vitro. The activ ity  
of the thermostable anti-thiamine factor, "the SF factor" (Konishi, 1984) in 
vivo  in the equine and the observation here, o f the lowered kynurenic and 
xanthurenic le v e ls  in the quercetin- and shikimate-fed rats appear to be 
in d ica tive  o f possib le in v ivo  anti-thiam ine a c t iv ity  o f constituents o f 
bracken other than thiaminase.
It  is pertinent to note that the xanthurenic and kynurenic acid levels 
were most significantly lower in the test groups at week 4 which is also the 
period during which the anti-thiamine activ ity  of bracken is most prominent, 
when ataxia was evident. Is  th is  suggestive o f in v ivo  anti-thiam ine 
activ ity  by shikimate and quercetin?
This does not rule out the possib ility  of a direct inhibitory e ffect of 
the tes t compounds on any or several o f the enzymes responsible fo r  the 
metabolism of tryptophan to produce kynurenic and xanthurenic acid (Figure 
4.2). In addition i t  ought to be borne in mind that tryptophan metabolism is
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influenced by the nature of the gut flora (Williams, 1972). This is in turn 
influenced by the diet and therefore any combination of factors including an 
action v ia  the antithiamine e f fe c t  in d irec tly  in fluencing the enzymes 
themselves or an a ltera tion  in the gut flo ra  component o f tryptophan 
metabolism may serve to explain the differences in tryptophan metabolism in 
the three te s t .groups compared to the control.
However the examination o f the pathway o f tryptophan metabolism by 
examining the le v e l o f to ta l 5-hydroxyindoles in the urine did not reveal 
any significant differences between the test and control groups except for 
the shikimate group at weeek 4. I t  would be expected that these metabolites 
may be excreted in larger quantities in the thiamine-deficient animals where 
the kynurenine pathway is impaired.
An hypothesis to explain th is  apparent lack o f s h ift  towards indole 
pathway may be that the 5-hydroxyindoles so produced have been N-nitrosated 
by the n it r i t e  which was found to atta in  high le v e ls  in quercetin- and 
bracken-fed rats at week 4, hence the apparent absence o f elevated 5- 
hydroxyindoles in the test groups, which would normally be expected. When 
rat peritonea l mast c e l ls  were treated JLn v itro  with some fractions of 
bracken, elevated levels of histamine were detected, t w o  B-glucopyranosides 
called braxin Al and A2 were identified as responsible for this a ctiv ity  of 
bracken (Saito and Mochizuki, 1986). I t  is  therefore plausible to suggest 
that the sh ift towards the indole pathway may be undetectable in vivo due to 
the concomitant and overriding e ffect of N-nitrosation.
Therefore it is not certain whether the metabolism of tryptophan is 
significant in bracken-induced carcinogenesis, especially as the specific 
identity of the N-nitrosatable compounds produced in the NAP on bracken-, 
quercetin-and shikimate-fed animals is unknown. If the identity of these N- 
nitrosatable compounds is known, it may be possible to affirm the view that 
there is a shift away from the kynurenine pathway towards the indole pathway 
and that the products of that pathway are involved in N-nitrosation.
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4.10 Conclusion
The potential of bracken-fed rats for N-nitrosation has been 
demonstrated by these studies, but the identity of the bracken carcinogen is 
still unknown.
The role of tryptophan metabolism in the carcinogenicity of bracken was 
not conclusive from these studies but the lower levels of xanthurenic and 
kynurenic acids in the test rats is consistent with the pattern in thiamine- 
deficient animals (Dalgleish, 1955). The significance of thiamine deficiency 
in relation to the process of N-nitrosation and tryptophan metabolism may be 
more apparent if it is considered that mice on a vitamin B complex-deficient 
diet and treated with arecoline and potassium nitrite had a higher incidence 
of tumours than mice on a normal diet (Bhide et al., 1984). While it is 
possible to attribute these effects to other constituents of the B-complex 
group of vitamins other than thiamine, it is nevertheless an important point 
to consider the possible role of the anti-thiamine phenomenon as a 
contributor to the enhancement of N-nitrosation, and the alteration of 
tryptophan metabolism. The hypothesis being put forward here is that the 
products of altered tryptophan metabolism in thiamine-deficje^j-it animals may 
be available for N-nitrosation.
CHAPTER FIVE
GENERAL DISCUSSION AND CONCLUSION
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General Discussion
The central issue that remains unresolved in studies on bracken 
carcinogenesis is the identity of the carcinogen(s), and it is hoped that 
from it will proceed an understanding of the pathogenesis of the disease, 
and the mechanisms of action whereby cancer is induced in bracken- 
intoxicated animals. The identification of the bracken carcinogen may reveal 
a new class of compounds hitherto unrecognised, or a familiar class of 
compounds, hitherto thought to be safe. This area of study thus has immense 
scientific and public health importance.
Various approaches have been attempted in trying to determine the 
identity of the bracken carcinogen(s) but none of the candidate carcinogens 
nominated so far has met all the requirements nor explained the various 
features of bracken-induced carcinogenesis.
In chapter Two, an initiation-promotion hypothesis was examined as an 
explanation for the mediation of bracken-induced carcinogenesis. The ability 
of shikimate on its own to enhance ornithine decarboxylase in the tissues of 
rats so treated suggests a tumour promoting ability. This implies the 
presence of a tumour initiator. It has not been possible to determine what 
this might be, but some candidates can be suggested including quecetin and 
ptaquiloside, both of which are mutagens. LA
From the studies in Chapter Four, it was concluded that the nitrosation 
of some nitrosatable entities in bracken may offer a basis for explaining 
bracken-induced carcinogenesis. It was possible to identify one such 
potentially nitrosatable compound as pterolactam, but it is probably not the 
only one.
The nitrosatable compounds formed in bracken-intoxicated animals would 
probably be nitrosamides rather than nitrosamines, although a mixture of 
both cannot be discounted. The nitrosamides tend to attack organs of rapid 
cell turnover such as the intestinal tract and the bone marrow, that is they 
tend to act in a "radiomimetic" manner. The nitrosamines tend for the most 
part to be organ-specific. Where specific organs like the liver are 
attacked, the nitrosamides tend to induce periportal rather than 
centrilobular necrosis which is seen in toxic injury induced by 
nitrosamines. The lesions observed in the liver of the bracken-fed rats in
the.28-day study (Chapter Three) were those o f p eriporta l necrosis. The 
bracken-induced to x ic ity  in bovines consists o f the shorter term bovine 
bracken poisoning caused by bone marrow aplasia with resultant haemorrhaging 
and the longer term alimentary tract and bladder tumours. Both these lesions 
could be attributable to the actions of compounds acting in a radiomimetic 
manner and the nitrosamides serve a unifying hypothesis for these syndromes. 
Apart from the sub-acute and chronic lesions which may be explained by the 
actions o f a nitrosamide, the teratogen ic e ffe c ts  o f bracken may also be 
explained on that basis. For while the nitrosamides are capable o f 
te ra togen ic ity , the nitrosamines are generally incapable o f th is  except 
where infused intravenously late in pregnancy (Magee et al., 1976). Bracken 
has been amply demonstrated to be capable of teratogenicity (Yasuda et al.,
1979). The nitrosamides are also powerful mutagens being active in a l l  the 
usual microbial test systems and in Drosophila, while the nitrosamines are 
active in Drosophila, but require activation to be active in the microbial 
assay systems (Magee et a l., 1976). This is  due to  the requirement o f 
nitrosamines for activation while the nitrosamides do not require activation 
but tend to decompose to active species (Lobl, 1972). This may also account 
fo r  the fa ilu re  in th is and severa l other previous studies to id en tify  a 
bracken carcinogen intact, because of the ease and rapidity of decomposition 
of the nitrosamides.
From the foregoing, the unifying role of the "nitrosamide hypothesis" 
in serving as a basis for the biological activity of bracken is evident, but 
it need not be the only explanation for the various effects observed in 
intoxicated animals, for as has been shown in Chapter Two, shikimate is a 
tumour promoter by virtue of its ornithine decarboxylase enhancing property. 
Besides it was also shown to be capable of inducing bone marrow aplasia, it 
is debatable to what extent and degree, shikimate can influence these 
changes. That shikimate, a compound widely distributed in various human 
foods should bring about these actions is of public health significance, but 
it ought to be borne in mind that injpa&'imice, shikimate had induced both £  
gastric carcinoma and leukaemia (Evans and Osman, 1974). It is not unusual 
for rats to be more resistant to some chemical compounds to which mice are 
more susceptible (Evans et al., 1982). The tumour promoting activity of 
shikimate may therefore exist in parallel with a full carcinogenic effect due 
to another compound, which as suggested above might be a nitrosamide.
The role of querqetin is less clear. I t  was able to induce bone marrow 
hypoplasia in the rat as seen in Chapter Two but its  carcinogenic properties 
were not so clearly defined. However quercetin is a mutagen, a catalyst of 
N-nitrosation and in one report, a carcinogen. I t  is possible to speculate 
that the one report o f i t s  carcinogen icity (Pamukcu et a l., 1980b) was due 
to the presence of nitrosatable entities as contaminants in the feed and the 
presence o f quercetin thus catalysed a process which would in its  absence 
probably be reversed by normal detoxification mechanisms. Animal feed may 
occasionally be comtaminated by nitrosamines and n itrosatab le e n t it ie s  
(Silverman and Adams, 1983). I t  would appear that this one report by Pamukcu 
et a l. (1980b) is an aberrant report complicated by extenuating factors, one 
of which has been speculated upon above. I t  remains however to determine i f  
quercetin might be an in itiator. It  is a line of inquiry worth pursuing i f  
possible by combining i t  with shikimate in an initiation-promotion assay. 
That quercetin may act as a promoter in conjunction with other chemicals is 
illu s tra ted  by the resu lts obtained for ornithine decarboxylase when 
quercetin was combined with cyclophosphamide (Tables 2.4 and 2.7), saccharin 
(Table 2.5), lithoch o la te  (Table 2.6)-, BBN (Table 2.8) and MNNG (Table 2.9). 
These further buttress the need for a future line of inquiry to re-examine 
quercetin 's ro le  in bracken-induced ca rc in ogen es is  e s p e c ia l ly  i t s  
interaction with other constituents of bracken.
The acute or sub-acute toxic effects of bracken include the 
avitaminosis which in ruminants causes cerebrocortical necrosis and in 
monogastrics causes ataxia. As was investigated in Chapter Three, the latter 
may be caused in part by the cyanogenic glycoside prunasin, which upon 
hydrolysis yields cyanide, and nitrite, which was found in very high levels 
in the urine of bracken-fed rats. Nitrite so detected may arise from the 
reduction of.nitrate which is very commonly found in vegetables and plants, 
or may arise as a breakdown product of N-nitroso compounds. In addition, the 
gut flora may produce nitrite as part of its metabolic profile. Any of these 
three possibilities may occur with the bracken-intoxicated animals and is 
clearly deserving of further investigation. But here again, a case could be 
made for the role of the nitrite from the breakdown of the nitrosamide as a 
co-contributor to the development of ataxic, neuropathy in bracken- 
intoxicated monogastrics. The unifying nature of the nitrosamide hypothesis 
thus spans the acute syndromes both in monogastrics and ruminants and the 
chronic (carcinogenic) syndrome in all species tested so far.. In any case 
however, it is unlikely that there will be one single agent directly
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responsible alone for a l l  the .signs seen in bracken poisoning. Bracken 
tox icity remains a m ultifactorial phenomenon and much remains to be done to 
identify the role of each of these factors in the overall context of bracken 
tox ic ity .
In summary the main conclusions of this study are:
1. Shikimate is  a tumour promoter based on the enhanced a c t iv ity  of 
orn ith ine decarboxylase in the tissues o f rats fed shikimate. i t  is  also 
capable of inducing bone marrow aplasia in rats.
2. Cyanide and n i t r i t e  are a d d it io n a l contributory factors to the 
development of ataxia in bracken-intoxicated rats.
3. N-nitrosation was identified as a potentially significant process in the 
mediation o f bracken-induced carcinogenesis, and i t  was suggested that 
though the id en tity  o f any n itroso compounds was not determined, the 
ch aracteris tics  o f bracken-induced carcinogenesis, suggested that 
nitrosamide as the lik e ly  cause.
4. Although quercetin was shown to be capable o f inducing bone marrow 
aplasia , it s  in it ia t in g , promoting or carcinogenic ro le  could not be 
conclusively determined. Quercetin, however, is a catalyst of N-nitrosation 
which suggests that quercetin may play a more c r i t ic a l  ro le  in bracken- 
induced carcinogenesis than hitherto thought.
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APPENDIX III Structures of Some Toxicologically Significant Constitu 
Bracken e n t s  o f
Kaempferol
Glucose
Isoquercitrin
q J-Rutinose 
OH 0
Rutin
HO A — -o 0-CH 2
ch3
OH OH hoN  
Hesperidin
OH
Q 0
OH
HO
CH20H
OH 0
OH
HO
C H:
OH 0 
Naringin
OCH:
OH OH
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COOH
HO Y  OH 
OH
Shikimic acid
H
0-C-C6H5
CN
Prunasin
CH=CHCOOH
K ^ 0 C H 3
OH
Ferulic acid
,CH=CHCOOH
HO. 
HO-// W
HO
HO
COOCH 
HCOH
HO- // \\ COOCH
HO
HO
HCOH
H° - y x
HO
HCO- 
COOCH2
HOOCCH 
HCCOOH 
Fumaric acid
2HC—  c h 2 
1 i OH 3C~ C^  jyj ^  C~0
H H
Pterolactam
A Tannin ( corilagin )
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R.
R-
R'
V
Structure Compound R 1 r 2
Pterosin Z -C H ?OH -H
Pterosin I -C H ‘ OCH. -H
1 Pteroside Z -CH,OGlu -H
(3R) pterosin D -CHyOH -OH
(JS) pteroside S -CH^OGiu -OH
(2S) pterosin A -CH-O H -H
(2S) pterosin K -CPCCI -H
II (ZR, JR) pterosin U -C HjO H -OH
(25) pteroside A -CH^OGIu -H
(2R) pterosin B •c h o h -H
(2R) pterosin F •CH^CI -H
(2R) pterosin E -COOH -H
(♦) pterosin O -C H -O C H , -H
(2R) palnrutyl pterosin B -CH^Opalmityl -H
III Acetyl-A -dehydropterosin B -CHyOAc .. -H
(2R) pteroside 8 -CI-COGlu • -H
(2S, )S) pterosin C -CH-O H -OH
(2S, JS) pterosin J -CHyCI -OH
(2S, JS) •cetylpteraein C -CHyOAc -OH
(2R, JR) pteroside C -CHjOGtu -OH
IV (2S) pterosin G - c h 2o h CH-Q H
H
Pterosin N - c h 2o h
OH
V (ZS) pterosin P -C H O H -H
■ (2S) pteroside P -C H 2OGlu , ‘ H
Aquilide A
(Ptaquiloside)
glucose
Appendix IV
A verage Calculated Com position o f Normal Rodent D iet
Moisture (% ) 8.8
Ether ex tract (% ) 3.5
Crude protein (% ) 21.5
Crude fib re (% ) 2.7
Gross energy (MJ/kg) 17.2
D igestib le energy (MJ/kg) 14.2
Lysine (% ) 1 .1
Methionine (% ) 0.39
Calcium  (% ) 0.90
Phosphorus (% ) 0.80
Vitam in A (i.u./kg) 11,000
Vitam in D (i.u./kg) 1,200
a-tocophenoi (i.u./kg) 24
Vitam in K (mg/kg) 10
R iboflav in  (mg/kg) 7
Pyridoxine (mg/kg) added 1
Panthothenic acid (mg/kg) 17
N icotin ic  acid (mg/kg) 80
Choline chloride (mg/kg) added 450
Cyanocobalam in (m cg/kg) 15
Manganese (mg/kg) 65
Iron (mg/kg) 100
Iodine (mg/kg) 0.5
Copper (mg/kg) 20
Zinc (mg/kg) 40
Cobalt (mg/kg) 1
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